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Abbreviations
D, distal
d, dorsal
di, diencephalon
dOS, dorsal optic stalk
e, eye
FB, forebrain
FP, floor plate
HB, hindbrain
HPE, holoprosencephaly
hyp, hypothalamus
l, lens
lp, lens placode
lv, lens vesicle
MB, midbrain
mes, mesencephalon
MHB, midbrain hindbrain boundary
N, nasal
Nc, notochord
nr, neural retina
OC, optic chiasm
oc, optic cup
OD, optic disc
ON, optic nerve
os, optic stalk
ot, optic tectum
ov, optic vesicle
P, proximal
r, retina
RGC, retinal ganglion cells
rh, rhombencephalon
RPE, retina pigmented epithelium
SE, surface ectoderm
T, temporal
tel, telencephalon
v, ventral
vF, ventral forebrain
vOS, ventral optic stalk
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Resumen
Los miembros de la familia Hedgehog (Hh) activan una vía de señalización conser-
vada evolutivamente que es crucial para el desarrollo embrionario y para la homeostasis de 
tejidos adultos. La activación de la via es iniciada por la unión del ligando Hh a la proteína 
de transmembrana Patched (Ptch). Sin embargo estudios recientes han demostrado que otras 
proteínas asociadas a membrana, como Cdon (cell-adhesion-molecule-related/down-regulat-
ed by oncogenes), pueden unir proteínas Hh y cooperar en la activación de su vía. La inacti-
vación génica de Cdon en ratones provoca holoprosencefalia (HPE), una anomalía congénita 
que se caracteriza por defectos en la línea media del cerebro anterior asociada frecuentemente 
a mutaciones en genes de la via de Hh y por lo tanto a una reducción de su señalización. Este 
fenotipo es consistente con la función propuesta de Cdon como co-receptor de Hh. La HPE 
se asocia de manera frecuente a defectos oculares, pero la relevancia de Cdon en el desarrollo 
del ojo de los vertebrados ha sido poco analizada. 
En este estudio hemos investigado la expresión y funcion de Cdon durante la for-
mación temprana del ojo. Los fenotipos obtenidos después de la pérdida de función de Cdon 
fueron analizados con marcadores específicos de tejido usando técnicas de inmunohistoqui-
mica o de hibridación in situ (ISH). Tanto en embriones de pollo como de pez cebra, Cdon 
se expresa de manera temprana en el mesodermo axial, en la retina neural presuntiva y en 
áreas dorsales del cerebro anterior entre otras regiones. Estudios previos han demostrado que 
la pérdida de la función de Hh provoca un fenotipo de ciclopia con una reducción del tallo 
óptico. La reducción de la actividad de Cdon produjo en cambio una marcada expansión del 
tallo óptico  interfiriendo con el cierre de la fisura óptica (defecto conocido como coloboma). 
La expansion del tallo óptico observada en los morfantes de Cdon fue rescatada al tratar los 
embriones con un inhibidor de la vía de Hh, indicando que la función de Cdon es dependiente 
de Hh. Estudios recientes en Drosophila han sugerido que los homólogos de Cdon (Ihog/
Boi), además de actuar como co-receptores de Hh, pueden también limitar la difusión de Hh 
y por lo tanto interferir con la expresión de genes diana de Hh.
Estas evidencias dan lugar a considerar que Cdon pueda actuar de una manera simi-
lar durante la regionalización del ojo. Para evaluar esta posibilidad, hemos diseñado MO 
específicos para interferir el procesamiento normal del pre-ARNm de Cdon. De esta manera 
removimos de manera eficiente los exones que codifican para los dominios de unión a Shh o 
Ptch en Cdon. Estos estudios demuestran que la interacción entre Cdon-Ptch no parece tener 
relevancia en el fenotipo de los embriones mientras que la interacción entre Cdon-Shh produ-
jo coloboma y aumento del tallo óptico. Adicionalmente, la expresión ectópica de Cdon en 
el tubo neural de pollo induce una acumulación de Shh en las células que expresan Cdon en 
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regiones cercanas a la placa del suelo (células productoras de Shh). Por lo tanto proponemos 
que Cdon expresado en la retina protege a la copa óptica de la actividad de Shh mediante 
su unión previniendo de esta forma su difusión. Esto conlleva a considerar que Cdon puede 
actuar como un modulador negativo de la vía de Hh en vertebrados.
De manera complementaria estudiamos otras moléculas que podrían estar actuando 
durante el desarrollo en respuesta a la función de Cdon. La expresión de Fgf8 se encuentra 
expandida en morfantes de Cdon y se conoce que la vía de FGF es necesaria para la especifi-
cación de la retina (Pittack et al., 1997; Hyer et al., 1998) así como también de determinar 
el eje naso-temporal de la retina (Picker and Brand, 2005). La señalización de FGF también 
controla el cierre de la fisura óptica (Chen et al., 2012). Acorde a estas evidencias, rescatamos 
el fenotipo de los morfantes de Cdon mediante el bloqueo farmacológico de la vía de FGF 
o usando un fondo mutante para Fgf8 en pez cebra (ace). Esto sugiere que la vía de señal-
ización de FGF media la función de Cdon.
El conocimiento sobre cómo se regula la expresión de Cdon durante el desarrollo es 
limitado. Por esa razón comenzamos un análisis de secuencias con posible actividad regu-
ladora en el locus de Cdon. Aislamos nueve secuencias que se encuentran conservadas en la 
evolución y comprobamos su actividad enhancer. Algunas de las secuencias parecen fun-
cionar como enhancer. En particular, una de las secuencias (chr18:42,516,402-42,517,273) 
dirige la expresión de GFP de manera específica en el telencéfalo de embriones de pez cebra.
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Introducción
Durante el desarrollo embrionario es fundamental la acción de vías específicas de 
señalización. Estas vías se activan mediante la unión de morfogenos a sus receptores en cé-
lulas receptoras, lo que desencadena una  cascada intracelular específicas de transducción. 
Diferentes moléculas de señalización han sido identificadas, las cuales se pueden agrupar 
en diferentes familias génicas. Entre las más relevantes y mejores estudiadas se encuentran: 
wingless (Wnt), transforming growth factor-β (TGF-β), fibroblast growth factor (FGF) y 
Hedgehog (Hh). 
Los receptores  de la vía de señalización de Hh son Patched (Pcth) (Hooper and 
Scott, 1989; Nakano et al., 1989; Stone et al., 1996; Fuse et al., 1999) y la proteína asociada 
Smoothened (Smo) (Alcedo et al., 1996; van den Heuvel and Ingham, 1996). Además en los 
últimos años se han identificado otras proteínas capaces de unirse a los ligandos Hh. Una 
de estas moléculas es Cdon (cell adhesion molecule-related, down-regulated by oncogenes 
(también referido como Cdo)) (Kang et al., 1997; Cole and Krauss, 2003). 
Cdon ha sido caracterizada como una glicoproteína de superficie celular que pertenece 
al subgrupo de la superfamilia de inmunoglobulinas (Ig) de moléculas de adhesión celular 
(CAMs). Cdon es capaz de unir de manera directa los ligandos Hh (Okada et al., 2006; Ten-
zen et al., 2006; Yao et al., 2006; McLellan et al., 2008) y de interaccionar con Ptch1 (Bae et 
al., 2011). Ratones deficientes en Cdon presentan HPE, una malformación congénita carac-
terizada por defectos faciales y malformaciones en el cerebro y en los ojos (Cole and Krauss, 
2003; Zhang et al., 2006; Zhang et al., 2009; Hong and Krauss, 2012).
El paso inicial en la formación de los ojos es la especificación de un dominio coher-
ente de células en la placa neural anterior durante la gastrulación (Chuang and Raymond, 
2002). El campo de ojo es definido por la expresión de una serie de factores de transcripción 
altamente conservados. Una vez definido el campo de ojo, sus células neuroepiteliales evagi-
nan para formar las vesículas ópticas. Estás vesículas  se regionalizan a lo largo de eje naso-
temporal en dos dominios laterales (retina) y dos mediales (tallo óptico). El establecimiento 
de esta regionalización es definida por la expresión de los factores de transcripción Pax2 y 
Pax6 (Schwarz et al., 2000).
Después de la evaginación de las vesículas ópticas, comienza la formación de la copa 
óptica. Durante este proceso, se vuelve evidente una estructura ventral que es la fisura óptica. 
Esta estructura es transitoria y es necesario que se cierre durante una ventana de tiempo es-
pecífica para que el ojo se desarrolle y funcione de manera normal. 
La vía de señalización de Hh actúa en diferentes pasos del desarrollo ocular. Estos 
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incluyen la separación de las vesículas ópticas, el establecimiento del eje próximo distal 
(Ekker et al., 1995; Macdonald et al., 1995; Chiang et al., 1996), el desarrollo de la fisura 
óptica (Dakubo et al., 2003; Morcillo et al., 2006), la neurogénesis de la retina (Neumann and 
Nuesslein-Volhard, 2000), la diferenciación del epitelio pigmentario de la retina (RPE) (Per-
ron et al., 2003), la proliferación y supervivencia celular (Neumann and Nuesslein-Volhard, 
2000; Zhang and Yang, 2001), la organización laminar de la retina (Wang et al., 2002) y 
la guía de los axones de las células ganglionares de la retina (RGC) (Trousse et al., 2001; 
Sanchez-Camacho and Bovolenta, 2008).
A pesar de estas observaciones, se conoce poco sobre los mecanismos moleculares a 
través de los cuales Cdon participa en el desarrollo del ojo y si su función está relacionada a 
la vía de señalización de Hh.  Por esto decidimos explorar el papel de Cdon durante el desar-
rollo del ojo con el objetivo de entender su función y relación con la vía de señalización de 
Hh.
25
Resumen en Castellano
Objetivos
La función de Cdon durante el desarrollo ha sido determinada a partir de es-
tudios con ratones mutantes de Cdon. En estos estudios sin embargo la función es-
pecífica de Cdon en el ojo ha sido pobremente explorada. Para completar esta falta 
de conocimiento abordamos los siguientes objetivos específicos en embriones de pez 
cebra y de pollo como sistemas modelo.
El objetivo principal de este estudio fue explorar el rol de Cdon durante el 
desarrollo del ojo a través de los siguientes objetivos específicos. 
•	 Determinar si el patrón de expresión embrionaria de Cdon esta conservado en 
vertebrados.
•	 Analizar si Cdon tiene un papel en el desarrollo del ojo de los vertebrados.
•	 Determinar si la función de Cdon en el ojo es dependiente de Hh.
•	 Caracterizar los elementos regulatorios que dirigen la expresión de Cdon du-
rante el desarrollo del cerebro anterior.
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Resultados
En embriones de pez cebra Cdon se expresa en la vesícula de Kuppfer y en la línea 
media en estadios de gastrulación. Posteriormente Cdon se expresó abundantemente en la 
vesícula y la copa óptica y en otras regiones del embrión como por ejemplo el tubo neural 
dorsal. La expresión de Cdon en pollo es similar. Un análisis más detallado de la expresión 
de Cdon en estadios tempranos del desarrollo del ojo develó que el patrón de expresión es 
similar en pez cebra, pollo y ratón.
Para entender el papel funcional de Cdon en el desarrollo, interferimos con su expre-
sión inyectando (pez cebra) o electroporando (pollo) oligonucleótidos anti-sentido (morfoli-
nos, MO). En pez cebra observamos que los embriones deficientes en Cdon poseen defectos 
oculares en la región ventral de la retina. Los embriones morfantes para Cdon presentaron un 
fallo en el cierre de la fisura óptica como también una expansión del tallo óptico y de la retina 
ventral. Mediante trasplante de células en pez cebra y electroporación de un MO específico 
en embriones de pollo, determinamos que la expresión de Cdon en la retina es la responsable 
de mantener bajos los niveles de Pax2 en esta región. 
 El fenotipo observado en los morfantes de Cdon es consistente con una ganancia de 
la vía de señalización de Hh. Para comprobar si la vía de Hh se encuentra expandida en los 
embriones con bajos niveles de Cdon, bloqueamos la vía mediante la administración de ci-
clopamina. Este tratamiento produjo un rescate del fenotipo de tallo óptico en los morfantes 
de Cdon. Además, mediante el uso de MO que interfieren el procesamiento del pre-mARN 
de Cdon fuimos capaces de observar que el dominio de unión a Shh en Cdon es importante 
para su función durante el desarrollo del ojo. La electroporación de Cdon en el tubo neural de 
pollo sugirió  que Cdon es capaz de unirse a Shh de manera eficiente.
Como FGF es una vía que participa en la ventralización de la retina, hipotetizamos 
que la vía de FGF media la actividad de  Cdon. Para comprobar este hipótesis  bloqueamos la 
vía de FGF mediante la administración de SU5402. Este tratamiento produjo un rescate del 
fenotipo de tallo óptico en los morfantes de Cdon. Debido a que FGF es necesario para una 
correcta regionalización de los dominios nasal y temporal de la retina, decidimos analizar 
este proceso en los morfantes de Cdon. Como era de esperar, el dominio nasal de la retina se 
presentó expandido respecto al dominio temporal en morfantes de Cdon. Inyectando el MO 
de Cdon en mutantes para Fgf8 (ace) pudimos observar un rescate del fenotipo.
Existe poca información sobre cómo se regula la expresión  de Cdon durante el desar-
rollo. Por lo tanto, decidimos intentar identificar las regiones reguladoras del gen que pudie-
sen funcionar  como enhancer durante el desarrollo. La comparación de secuencias y marcas 
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epigenéticas (H3K27AC) permitieron identificar varios posibles enhancers. Determinamos 
nueve secuencias no-codificantes del locus de Cdon que se encuentran evolutivamente con-
servadas. Clonamos estas secuencias en un vector reportero e inyectamos embriones de pez 
cebra. Hasta el momento logramos determinar una secuencia de 872pb (chr18:42,516,402-
42,517,273) que dirige la expresión de una proteína reportera al telencéfalo de los embriones 
de pez cebra. 
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Conclusiones
1. El patrón de expresión embrionario de Cdon en el ojo se encuentra conservado 
desde teleósteos hasta mamíferos.
2. Una reducción de los niveles de expresión de Cdon produce defectos oculares 
ventrales y una expansión del tallo óptico en pez cebra.
3. La expresión de Cdon en la retina presuntiva previene la expansión del tallo óptico. 
4. La vía de señalización de Hh media el aumento del tallo óptico observado en los 
morfantes de Cdon. 
5. La interacción de Cdon con Shh (pero no con Ptc) es crítica para establecer el 
límite entre tallo óptico y retina neural. 
6. Células neuroepiteliales que expresan Cdon de manera ectópica, pueden acumular 
la proteína Shh secretada desde la placa del suelo.
7. Cdon actúa como un modulador negativo de la vía de señalización de Hh durante 
la formación del ojo.
8. La vía de señalización de FGF media el aumento del dominio de tallo óptico en los 
morfantes de Cdon. 
9. Cdon es requerido para un correcto establecimiento de los dominios nasal y tem-
poral de la retina. 
10. Fgf8 media la actividad de Cdon durante el establecimiento de los dominios nasal 
y temporal de la retina.
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Discusión
Shh liberado desde la línea media es crítico para establecer y mantener la regional-
ización próximo-distal del ojo, controlando el balance de la expresión de Pax2/Pax6 en el 
tallo óptico y en la retina respectivamente (Macdonald et al., 1995; Take-uchi et al., 2003). 
En este trabajo, proponemos que Cdon, una molécula capaz de unir Shh, puede actuar como 
un modulador negativo de la vía de señalización de Hh en vertebrados. Cdon expresado en 
la retina protege a la copa óptica de la actividad de Shh mediante la unión directa de Shh, 
controlando así su difusión. Esta función es necesaria para establecer una correcta region-
alización próximo-distal del ojo. En ausencia de Cdon, el gradiente de Shh se expandiría a 
regiones más distales generando un aumento del dominio de tallo óptico a expensas de la 
retina.
Trabajos previos han propuesto que Cdon funciona como un modulador positivo de la 
vía de señalización de Hh (Tenzen et al., 2006; Zhang et al., 2006). Sin embargo, de manera 
inesperada, el fenotipo de ojo que presentan los morfantes de Cdon es compatible con una 
ganancia de función de la vía de señalización de Hh. Los morfantes de Cdon se caracterizan 
principalmente por un aumento de dominios proximales como es el tallo óptico, evidenciado 
por el aumento de expresión del marcador Pax2.1 y defectos ventrales en el ojo. Este mismo 
fenotipo se ha observado en el pez teleósteo Astyanax mexicanus (Yamamoto et al., 2004), en 
morfantes de Zic2a (Sanek et al., 2009) y en el mutante de Ptc1 Blowout (Lee et al., 2008). 
En todos estos modelos, la vía de señalización de Hh se encuentra claramente aumentada. 
En nuestro modelo, pudimos revertir la expansión del dominio de tallo óptico mediante el 
bloqueo de la vía de Hh. Así como también pudimos obtener un fenotipo similar al de los 
morfantes de Cdon removiendo el dominio de unión a Shh en Cdon. Los resultados obteni-
dos sugieren que la vía de señalización de Hh se encuentra sobreactivada en los morfantes 
de Cdon.
A pesar de la posible implicación de la vía de Hh en el fenotipo de los morfantes de 
Cdon, no fuimos capaces de observar una modificación en los patrones de expresión de dis-
tintos genes cuya expresión varía en respuesta a la actividad de la via de Hh como es Ptc1. 
Creemos que esto podría deberse a la baja sensibilidad de la técnica empleada (ISH) así como 
a la capacidad que tiene la vía para amortiguar cambios en alguno de sus componentes. 
Los morfantes de Cdon poseen un fenotipo ocular similar a los mutantes de Cdon en 
ratón (Zhang et al., 2009), sin embargo la expresión de marcadores moleculares se encuen-
tra modificada de manera distinta en ambos modelos. Creemos que esta diferencia se debe 
a que los defectos observados en mutantes de Cdon dependen de defectos de línea media, 
que en cambio no parecen estar presentes en  los morfantes de Cdon. De esta manera, con 
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las evidencias obtenidas mediante la reducción de los niveles de Cdon específicamente en el 
ojo, creemos que el fenotipo que presentan los morfantes de Cdon se debe a la ausencia de 
expresión de Cdon en el ojo.
La ausencia de Cdon interfiere con la vía de señalización de Hh, pero parece afectar 
también a la vía de señalización de FGF. Las vías de señalización de FGF y de Hh actúan en 
un ciclo de retroalimentación positiva en diferentes contextos durante el desarrollo (Brewster 
et al., 2000), incluyendo el desarrollo del cerebro anterior (Bertrand and Dahmane, 2006). 
Una posible explicación al aumento de señalización de ambas vías en los morfantes de Cdon 
es que exista una heterocronía entre el comienzo de la expresión de Shh y Fgf8 en los mor-
fantes. Este efecto ha sido observado en el pez teleósteo Astyanax mexicanus (Pottin et al., 
2011). Es importante para futuros estudios analizar la posible implicación de Cdon en la vía 
de señalización de FGF como así también en otras vías de señalización como puede ser la de 
Wnt.
En la actualidad, existe poca información sobre cómo funciona la regulación del gen 
Cdon. Se sabe que Cdon y Boc parecen estar regulados de manera negativa por la vía de 
señalización de Hh en estadios tempranos del desarrollo embrionario (Tenzen et al., 2006; 
Bergeron et al., 2011). Hemos podido identificar una secuencia no codificante, localizada 
dentro del primer intrón de Cdon que tiene actividad enhancer. Sin embargo, mediante la ob-
servación de secuencias conservadas y del perfil correspondiente a distintas modificaciones 
de histonas, creemos que el primer intrón de Cdon contiene varias secuencias que podrían 
dirigir la expresión del gen durante el desarrollo. 
En conclusión, en este trabajo proponemos que Cdon es capaz de actuar como un 
modulador negativo de la vía de señalización de Hh en vertebrados, al menos en el contexto 
del desarrollo del ojo. La descripción de esta nueva función, ayudará a entender mejor la 
complejidad y dinámica de la vía de señalización de Hh.
ABSTRACT
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Hedgehog (Hh) family members activate an evolutionarily conserved signal transduc-
tion pathway crucial for embryonic development and adult tissue homeostasis. Pathway acti-
vation is initiated by binding of the ligand to the seven-pass transmembrane protein Patched 
(Ptch). Recent studies have however demonstrated that other membrane-associated proteins, 
including Cdon (cell-adhesion-molecule-related/down-regulated by oncogenes), can bind Hh 
proteins and cooperate in Hh mediated signaling. Consistent with the proposed function as 
a Hh co-receptor, genetic inactivation of Cdon in mice causes holoprocencephaly (HPE), a 
human congenital anomaly defined by forebrain midline defects that is often caused by muta-
tions in genes of the Hh pathway. HPE is also frequently associated to multiple eye defects 
but whether Cdon is relevant to vertebrate eye development is still poorly explored.
To address this issue, we investigated Cdon distribution during zebrafish and chick 
early eye formation and analyzed the consequences of interfering with its expression. In both 
chick and zebrafish embryos, Cdon was expressed in the early axial mesoderm and then in 
the presumptive neural retina and dorsal forebrain, among other regions. Previous studies 
have demonstrated that loss of Hh function causes a cyclopic phenotype with reduction of 
the optic stalks. In contrast, knock-down of Cdon activity caused a marked expansion of the 
expression of optic stalk markers, such as Pax2 and Fgf8 and interfered with optic fissure 
closure (a defect known as coloboma). The expansion of the optic stalk observed in Cdon 
morphants was counteracted by treating the embryos with a drug that block Hh signaling, 
indicating that Cdon function is Hh dependent. Recent studies in Drosophila have suggested 
that Cdon homologs (Ihog/Boi), besides acting as Hh co-receptors, can limit Hh diffusion 
thereby interfering with the expression of Hh target genes. This raises the possibility that 
Cdon may act in a similar way during optic vesicle patterning. To address this possibility, 
we have designed splice-site specific MO, which efficiently removed Shh or Ptch interacting 
domains in the Cdon protein. Notably, abrogation of Cdon-Ptch interaction seemed to have 
no effect whereas lack of Cdon–Shh binding caused coloboma and Pax2 up-regulation. In 
agreement with this result, the ectopic expression of Cdon in the chick ventral neural tube 
induces a detectable Shh accumulation in the Cdon expressing cells closer to the floor plate 
(the Shh producing cells). We thus propose that Cdon expressed in the retina acts to protect 
the optic cup from Shh activity by binding and preventing Shh diffusion. This implies that 
Cdon can act as a negative modulator of Hh signaling in vertebrates. 
Looking for molecules that downstream of Cdon might be implicated in the Cdon 
morphant phenotype, we focused on Fgf8, the expression of which is highly expanded in the 
morphants. FGF signaling controls the specification of the neural retina (Pittack et al., 1997; 
Hyer et al., 1998) and determinates the naso-temporal axis of the eye vesicle (Picker and 
Brand, 2005). FGF signaling also controls the closure of the optic fissure (Chen et al., 2012). 
In agreement with these evidences, we rescued the Cdon morphant phenotype with pharma-
cological blockade of FGF pathways or in an Fgf8 mutant background (ace). This suggests 
that FGF signaling operates downstream of Cdon function.
At the moment there is little information about the precise regulation of Cdon. To un-
derstand how Cdon expression is regulated during forebrain development we have undertak-
en an analysis of its regulatory elements. We isolated nine evolutionary conserved sequences 
on the Cdon locus and tested their enhancer activity. Some of the isolated sequences appear 
to have enhancer activity. One of the sequences (chr18:42,516,402-42,517,273) drives the 
expression of a reporter gene (GFP) specifically in the telencephalon of zebrafish embryos.
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Developmental biology and secreted signaling molecules
Developmental biology seeks to explain how the structure of organisms changes with 
time.  During the course of embryonic development as the fertilized egg develops into a com-
plete organism, multiple developmental processes take place. The formation of the body plan 
and the organization of the different tissues and organs in multicellular organisms are central 
areas of research in developmental biology. This level of organization highly depends on an 
efficient communication among cells.
The capacity of a cell to secrete a product, which preceded multicellularity in the history 
of life, acquired a new meaning once multicellularity arose: it provided a mean for establish-
ing differences across an otherwise undifferentiated population of cells (Fig.1) (Newman 
and Müller, 2006). Signaling between cells is an essential condition for the development of 
multicellular organisms and to control regional specification, proliferation, differentiation, 
morphogenesis as well as growth. These processes and the action of specific signaling path-
ways are triggered by the secretion of molecules that interact with receptor proteins in the 
receiving cells activating specific intracellular transduction cascades. These specific cascades 
finally control the activity of sets of transcription factors, which then dictate the fate of the 
responding cells by orchestrating the genomic response to extracellular information.  
Different secreted signaling molecules that modulate intracellular signaling cascades and 
transcription control have been identified during the last decades. These molecules can be 
grouped in distinct gene families. The wingless (Wnt), transforming growth factor-β (TGF-β), 
fibroblast growth factor (FGF) and Hedgehog (Hh) families are among the largest and best 
studied molecular systems.
Fig. 1. Schematic model of pattern formation. The yellow circles depict an undifferentiated epithelium. A) The cells 
at the bottom begin to differentiate (purple perimeter). B) Terminally differentiated cells (purple circles) start secreting 
a morphogen (purple gradient in C). C) The concentration of the morphogen is higher near the source and decreases 
with the distance. If cells can respond to threshold concentration of this molecule, for instance, above a particular 
concentration, they adopt a specific fate (red triangles). D) Responding cells that are exposed to lower concentrations 
of the morphogen can adopt a different fate (green stars). Thus, the gradient confers positional information to the cells. 
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Members of the Wnt family are secreted ligands that regulate numerous developmental 
pathways (Cadigan and Peifer, 2009; van Amerongen and Nusse, 2009). Wnts bind to mem-
bers of the family of Frizzled receptors, activating a canonical signaling pathway that targets 
members of the LEF/TCF transcription factor family. These transcription factors control gene 
expression programs that regulate cell fate and morphogenesis (van Amerongen and Nusse, 
2009). Wnts also activate the so-called non-canonical pathways, which regulate planar cell 
polarity by stimulating cytoskeletal reorganization (Veeman et al., 2003).
TGFβ superfamily ligands bind to a type II receptor, which recruits and phosphorylates 
a type I receptor. The type I receptor then phosphorylates receptor-regulated SMADs (R-
SMADs), which thereafter bind the coSMAD SMAD4. R-SMAD/coSMAD complexes accu-
mulate in the nucleus, where they act as transcription factors and participate in the regulation 
of target gene expression (Shi and Massague, 2003). Bone morphogenetic proteins (BMPs) 
and nodal belong to this family. 
FGF ligands, with the exception of the intracellular FGFs (iFGFs, FGF11-14), signal 
through a family of tyrosine kinase receptors, the FGF receptors (FGFRs). FGF ligands bind 
the extracellular domain of the FGFRs in combination with heparan sulphate to form a 2:2:2 
FGF:FGFR:heparan complex. The dimerization of the receptor results in the transphosphory-
lation of specific intracellular tyrosine residues. This triggers the activation of different cyto-
plasmic signal transduction pathways: the Ras/ERK pathway, which is associated with pro-
liferation and differentiation; the Akt pathway, associated with cell survival and the protein 
kinase C (PKC) pathway, involved in cell morphology and migration (Schlessinger, 2000; 
Dailey et al., 2005; Mohammadi et al., 2005).
Although the members of these families activate particular intracellular cascades, there 
are many cross-regulations among the different components and integration among these 
and other signaling pathways, forming a complex network. This super organization adds 
complexity to the system and makes it harder to understand specific functional mechanisms. 
Nevertheless, the fact that signaling pathways are used repeatedly during development and 
in the maintenance, regeneration and pathology of the adult organism makes the research of 
their function, mechanisms and interactions interesting and useful.
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Hedgehog signaling
The Hedgehog family is one of the most studied families of signaling molecules. This 
family was identified over thirty years ago in a Drosophila screen aimed at identifying larval 
patterning genes (Nusslein-Volhard and Wieschaus, 1980). From this discovery, many studies 
have elucidated that Hh signaling plays a central role in the development of most metazoans. 
This signaling pathway is redeployed multiple times in the life of an organism with a myriad 
of specific effects, and is involved in several human pathologies, including many types of 
cancers. A schema of the main molecular players of this family is depicted in figure 2.
Hh proteins are secreted signaling molecules that mediate essential tissue-patterning 
events during embryonic development and regulate homeostasis and regeneration of adult 
tissues. There are three Hh homologs in amniote vertebrates: Sonic (Shh), Desert (Dhh) and 
Indian hedgehog (Ihh) (Fietz et al., 1994) and there are five members in teleost: Shh, Dhh, 
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Fig. 2. Schematic representation of the Hedgehog signaling pathway. Components identified in vertebrates and 
Drosophila are shown. A Hh producing cell is depicted in A and Hh receiving cells are represented in B-D. A) The Hh 
precursor is processed and released into the extracellular space. B) HhN is titrated by Ihog and Boi at the cell mem-
brane. C) HhN is received at the cell membrane of a responding cell. HhN binding to Patched releases Smoothened 
(Smo) inhibition activating the Gli2/3 transcription factors (ON-state). D) If HhN does not reach the surface of the 
receiving cell, Smo remains inactive (OFF-state). The Hh pathway components and their relationships are detailed in 
the text. (Modified from Ingham, 2012.).
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Tiggy winkle hedgehog (Twhh), Echidna hedgehog (Ehh), and Qiqihar hedgehog (Qhh). 
These proteins differ primarily in their tissue distribution (Ingham and McMahon, 2001; 
Ingham et al., 2011). Shh is the only member expressed in the vertebrate central nervous sys-
tem (CNS), mostly in ventral structures such as the floor plate or the ventral forebrain. Shh 
catched the attention of many researchers because it acts as a morphogenetic factor in many 
organizing centers also outside the CNS, including the zone of polarizing activity in the limb 
bud, the notochord and prechordal plate within the axial mesoderm (Echelard et al., 1993; 
Krauss et al., 1993; Riddle et al., 1993; Chang et al., 1994; Roelink et al., 1994).
The release and reception of Hh ligands have been extensively studied in flies and mice, 
and have revealed that nearly all core components of the pathways are highly conserved (Go-
odrich et al., 1996; Ryan and Chiang, 2012). In Hh producing cells, Hh is autocleaved (HhN) 
and covalently modified by the attachment of cholesterol to its C terminus, which confers 
Hh high affinity for the plasma membrane (Beachy et al., 1997). Hh is also palmitoylated 
at its N terminus. Once Hh undergoes the intracellular processes described above (HhN-p), 
Dispatched (Disp), a 12-pass transmembrane protein belonging to the RND family of bacte-
rial transporters, contributes to the final release of HhN-p (Burke et al., 1999; Kawakami et 
al., 2002; Ma et al., 2002; Tukachinsky et al., 2012). In vertebrates, the release of ShhN-p is 
also mediated by metalloprotease ectodomain shedding, resulting in a soluble and biologi-
cally active morphogen (Dierker et al., 2009). Multiple sheddases (ADAM10, ADAM12 and 
ADAM17) can contribute to ShhN-p release (Ohlig et al., 2011).
In the receiving cells, the core components that mediate Hh signal response are Patched 
(Ptch), a 12-pass integral membrane protein (Hooper and Scott, 1989; Nakano et al., 1989; 
Stone et al., 1996; Fuse et al., 1999), and Smoothened (Smo), a seven-pass integral mem-
brane protein with homology with G-protein-coupled receptors (Alcedo et al., 1996; van den 
Heuvel and Ingham, 1996). Ptch inhibits the activity of Smo, a positive regulator of Hedge-
hog pathway activation (Denef et al., 2000; Taipale et al., 2002). Binding of Hh ligands to 
Ptch relieve this inhibition (Ingham et al., 1991; Chen and Struhl, 1996; Marigo et al., 1996), 
triggering a cascade of intracellular events that lead to the accumulation of the gene-activat-
ing form of the Gli transcription factors (Gli1-Gli3). 
Gli2 and Gli3 (but not Gli1) are bifunctional transcription factors: their full-length forms 
act as transcriptional activators, but they can be converted into lower-molecular-weight tran-
scriptional repressors. This conversion is achieved by the phosphorylation of a series of mo-
tifs within the carboxy-terminal domain of the protein. These motifs are sequentially phos-
phorylated by the protein kinase A (PKA), the glycogen synthase kinase 3 β (GSK3 β), and 
the casein kinase I (CKI) to generate recognition signals for the F-box protein β-transducin 
repeat-containing protein (β-TrCP). This phosphorilation catalyzes the ubiquitylation of the 
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carboxyl terminus, targeting it for degradation by the proteasome to yield the truncated ami-
no-terminal repressor forms, Gli2/3R (Ingham et al., 2011). Gli2/3R bind to Hh target genes 
to repress their transcription. A notable difference between the vertebrate and non-vertebrate 
Hh signaling is that in vertebrates the primary cilium is involved in the signal transduction. 
Primary cilia are microtubule-based, non-motile structures that project from the surface of 
nearly all vertebrate cells but that are conspicuously absent in most Drosophila and inverte-
brate cell types (Goetz and Anderson, 2010). Gli2/3 proteins appear to shuttle up and down 
the primary cilium in association with the Cos/Kif7 and SuFu proteins; in the absence of 
Smo activity, this association seems to promote their processing at the base of the primary 
cilium. Binding of HhN to Ptch promotes Smo release which is then transported to the tip 
of the primary cilium. The process requires Kif3a and β-arrestin activity. At the tip of the 
cilium, Smo promotes the dissociation of the Gli2/3-Cos-SuFu complex (Tukachinsky et al., 
2010), releasing the full-length highly labile forms of the Gli proteins. These translocate to 
the nucleus and activate transcription of target genes, such as Ptch1, which attenuates the 
signal, Gli1, which amplifies the signal, and genes encoding the cell cycle regulators, Myc, 
cyclin D, and E.
      After being released, Hh ligands diffuse in the extracellular space with a complex mecha-
nism. Heparan sulfate proteoglycans (HSPG) play a crucial role shaping the gradient of the 
HhN-P form of Hh in the extracellular space, modulating its long-range diffusion (The et al., 
1999; Bornemann et al., 2004; Ayers et al., 2010; Ayers et al., 2012). Furthermore, membrane 
extensions resembling filopodia (cytonemes) appears to mediated the delivery of Hh (Rojas-
Rios et al., 2012). 
The dynamics of the establishment of Hh gradient is very complex. As with other mor-
phogenes, the temporal adaptation of cells to a Shh gradient integrates the concentration 
and duration of the signal to control differential gene expression (Pages and Kerridge, 2000; 
Dessaud et al., 2007). Additionally different cells may harbor different sets of Hh pathway 
components thereby responding to Hh ligands in different manners. Therefore Hh signaling 
seems to implicate the function of a variety of distinct molecular modules which are context-
dependent.  In addition to canonical pathway components, in the last few years a number of 
transmembrane or peripheral membrane proteins have been identified, which bind to Hh, 
playing a key role in shaping the extracellular gradient and thus finally modulating its sig-
naling. In vertebrates, these Hh-binding proteins are: Cdon (cell adhesion molecule-related, 
down-regulated by oncogenes, (also noted as Cdo) (Kang et al., 1997; Cole and Krauss, 
2003), Boc (Brother of Cdo) (Kang et al., 2002), Gas1 (Allen et al., 2007; Martinelli and Fan, 
2007), Hh interacting protein (Hhip) (Chuang and McMahon, 1999) , LRP2 (McCarthy et al., 
2002; Christ et al., 2012) and Scube2 (Hollway et al., 2006; Creanga et al., 2012).
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Fig. 3. Schematic diagram representing the structure and the interactions of Cdon and Boc. A) Comparison of 
the domain organization of Boc and Cdon with that of their Drosophila homologs, Boi and Ihog. Numbers indicate 
the position of each Fibronectin type III (FnIII) domain. B) Cdon forms homo- and heteromeric complexes binding to 
Neogenin and N-cadherin and interacts with the cytosolic proteins JLP, Abl, Bnip-2. Within the Shh signaling pathways 
Cdon (B) and Boc (C) associate with Shh, Dhh, Ihh and Ptch1. (D) Boc and Cdon can interact in cis and bind Gas1. 
Arrows and dotted lines depict protein interactions. Ig, Immunoglobulin domain. FnIII, Fibronectin type III domain.
Cdon and Boc transmembrane proteins
Cdon and Boc proteins have been characterized as cell surface glycoproteins belonging to 
a subgroup of the Immunoglobulin (Ig) superfamily of cell adhesion molecules (CAMs), that 
also includes L1 and the Robo axon-guidance receptors (Kamiguchi and Lemmon, 2000). 
Their ectodomain respectively contains five and four Ig-like domains, followed by three fi-
bronectin III (FNIII) repeats (Fn1-3), a single trans-membrane domain and a divergent intra-
cellular region of variable length (Fig. 3A), which may account for some of their functional 
differences (Kang et al., 2002; Mulieri et al., 2002). The Drosophila homologues Ihog and 
Boi present four Ig domains and only two FNIII repeats (Fn1, 2) (Kang et al., 2002; Yao et al., 
2006). Sequence analysis reveals that Cdon/Boc Fn2 and Fn3 are respectively homologous to 
the Fn1 and Fn2 of Ihog/Boi (Kang et al., 2002). Notably, Cdon homologs have been found 
in the genomes of the sponge Amphimedon queenslandica and the placazoan Trichoplax ad-
haerens, where no other Hh signaling homologs components have been found. Thus Cdon 
predates the origins of the Hh pathway (Srivastava et al., 2010; Ingham et al., 2011).
Cdon and Boc form homophilic and heterophilic complexes in cis by interaction of the 
ecto- and intracellular domains (Kang et al., 2002) (Fig. 3B–D). Cdon has been shown to 
interact also with Neogenin (Kang et al., 2004), an Ig/FnIII CAM family member that acts as 
receptor for the axon guidance cue Netrin. Furthermore, during myoblast and neuronal dif-
ferentiation, cis-interaction of N-Cadherin with Fn1 (Kang et al., 2003; Lu and Krauss, 2010) 
promotes binding of the Cdon intracellular domain to Bnip-2 and JLP, two proteins that func-
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tion as scaffolds for small GTPases and p38 pathway components, respectively (Takaesu et 
al., 2006; Kang et al., 2008; Oh et al., 2009).
Notably Cdon/Boc and Ihog/Boi bind members of the Hh family with high-affinity, but, 
notably, with different and evolutionary non-conserved modes (Okada et al., 2006; Tenzen 
et al., 2006; Yao et al., 2006; McLellan et al., 2008). Biochemical, biophysical, and X-ray 
structural studies demonstrated that Shh-Cdon interaction is calcium dependent and involves 
a previously unappreciated binuclear calcium-binding site on ShhN (McLellan et al., 2008) 
and the Cdon/Boc Fn3 domain (Tenzen et al., 2006; Yao et al., 2006; McLellan et al., 2008) 
This interaction mode is conserved for all vertebrate Hh proteins (Kavran et al., 2010). In 
addition, CDON also binds PTCH1 through Fn1-2 domains (Bae et al., 2011). 
Cdon deficient mice display different forms of holoprosencephaly (HPE) with strain-
specific severity. HPE has been defined as the failure of the most anterior portion of the CNS 
(forebrain) to divide into two distinct cerebral hemispheres during development [see (Gongal 
et al., 2011)]. In Cdon mutants, HPE goes from mild facial defects to brain and eye malfor-
mations (Cole and Krauss, 2003; Zhang et al., 2006; Zhang et al., 2009; Hong and Krauss, 
2012) suggesting that Cdon has some spatio-temporal unique function during embryonic 
development. Nevertheless, defects of Cdon−/− embryos aggravate in absence of Boc. Indeed, 
Cdon−/−;Boc−/− animals display severe brain defects and strong craniofacial anomalies, associ-
ated to reduced expression of Shh and its target genes (Zhang et al., 2011). 
In Drosophila, loss of either Boi or Ihog function has no consequences in the develop-
ment of the imaginal discs that are normally strongly dependent on Hh signaling. Their com-
bined inactivation however recapitulates hh loss of function, suggesting that Boi and Ihog 
play a redundant function in Hh pathway activation (Camp et al., 2010; Zheng et al., 2010). 
Notably, Ihog and Boi have been also related to the formation of the Hh gradient, as both 
proteins can sequester and titrate the amount of ligand available for Ptch binding, thus limit-
ing long-range signaling (Hartman et al., 2010; Yan et al., 2010; Zheng et al., 2010; Bilioni et 
al., 2012). One proposed model is that Ihog has biphasic activity, so that low Ihog expression 
favors Hh–Ptch interaction and hence enhanced signal transduction to the nucleus, whereas 
increased Ihog expression partially titrates Hh from binding to Ptch, reducing the level of sig-
naling. The corollary is that Ihog expression is downregulated in target cells, transducing the 
highest level of Hh signaling (Yan et al., 2010). Whether Cdon and/or Boc work in a similar 
manner in vertebrates is still unknown. 
In vertebrates, Boc, Gas1 as well as Cdon play overlapping and essential roles during 
early Hh-dependent patterning of the mammalian ventral neural tube and further contribute 
the specification of different neural progenitors (Allen et al., 2011). Only embryos deficient 
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in the three genes die before birth and are characterized by a phenotype similar to that in Shh 
null embryos, with severe HPE (Allen et al., 2011; Izzi et al., 2011). This overlapping activity 
does not seem to be entirely conserved in zebrafish, where loss of Boc function, that charac-
terizes the umleitung (uml) mutant, is sufficient to cause defects in patterning of the ventral 
neural tube, somites and upper jaw. Mechanistically, Boc seems to be required to maximize 
the response of cells exposed to high Hh concentrations; in its absence, cells no longer ex-
press genes that are normally activated by high Hh levels (Bergeron et al., 2011).
In addition, Boc, but not Cdon, has been implicated in Shh-induced axon guidance. In-
activation of either Smo or Boc in mouse commissural neurons disrupts the trajectory of the 
axons at the ipsilateral edge of the floor plate, indicating that signaling through both of these 
molecules is necessary to attract pre-crossing axons to the midline (Charron et al., 2003; 
Okada et al., 2006).
Mutations in CDON, as in mouse, have been associated with human HPE (Bae et al., 
2011). However, besides HPE, alterations in Shh signaling cause other severe pathologi-
cal conditions including Carpenter, Ellis-van Creveld, Smith-Lemli-Opitzl and Pallister-Hall 
Diseases, Greig Cephalopolysyndactyly or the Gorlin syndrome (Cohen, 2010). Cdon does 
not seem to be involved, at least so far, in those anomalies.
Search for possible implications of Cdon and Boc in these conditions is thus a necessary 
step toward the understanding of the possible medical implication of these molecules. The 
development of the ventral forebrain and the retina is controlled by similar molecular mecha-
nisms. This suggests that Cdon and Boc genes may be possible candidates for inborn ocular 
malformations. 
Eye Development
The vertebrate embryonic brain is composed by three main structures arranged along the 
anterior-posterior axis: the forebrain, the midbrain and the hindbrain. The forebrain arises 
from the anterior-most neuroectoderm during gastrulation, and by the end of somitogenesis 
it comprises the dorsally positioned telencephalon, the eyes, the ventrally positioned hypo-
thalamus, and the more caudally located diencephalon (Fig. 4). This general organization of 
the forebrain is conserved in all vertebrates (Wilson and Houart, 2004). Eye formation begins 
during gastrulation, with the emergence of a group of cells, the eye field, located centrally in 
the developing forebrain (Adelmann, 1929). 
The eye undergoes many complex morphological changes that are somewhat difficult to 
visualize in three dimensions. The main axes used to refer to the morphology of the eye are 
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Fig. 4. Organization of the forebrain in embryonic zebrafish. A) The cartoon depicts a frontal view of the forebrain 
and the relationship between the eyes and the brain. Abbreviations: cf, choroid fissure; hy, hypothalamus; l, lens; nr, 
neural retina; os, optic stalk; t, telencephalon. Adapted from Wilson and Houart, 2004. B) The picture represents an eye 
at the optic cup stage connected by the optic stalk. The axes are depicted below the eye. Abbreviations: d, dorsal; D, 
distal; N, nasal (anterior); P, proximal (medial); T, temporal (posterior); v, ventral.
depicted in Figure 4b.
The initial step in eye formation is the specification of a coherent domain of cells in the 
anterior neural plate during gastrulation (Chuang and Raymond, 2002). The eye field is de-
fined by the overlapping expression of highly conserved transcription factors. Once the eye 
field is established, its neuroepithelial cells evaginate to form the optic vesicles (Fig.5A). 
The optic vesicles become then patterned along the proximo-distal (P-D) axis in two lateral 
(retina) and two medial domains (optic stalk). The optic stalk connects the optic vesicle to the 
forebrain and finally differentiates generating the glial cells of the optic nerve.  The establish-
ment of the early P-D patterning of the optic vesicles is defined by the expression of the ho-
meobox transcription factors Pax2 and Pax6 (Schwarz et al., 2000). Normally, Pax6 expres-
sion is restricted to the developing retina and retina pigmented epithelium (RPE), whereas 
Pax2 expression is localized to the optic stalk. 
At the optic vesicle stage, the presumptive retinal cells come in close contact with the sur-
face ectoderm. This event is followed by a complex series of reciprocal inductive interactions 
that result in the formation of the lens placode from the surface ectoderm and the invagination 
of the underlying optic vesicle to form a bilayered optic cup (Fig. 5B) (Graw, 2010). Studies 
using embryonic stem cell aggregates have recently suggested that optic cup morphogen-
esis depends on intrinsic self-organizing programs, involving stepwise and domain-specific 
regulation of local epithelial properties (Eiraku et al., 2011; Nakano et al., 2012). Optic cup 
formation occurs approximately between 14 and 24 hpf in the zebrafish (Schmitt and Dowl-
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Fig. 5. Summary of early eye development in vertebrates. In panels A–C, presumptive or differentiated eye tissues 
are color-coded: blue, lens; yellow, neural retina; light blue, non-neural surface ectoderm, orange, ventral optic stalk; 
red, dorsal optic stalk; pink, ventral forebrain; green, retinal pigmented epithelium (RPE), violet; retinal ganglion 
cell projections. Dotted line depicts the optic stalk regression. A)  Formation of the optic vesicle is initiated by an 
evagination (indicated by asterisk) of the presumptive forebrain region. The optic vesicle region is divided into ventral 
optic stalk (VOS), neural retina (NR), retinal pigmented epithelium (RPE) and dorsal optic stalk (DOS). Growth of 
the optic vesicle culminates with the close contact between the lens placode (LP) and the presumptive neural retina 
(NR). B) During optic cup formation, the optic vesicle invaginates and the lens vesicle (LV) and neural retina (NR) are 
established. C) Later on, the axons from the ganglion cells of the retina (RGC) meet at the posterior pole of the eye, 
exit through the optic disc (OD) and travel along to the optic nerve. Abbreviations: dOS, dorsal optic stalk; l, lens; lp, 
lens placode; NR, neural retina; OD, optic disc; ON, optic nerve; RGC, retinal ganglion cells; RPE, retina pigmented 
epithelium; SE, surface ectoderm; vF, ventral forebrain; vOS, ventral optic stalk.
ing, 1994). During this process a transient structure becomes evident in the ventral region, 
this is the optic fissure (or choroid fissure). The fissure forms as the walls of the invaginating 
optic vesicle deepen. The optic fissure extends from the most distal point of the optic cup to 
the proximal end of the optic stalk (Fig. 4A). 
Eye morphogenesis in zebrafish is similar to that observed in other vertebrates (Li et al., 
2000). However, during evagination in most vertebrates, the optic vesicle form a hollow 
structure, whereas in zebrafish the developing optic vesicles are solid masses with the optic 
stalk positioned anteriorly (Kimmel et al., 1995). Subsequent rotation of the optic vesicle 
brings the optic stalk into a ventral position (Schmitt and Dowling, 1994).  Despite these dif-
ferences, the regulatory components required for eye field specification and morphogenesis 
are conserved among species (Chuang and Raymond, 2002).
Once the optic cup is formed around 25hpf, a wave of differentiation begins in the ventro-
nasal retina, adjacent to the choroid fissure, and spread with a fan-shape to the dorsal and 
temporal retina (Masai et al., 2000; Neumann and Nuesslein-Volhard, 2000). The pool of 
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retinal progenitor cells expands by proliferation and will subsequently generate six types 
of neurons: the retinal ganglion cells (RGCs), amacrine cells, horizontal cells, bipolar cells, 
and the light-sensitive photoreceptor cells (rods and cones) and other type of glial cells, the 
Müller cells
RGCs are the first cells to differentiate cells in the retina, (Schmitt and Dowling, 1996). 
Following their differentiation, RGCs extend their axons into the optic fiber layer at the in-
ner surface of the retina, where they grow in a highly direct, radial fashion towards their 
exit point, the optic disc (Fig. 5C). The optic disc is a structure that constitutes the interface 
between the optic stalk and the retina, and develops from the edges of the optic fissure. The 
axons enter the optic nerves and extend towards the ventral midline of the diencephalon, 
where the two nerves meet and form the optic chiasm, a major brain commissure. In species 
with eyes located laterally, all axons cross the midline at the chiasm, whereas in animals with 
binocular vision a proportion of axons originating in the temporal region of the retina do 
not cross but instead project ipsilaterally. Irrespective of their behaviour at the chiasm, RGC 
axons then project dorsally within the optic tracts towards their targets in the midbrain and 
thalamus (see Erskine and Herrera, 2007).
Mesodermal and neural crest cells also contribute to eye development. Periocular mes-
enchyme cells (POMs) enter the eye through the optic fissure beginning around 24 hpf in 
zebrafish (Soules and Link, 2005). These cells will ultimately contribute to specialize ante-
rior structures, including the corneal endothelium and the hyaloid vasculature (Soules and 
Link, 2005; Langenberg et al., 2008). As the POM that give rise to the retinal vasculature 
enter and the RGC axons leave the eye, the fissure lips fuse to close permanently. A timely 
closure of the optic fissure is critical for normal eye development and function. Failure of 
the choroid fissure to close leads to the formation of a permanent opening of the ventral 
retina, a condition known as coloboma (Fig. 6 A-C). The term coloboma refers to a family 
of common ocular pathologies that can cause severe visual impairment  (Chang et al., 2006). 
The closure of the optic fissure requieres two events: the edges of the optic fissure need to 
become closely apposed, and the apposed edges need to express at the right time a number of 
molecular components appropriate to bring about the fusion. Disruption of either one or both 
of these processes may result in the formation of a coloboma. Colobomata can have variable 
appearances, since any of the structures traversed by the optic fissure, from the iris to the op-
tic nerve, in the infero-nasal quadrant of the eye can be involved: iris, ciliary body, zonules, 
choroid, retina, and optic nerve.
Besides coloboma, other congenital eye disorders, including anophthalmia, microphthal-
mia, aniridia, and retinal dysplasia arise from an abnormal eye development. Thus, under-
standing the mechanisms that lead to initial specification and differentiation of ocular tissues 
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is critical to identify the causes of these defects.
Hedgehog signaling in eye development
Ingham and McMahon reported in a review in 2001 that Hh signaling plays a role in more 
than 20 different tissues, organs and/or cell types. Since then the number of the described Hh 
functions has still considerably increased.
Hh signaling acts at different steps of eye development. These include, the separation 
of the optic vesicles, the establishment of the P-D axis (Ekker et al., 1995; Macdonald et 
al., 1995; Chiang et al., 1996), the development of the optic fissure (Dakubo et al., 2003; 
Morcillo et al., 2006), retinal neurogenesis (Neumann and Nuesslein-Volhard, 2000), RPE 
differentiation (Perron et al., 2003), cell proliferation and survival (Neumann and Nuesslein-
Volhard, 2000; Zhang and Yang, 2001), the laminar organization of the retina (Wang et al., 
2002), and the guidance of the RGCs axons (Trousse et al., 2001; Sanchez-Camacho and 
Bovolenta, 2008).
During early eye development Shh secreted from the midline in the ventral forebrain, 
plays a primary role in the splitting of the eye field in two individual optic vesicles and in 
establishing the P-D axis of the optic vesicle. Gain of function experiments led to the con-
clusion that Shh promotes the expression of Pax2, a marker of the optic stalk, and represses 
the expression of Pax6, a retinal marker, forming a precise boundary between the retina and 
the optic stalk. Basically, Shh signaling induces the specification of optic stalk tissue at the 
expense of the neural retina (Macdonald et al., 1995; Schwarz et al., 2000). Hh signaling 
maintains the optic stalk-retina interface also by regulating Vax gene activity (Take-uchi et 
Fig. 6. Developmental defects associated to the failure of the optic fissure closure. A) View of the forebrain struc-
tures; the grid indicate the plane of view of the cartoons in B and C. B) In a normal eye the optic fissure allows for 
passage of the hyaloid artery (red) into the eye and of the retinal axons (violet) out of the eye into the optic nerve. C) 
In a colobomatous eye, the temporal and nasal borders of the fissure fail to fuse, and at least in teleosts, the axons of 
the RGC project aberrantly around the eye or leave the retina from ectopic locations. Additionally, the hyaloid artery 
does not form properly.
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al., 2003). 
Hh signaling interacts with various signaling pathways to produce distinct temporal and 
spatial outcomes. Particularly, the interaction between the Hh and FGF pathways is essential 
for correct forebrain patterning (Bertrand and Dahmane, 2006). The specific mechanism of 
this interaction however is still unclear. Similar to Hh signaling, FGF pathway reiterative 
contributes to eye development. Studies in zebrafish, frog and chicken have suggested that 
FGF signaling regulates the initial formation of the eye field (Moore et al., 2004), the speci-
fication of the neural retina (Pittack et al., 1997; Hyer et al., 1998), the determination of the 
naso-temporal axis of the eye vesicle (Picker and Brand, 2005), and the differentiation of 
retinal neurons (Guillemot and Cepko, 1992; Martinez-Morales et al., 2005). FGF signaling 
also controls the closure of the optic fissure by modulating retinal progenitor proliferation. 
Inactivation of Fgfr1 and Fgfr2 in the developing optic cup results in coloboma in mice 
(Chen et al., 2012).
Following the formation of the optic cup, retinal neurogenesis is initiated and RGCs 
begin to express Shh which spreads the wave of RGC differentiation throughout the retina 
(Neumann and Nuesslein-Volhard, 2000). 
So far it has been difficult to develop a picture of the precise interactions between Hh 
proteins and their cell surface partners, of their molecular consequences and of how these 
interactions control eye development in vertebrates. 
A few observations highlight the importance of the different Hh surface components in 
eye development. Loss of Xhip (Hhip Xenopus homolog) results in the suppression of lens 
placode formation (Cornesse et al., 2005). In LRP2/megalin mutant mice the eyes are small 
or absent although with little penetrance (Willnow et al., 1996). Gas1 mutant mice display 
microphthalmia and present an ectopic overgrowth of neural retina in the ventral region of 
the RPE (Lee et al., 2001). Scube2 is expressed in the neuroepithelium of the optic cup 
in mice but its function there is unknown (Xavier and Cobourne, 2011). Boc mutant mice 
present defects at later stages of eye development. After optic cup formation, RGC axons 
are guided by Shh (Trousse et al., 2001; Sanchez-Camacho and Bovolenta, 2008) and Boc 
contributes to the specification of the RGCs that project ipsilaterally (Sanchez-Arrones et al., 
2013, submitted) and possible contributes also to the  segregation of ipsilateral axons at the 
optic chiasm (Fabre et al., 2010). Despite these observations, little is known about the mo-
lecular mechanisms with which these Hh interacting proteins contribute to eye development 
and whether their function is related to Hh signaling transduction. 
Cdon mutant mice present eye defects which have been analyzed only superficially 
(Zhang et al., 2009). We therefore decided to explore Cdon function during eye development 
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using the zebrafish and chick as model systems. We also investigated Cdon relationship with 
Hh signalling.
OBJECTIVES
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Objectives
 The function of Cdon during development has been determined in studies that have 
used Cdon mutant mice. However, the specific function of Cdon in eye development has 
been poorly explored. To fill this gap we addressed its function using the zebrafish and chick 
embryos as model systems addressing the following specific aims.
• To determine if the embryonic expression pattern of Cdon is conserved in vertebrates.
• To investigate if Cdon is important for vertebrate eye development. 
• To understand if Cdon function in the eye is Hh dependent.
• To characterize the regulatory elements that drive Cdon expression in the developing 
forebrain.

MATERIALS	&	METHODS
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Maintenance of fishes and fish lines.
Adult zebrafish (Danio Rerio) were maintained at 28.5°C on a 14-hour light/10-hour 
dark cycle. Embryos (AB/Tu or WIK strains) were raised at 28°C and staged according to 
hours post-fertilization (hpf) and morphology (Kimmel et al., 1995). The following transgenic 
lines were used:  Tg(βactin:HRAS-EGFP) vu119, ath5::gap-gfp and Tg(-8.0 cldnb:lynGFP)
zf106    (Cooper et al., 2005; Haas and Gilmour, 2006; Zolessi et al., 2006). For convenience, 
these transgenic lines are referred to in the remainder of the text as βactin::mGFP, ath5::GFP 
and cldnb::GFP. The Fgf8a mutant acerebellar (ace) line was also used (Reifers et al., 1998). 
Zebrafish developmental stages from 1 cell stage to 72hpf are illustrated in figure 7 according 
to the classification of Kimmel et al., 1995. The morphogenetic steps of zebrafish eye for-
mation are summarized in Table I. Embryos were growth in E3 medium (NaCl, 5mM; KCl, 
0.17mM; CaCl, 0.33mM; MgSO4, 0.33mM, 10-5% Methylene Blue (Nuesslein-Volhard and 
Dahm, 2002)).
Table I. Summary of the features that characterize the morphogenesis of the eye and other zebrafish forebrain 
structures.
Optic primordium Other features
6-7 somites Solid mass of cells continuous with neural keel
Ventricle in neural keel appears. 
Mesenchyme migration ventral to 
optic primordia.
8-9 somites
Anterior border flattened. Posterior border rounded.  
Separation from neural keel commences along posterlor 
edge.
Constriction arises within forebrain.
10-12 somites Ventral bending. Early eye rotation. Optic lumen and optic stalk formation
Initial flexure of forebrain. Mesen-
chyme migration dorsal and ventral 
to optic primordia.
14-30 somites
(14-15 somites) Invagination from center. Posterior 
groove formation. Pseudostratified retina. Stretching of 
cubodial layer of pigmented epithelium
Lens placode formation. Aggrega-
tion of mesenchyme on proximal 
surface of eye.
(18-20 somites) Choroid flssure formation. Pigmented 
epithelium reduced to flat elongated layer with little 
proliferation.
Radial arrangement of lens cells.
>30 somites (24hpf)
Increase in retinal cell density optic stalk atrophy. 
Pigmented epithelium pigmentation begins. Late eye 
rotation begins
Mayor eye vasculature formed (e.g. 
hyaloid artery). Lens detached from 
ectoderm.
36hpf
Eye rotation completed. Choroid fissure at ventral pole. 
Posterior groove at dorsal pole. Optic axons exit eye. 
Choroid fissure closing.
Nasal placode anterior to eye.
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Fig7. A series of stages of the development of the zebrafish embryo, Danio (Brachydanio) rerio: from 1 cell stage to 72 
hpf. Adapted from (Kimmel et al., 1995).
Chicken embryos.
For this study we used chicken embryos (Gallus gallus domestica) of the White Leg-
horn breed raised in the Santa Isabel farm (Córdoba, Spain). The embryonic stages used in 
this study according to Hamburguer and Hamilton, 1951 are represented in figure 8 and listed 
in Table II.
Table II. List of the main characteristics of chicken embryo development at 38ºC from stage HH4 to HH14. 
Adapted from (Hamburger and Hamilton, 1992).
Stage Incubation time Main Feature Other features
4 18-19 hs Definitive Streak Maximal length of the primitive streak
5 19-22 hs Head-Process Notochord becomes visible
6 23-25 hs Head-Fold A definitive fold of the blastoderm anterior to the notochord
7 23-26 hs One somite Neural folds in the region of the head
8 26-29 hs Four somites Neural folds at the level of the midbrain
9 29-33 hs Seven somites Primitive optic vesicles are present
10 33-38 hs Ten somites Optic vesicles not constricted at base
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11 40-45 hs Thirteen somites Optic vesicles are constricted at the base
12 45-49 hs Sixteen somites Primary optic vesicles and optic stalk well established
13 48-52 hs Nineteen somites Distinct enlargement of the telencephalon
14 50-53 hs Twenty-two somites Primary optic vesicles begins to invaginate and lens placode is formed
Fig8. A series of developmental stages of the chick em-
bryo, Gallus gallus from HH4 stage to HH14. Adapted 
from (Hamburger and Hamilton, 1992).
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Morpholinos.
In table III are listed the morpholinos used in this study. CdonMO and cCdonMO are 
translation-blocking MOs and spl8MO, spl11MO and spl14MO are splice-blocking MO. The 
ctlMO and cctlMO are standard control MO from Gene Tools.  
Table III. List of morpholinos used in this study.
Name Sequence Modification Specificity
ctlMO CCTCTTACCTCAGTTACAATTTATA 3´- Lissamine -
CdonMO ATAATCTCAGGCCACCGTCCTCCAT 3´- Lissamine Danio Rerio
spl8MO ACTGTATGAACTCTTCTCACCTTGC - Danio Rerio
spl11MO GCAGTAACCTCACCTGGCTCAAGGT - Danio Rerio
spl14MO GACGGTACTTCAGACTCTCACCTTT - Danio Rerio
cctlMO CCTCTTACCTCAGTTACAATTTATA 3´-Carboxyfluorescein -
cCdonMO CCGACTGCATAGCGCCCGGACAGCA 3´-Carboxyfluorescein Gallus gallus
-Injections.
 In pilot experiments, morpholino oligonucleotides were injected at concentrations 
ranging from 50 to 300 uM in water by using a microinjector (FemtoJet, Eppendorf). Injec-
tion/electroporation with the concentrations shown in table IV gave the strongest phenotype 
without evidence of apoptosis. The results presented in this work were obtained using the 
amounts reported in table IV.
Table IV. MO working concentrations.
Name Working concentration
MO-Ctl 160uM-200uM
MO-Cdon 160uM
MO-Spl8 200uM
MO-Spl11 600uM
MO-Spl14 400uM
MO-cCtl 2mM
MO-cCdon 2mM
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-Test.
To confirm sequence specificity, the CdonMO or ctlMO were co-injected into medaka 
fish embryos at one-cell stage with the cRNA (50ng/ul) of a reporter construct (5´cdon-GFP) 
carrying the Cdon 5´ sequence upstream of the GFP sequence. As a control, CdonMO and 
ctlMO were coinjected also with GFP alone. To corroborate the exon removal capacity of 
spl8MO, spl11MO and spl14MO we performed RT-PCR from cDNA of injected embryos 
with the respective MO. The primers used are listed in table V.
Table V. Primers to verify splicing products in spl8MO, spl11MO and spl14MO injected embryos.
Name Sequence
Ex7F TATCCATCCTGCGAGGTTTG
Ex9R GACCTCATACAGGCTGGACG
Ex10F CCAATAAGAATCCCTCCAAAG
Ex12R CCAGCGTAACAGAATCTGAG
Ex13F ACACTCCATCCAGCAATAAC
Ex15R TCCTCCATAAGCACATGACG
Cryostat sections.
Fish, chicken and mouse embryos were fixed by immersion in 4% paraformaldehyde 
(PFA)-phosphate buffer (wt/vol) overnight at 4ºC. Embryos were then washed in phosphate 
buffer saline (PBS), incubated in a 30% sucrose-PBS solution (wt/vol), embedded and frozen 
in a 7.5% gelatin in 15% sucrose solution (wt/vol). Cryostat sections were processed for im-
munohistochemistry (IHC) or for in situ hybridization (ISH).
Immunohistochemistry (IHC).
Cryostat sections or whole embryos were stained by a standard protocol using antibod-
ies against the following antigens: Cdon (1:100, R&D system), Pax6 (1:500, Covance), Pax2 
(1:500, Zymed) and Fluorescein (1:500, Roche). Nuclei were counterstained with Hoecht.
In situ hybridization (ISH).
Chicken embryos were hybridized following the protocol described by Stern (Stern, 
1998). Digoxigenin- or fluorescein-UTP-labelled antisense chicken riboprobes were used to 
detect Pax2 and Cdon. Probes were visualized with NBT/BCIP (dark blue). Cdon chicken 
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probe was kindly provided by Ruth Diez del Corral (NotI/T3  pBSII KS+  probe 1.3Kb).
Zebrafish embryos were hybridized following Standard methods for whole-mount in 
situ hybridization. Digoxigenin-UTP-labelled antisense riboprobes were used to detect the 
markers listed in table VI.  The Boc and Cdon coding sequences were obtained by RT-PCR 
from cDNA of embryos collected at different developmental stages using specific primers 
(Table VII).
Table VI. Probes used in zebrafish
Gene Enzyme Polymerase
Tbx5.1 NotI T3
Vax1 NotI SP6
Fgf8 EcoRV SP6
Gli2 BamHI T7
Gli2b NcoI SP6
Gli3 SpeI T7
Pax2.1 (pax2a) BamH1 T7
Ptc1 BamH1, (o XbaI) T3
Shh HindIII T7
Nkx2.1a KpnI SP6
Nkx2.1b SacII T3
Nkx2.2 BamH1 T7
Foxg1 BamH1 T7
NLZ SalI SP6
Boc BspH1 SP6
Cdon KpnI SP6
FoxD1 speI T7
EfnA5a (347) XbaI T7
VSP SalI T7
Table VII. Boc and Cdon zebrafish probes.
Gene name Primer forward Primer reverse Vector Polymerase Restriction 
Enzyme
Boc CATCGATCCTTTCAATG-CAAG
GGGAGTATTCTT-
GTTTCATCCA
pDrive (Qia-
gen) SP6 BspH1
Cdon CATCGGGAGAATGT-GTTTCG
TCCAC-
CAATATCTTCATTCG
pDrive (Qia-
gen) SP6 KpnI
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mRNA and cDNA synthesis and cloning.
Embryos were injected with different splicing MO´s at 1-2 cells stage and at 24hpf 
were frozen in dry ice. RNA purification was performed with PureLink miniKit (Invitrogen) 
and cDNA was synthesized with iScript cDNA synthesis Kit (Bio-Rad). PCR products were 
run in agarose geles (1%-2%) and visualized with FastRed (Biotium). 
 5´Cdon-GFP construct was obtained by cloning the Cdon 5´ sequence, including 
its initial ATG. 5´Cdon was amplified by PCR with the following primers: zCdon_ClaI_ F: 
ATAATCGATCATCGGGAGAATGTGTTTCG and zCdon_NcoI_R: ATACCATGGCACG-
GAAAGAGAAAGAAAG. The amplified product was cloned upstream of the GFP sequence 
lacking the ATG in a pCS2 vector (pCS2-5´cdon-GFP). Capped RNA (cRNA) was synthe-
sized using pCS2-5´Cdon-GFP template and the mMessage mMachine® SP6 Kit (Ambion). 
The resulting mRNA was purified using RNeasy Mini Kit (Qiagen).
 Deletion of the fibronectin domains of Boc.  Boc-GFP expression vector was kindly 
provided by Ami Okada lab. PCR using Boc-GFP DNA as a template was performed with 
a PfuUltra DNA polymerase (Agilent) and the primers listed in table VIII. Primers were 
phosphorylated at the 5´ end to promote an efficient ligation reaction. The amplified products 
were ligated (Ligase, Roche) overnight at 16ºC and later digested with DpnI enzyme to re-
move the non-amplified DNA. The reaction product was used to transform Escherichia coli 
competent cells and individual colonies were selected to obtain the corresponding truncated 
construct. 
Table VIII. Primers used to perform deletion in Boc-GFP plasmid.
Construct Primer Forward Primer Reverse
BocΔFn1 CCCAAACCTGAGATCGTG GGCTACCTGCTCTTCTCC
BocΔFn2 GTGTCAGGCTACAGTGGC ATGGTCAGGCTGGCTGCT
BocΔFn3 TTTTCTGGTCAGCCTGGA CCTCTCATATACACGGCC
Chicken electroporation.
Fertilized chicken eggs were incubated at 38°C to reach the desired stage. pCAG vec-
tor carrying the coding sequence of mouse Cdon (pCAG-Cdon), was cloned by Francisco Lo-
pez Nieto. For ex ovo electroporation, pCAG-GFP and pCAG-Cdon were co-electroporated 
at 1ug/ul in HH5 chick embryos, then transferred to New culture (Voiculescu et al., 2008). 
The electroporation was performed at 5-6V with 3 pulses of 50ms at an interval of 500ms. 
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The electroporated embryos were selected and then fixed in PFA 4% or ethanol at HH11 for 
further processing. 
For in ovo chicken electroporations, embryos were injected in the optic vesicle with the fol-
lowing electroporation mixture: MO-control or MO-Cdon at 2mM, GFP DNA, 0.2% Fast 
Green and  15% sucrose The electrodes were place to both sides of the head. Electroporation 
conditions were: voltage, 14V; pulses, 5; interval, 300ms and pulse length, 50ms.  After the 
procedure, the embryos were incubated again at 38°C to reach HH14 stage and then fixed in 
PFA 4%.
Cell transfection.
Subconfluent Human Embryonic Kidney 293T (HEK293) cells were transiently co-
transfected with a construct encoding mouse Boc-GFP or pCAG-Cdon using the FuGENE 
HD Transfection Reagent (Roche). After 48 h, cells were visualized by fluorescence in a 
microscope or scraped in lysis buffer for Western Blot analysis. 
Western Blotting.
HEK293 cell or tissue samples (fishes, electroporated chicken eyes, mouse telen-
cephalon) were collected or dissected under a microscope, treated with lysis buffer (150 
mM NaCl , 1% NP40 , 50 mM Tris pH8 ) and denaturalized in protein loading buffer (50 
mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 1% β-mercaptoethanol, 12.5 mM EDTA and 
0.02 % bromophenol blue). Proteins were resolved by 6% SDSP-gels, blotted onto a PVDF 
membrane, blocked for 1 h in 5% milk in PBST, incubated over night at 4ºC with Cdon poly-
clonal antibody (R&D system) in blocking buffer, washed 4 times with PBST, and incubated 
for 1 h with peroxidase-conjugated secondary antibody. Labeled proteins were detected with 
the chemiluminescence reagent ECL (Amersham Biosciences).
Treatment with Hedgehog and FGF inhibitors.
Cyclopamine (Calbiochem) was used to antagonize Hh signaling. Embryos at 90% 
epiboly were incubated in E3 medium containing 1-120 uM Cya (dissolved in DMSO) at 
28ºC. Embryos were fixed in 4% PFA at 28 hpf. Embryos were treated with the drug SU5204 
(Calbiochem) to block FgfR activity (Mohammadi et al., 1997). Embryos at 90% epiboly 
were incubated in E3 medium containing 0.1-5 uM SU5204 (dissolved in DMSO) at 28ºC. 
Embryos were fixed in 4% PFA at 28 hpf. 
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Cell Transplantation Experiments.
Cell transplantation was performed essentially as described (Cavodeassi et al., 2005). 
Embryos injected with CdonMO were used as donors at the midblastula stage and cells were 
transplanted to early gastrula stage hosts (55%–65% epiboly) in the region fated to become 
the eye field (Woo and Fraser, 1995). Manipulated embryos were let develop until 28hp, and 
then either fixed and prepared for ISH or mounted for live imaging.
Imaging.
Sections were analyzed with a DM microscope, whereas whole embryos were ob-
served with a stereomicroscope (Leica Microsystems). Digital images were obtained using 
a Leica DFC500 and the Leica DFC350 FX camera. Some images were acquired with a 
confocal microscope (Zeiss). Images were processed with Photoshop® CS5 or ImageJ (Fiji) 
software. 
Statistical analysis.
Data analyses were performed in the IBM SPSS statistic software. The analysis of the 
collected data was conducted by t-test for two groups and ANOVA for three or more groups. 
Pearson’s chi-squared test (χ2) was performed to test statistically differences between treated 
(MO, drugs, electroporations) and not treated embryos.

RESULTS

69
Results
Embryonic expression pattern of Cdon in zebrafish and chicken.
The Cdon gene in Danio rerio has been poorly studied. There is only one Cdon copy 
in the zebrafish genome (NM_001081628), despite of the whole-genome duplication that 
occurred in the teleost lineage, subsequent to its divergence from mammals (Amores et al., 
1998; Jaillon et al., 2004). Amino-acid sequence alignments indicate that the zebrafish Cdon 
is closely related to the mammalian Cdon and shares similarities with the closely related Boc 
protein (Bergeron et al., 2011).
Partial information about Cdon expression in zebrafish is available at www.zfin.org. 
This information derives from ISH screening approaches (Thisse, 2001; Thisse, 2004). Par-
tial Cdon expression data have been also presented in a study of a zebrafish Boc mutant 
(Bergeron et al., 2011). Lack of a detailed description prompted us to clone the zebrafish 
Cdon and to analyze its expression pattern at different embryonic stages. We also cloned the 
Boc zebrafish homolog to compare their distribution.
Cdon full length was cloned by PCR amplification from a zebrafish cDNA library (see 
Material and Methods). Its expression profile was studied by ISH. Zebrafish embryos were 
fixed at different stages of development and hybridized in situ with the Cdon probe. Cdon 
was first expressed at the onset of gastrulation in the dorsal shield of the embryo (Kupffer´s 
vesicle or Spemann organizer) (Fig. 9A, A´). During gastrulation, Cdon was expressed in the 
ventral axial midline (Fig. 9B, B´), and by the end of gastrulation it localized to the presump-
tive neural crest (Fig. 9C, C´). Notably Cdon and Shh expression overlaped in the axial mid-
line (Fig. 9O-P´). By 1 somite stage, Cdon expression disappeared from the anterior ventral 
midline (Fig. 9D, D´) and became localized to more caudal domains of the dorsal neural tube. 
At 10 somite stage Cdon was still localized to the notochord and the floorplate of the spinal 
cord, in the ventral mesoderm, Kupffer´s vesicle and dorsal neural tube (data not shown). 
In the developing eye, Cdon expression was first detected after the evagination of the optic 
vesicles (Fig. 9E, E´). At 17 somite stage Cdon was highly expressed in the telencephalon 
and optic cups (Fig. 9F, F´). During pharyngula stage (24 hpf), Cdon was detected in the eyes 
and in more dorsal restricted areas of the telencephalon, diencephalon, midbrain, hindbrain 
and spinal cord (Fig. 9G, G´). In addition Cdon was expressed in the otic vesicles, proneph-
ros, somites, pectoral fins, surface ectoderm, optic lens among others (data not shown).
Comparative studies using chick embryos revealed a similar distribution of Cdon 
mRNA. Cdon expression was first detected in the Hensen´s node region during primitive 
streak grooving at HH4 (Fig. 9H). Later on the expression became evident in the presumptive 
neural crest cell at HH5, 6 (Fig. 9I, J) and in somites at HH7 (Fig. 9K). Notably, the expres-
sion in the ventral midline at these stages was very faint in comparison to the signal detected 
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Fig. 9. Cdon expression in zebraf-
ish and chicken embryos. Lateral 
(A-G) and dorsal (A´-G´) views 
of zebrafish embryos and ventral 
(H-L) and lateral (M, N) views 
of chicken embryos hybridized in 
toto with specific probes for Cdon 
at different stages of development. 
Coronal (O-P´) cryostat sections 
of zebrafish embryos hybridized in 
toto. In zebrafish, Cdon expression 
starts at 50% epiboly in the shield 
(A, A´) and by 75-90% epiboly 
Cdon transcripts are detected in the 
ventral midline (B, B´) overlap-
ping with Shh expression (O-P´). 
At tailbud stage Cdon expression 
is also observed in the presump-
tive neural crest (C, C´ arrow). At 
1 somite stage Cdon mRNA local-
izes to the presumptive neural crest, 
the ventral midline and becomes 
evident in the dorsal neural tube 
(D, D´). Later on, at 10-17 somite 
stages, expression is detected in the 
optic vesicles (E´, F´ arrowhead), 
prechordal plate and telencephalon 
(E-F´ arrow). At 24 hpf the expres-
sion becomes restricted to the retina 
and to the dorsal midline of the en-
tire neural tube (G, G´). In chicken 
embryos, Cdon expression is first 
detected in the Hensen´s node at 
HH4 (H), and later on in the pre-
sumptive neural crests (I, J) and 
in the somites (K arrowheads). At 
HH11 Cdon mRNA localizes to the 
optic vesicles and dorsal CNS (L, 
arrow and arrowhead respectively). 
At HH14-HH20 Cdon expression 
is restricted to regions of the tel-
encephalon, dorsal neural tube and 
retina (M-N´). Scale bars: 200 µm. 
In O-P´: d, dorsal; v, ventral and the 
dashed line indicates the midline.
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in zebrafish. At HH11 Cdon mRNA localized to the optic vesicles and the dorsal CNS (Fig. 
9L). At HH14 its expression was also found in the telencephalon (Fig. 9M) and, as in zebraf-
ish, the expression pattern became restricted to specific areas of the eyes and brain among 
others (Fig. 9N and data not shown).
Because of our interest in visual system development, Cdon expression in the eye 
was explored in detail in zebrafish, chicken and mouse embryos. At 10 somite stage, Cdon 
expression in zebrafish was restricted to the presumptive neural retina (Fig. 10A). Later on at 
24-48 hpf the expression became progresively restricted to the ciliary marginal zone (CMZ) 
of the retina (Fig. 10B, C). In chicken, Cdon expression was observed also in the retina at 
HH14. Cdon was expressed in the prospective lens, surface ectoderm and possibly in part of 
the RPE (Fig. 10D). Cdon expression profile in the eyes was evolutionary conserved in mice. 
At E9, Cdon immunostaining localized to the neural retina (Fig. 10E) and later on also to the 
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Fig. 10. Cdon expression in the presumptive retina is conserved among vertebrates. Coronal sections (A, C) and 
lateral view (B) of zebrafish and chicken (D) embryos hybridized with probes specific for Cdon and immunostaining of 
mouse coronal sections with a Cdon specific antibody (E-G). Cdon is expressed in the presumptive retinal domain of 
the optic vesicle in zebrafish at 10 somite stage (A, arrow), Later in development, the expression becomes restricted to 
the ciliary margin zone (CMZ) (B, C). Cdon is expressed in a similar manner in chicken HH14 (D) and in mice at E9 
and E10 (E, F). Later on, the expression becomes restricted to the CMZ at E15 (G). The black dashed lines in A indicate 
the midline and the optic vesicles. The white dashed line in E-G delineates the neural epithelium. Scale bars: 50 µm. 
l, lens; lv, lens vesicle; nr, neural retina; ov, optic vesicle; RPE, retinal pigmented epithelium; SE, surface ectoderm. 
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lens and surface ectoderm (Fig. 10F), to become finally restricted to the CMZ at E15 (Fig. 
10G). Notably, Cdon was accumulated at the basolateral plasma membrane at E10 and E15, 
as described for the Drosophila homolog Ihog (Fig. 10F, G) (Callejo et al., 2011).
 Cdon was expressed also in the optic tectum restricted to its proliferative area: the 
dorsal tectal marginal zone (TMZ) between 48-72 hpf (Fig. 11A, B). It homolog, Boc was 
expressed in the hypothalamus at 48 hpf (Fig. 11D). Boc was not expressed in the eye at early 
stages (Bergeron et al., 2011 and data not shown), but localized to the dorsal and lateral TMZ 
between 48-72 hpf (Fig. 11D, F). Boc expression overlapped also with Cdon in the CMZ at 
72 hpf (Fig. 11C, F). 
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Fig. 11. Distribution of Cdon and Boc in the visual system. Coronal sections of zebrafish embryos at 48 hpf and 72 
hpf hybridized with probes specific for Cdon and Boc. In the brain, Cdon and Boc mRNAs localized to the dorsal and 
lateral tectal marginal zones (A, D) at 48 hpf. Boc is also expressed in hypothalamus (D). At 72 hpf the expression of 
Cdon and Boc become more restricted but are still present in the tectal (B, E) and ciliary marginal zones (C, F). Ar-
rows indicate gene expression in proliferative regions. Scale bars: 50 µm. e, eye; hyp, hypothalamus; l, lens; nr, neural 
retina; ot, optic tectum.
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Knock-down of Cdon function causes alteration in the proximo-distal pat-
terning of the vertebrate eye. 
The conserved localization of Cdon expression in the prospective neural retina at 
early stages of ocular development suggests a possible important developmental role.
To explore this possibility, Cdon expression was knocked down in zebrafish using an 
antisense morpholino oligonucleotide (MO) complementary to the translation start site re-
gion of the Cdon mRNA (CdonMO). The CdonMO was designed and tested for its capability 
to block Cdon translation in a sequence specific manner (CdonMO injected embryos will be 
referred to as Cdon morphants). 
To verify that the selected MO was efficiently interfering with Cdon expression, we 
initially attempted to perform Western Blot and immunostaining of injected embryos using a 
specific antibody generated against mouse Cdon (R&D systems). Unfortunately, the antibody 
did not seem to cross-react with the fish protein (data not shown). Therefore, we used an 
alternative strategy. The CdonMO or a standard control MO (Gene Tools) were co-injected 
into medaka fish embryos with the cRNA of a reporter construct (5´cdon-GFP) carrying the 
zebrafish Cdon 5´ sequence upstream of the GFP sequence (Fig. 12A). Translation of this 
construct was efficiently knocked down by the Cdon specific MO (Fig. 12C) but not by the 
control MO (Fig. 12B). None of the two MOs interfered with the translation of GFP alone 
(Fig. 12D, E). 
CdonMO
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ctlMO CdonMO Fig. 12. Cdon morpholino efficently blocks Cdon translation in a 
sequence specific manner. An antisense morpholino (MO) comple-
mentary to the translation start site region of the Cdon gene (CdonMO) 
was designed. To confirm its specificity, the CdonMO or a standard con-
trol MO (Gene Tools) were co-injected into medaka fish embryos with 
the cRNA of a reporter construct (5´cdon-GFP) carrying the Cdon 5´ 
sequence upstream of the gfp sequence (A). Translation of this construct 
(evident by expression of GFP) was efficiently knocked down by the 
Cdon specific MO (C) (25/25 embryos) but not by the control MO (B) 
(20/20 embryos).  None of the two MO interfered with the translation of 
the GFP alone (D, E) (23/23 embryos). Scale bars: 40 µm.
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These experiments demonstrated that the designed MO can efficiently interfere with 
Cdon expression. Next CdonMO or a control MO were injected in zebrafish embryos at 1-2 
cells stage and their phenotypes were visualized in bright field at different developmental 
stages. The Cdon morphants displayed a clear defect in the ventral region of the retina (Fig. 
13B-C´) when compared to ctlMO injected embryos (Fig. 13A, A´). The ventro-nasal quad-
rant of the retina seemed abnormally folded (Fig. 13B´, C´) and the eyes were characterized 
by the presence of coloboma: the nasal and temporal regions of the retina were not properly 
fused (Fig. 13D, E). About 70% of the CdonMO injected embryos displayed eye anomalies 
(Fig. 13F).
Because previous studies have shown that MOs can have off-target effects mediated 
by the activation of p53, that leads to unspecific apoptosis (Robu et al., 2007), a p53MO was 
coinjected with CdonMO at 1-2 cell stage in zebrafish embryos. This MO did not prevent the 
eye abnormalities observed with CdonMO, indicating that the defects were specific (70% of 
ctlMO CdonMO
l l
vr[ vr[vr[
normal eye abnormal eye
ctlMO CdonMO
Fig. 13. Cdon morphants are characterized by defects in the ventral region of the eye. Bright field and lateral view 
of embryos injected with control (A, A´) or CdonMO (B-C´). CdonMO (B-C´) but not control MO (A, A´) injected 
embryos are characterized by alteration of the ventral retina (vr) at 28 hpf.  The red asterisks indicate the position of the 
choroid fissure in the ventral retina, which is still open at 36 hpf in Cdon morphants (B´, C´) originating a coloboma (E) 
not observed in controls (A´, D). Quantification of the percentage of injected embryos with a control MO or CdonMO 
displaying normal or abnormal eye phenotypes (F). T-tests: control MO versus CdonMO normal phenotype, p < 0.05; 
control MO versus CdonMO abnormal phenotype, p < 0.05. Control MO (n=144), CdonMO (n= 292). l, lens. Scale 
bars: 100 µm.
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the co-injected embryos at 28 hpf, n=52) (data not shown).
To confirm the presence of a coloboma in Cdon morphants, a transgenic membrane-
GFP βactin::mGFP zebrafish line (Cooper et al., 2005) was injected with CdonMO. Indeed, 
in CdonMO injected embryos the choroid fissure was still open at 36 hpf in contrast to what 
observed in controls (Fig. 14A, B). Despite the eye in figure B is smaller than control eye (Fig 
14B), it is important to note that Cdon morphants could display microphtalmia. The choroid 
fissure in the ventral side of the optic cup provides an entry point for newly forming blood 
vessels and the site of exit for the efferent retinal ganglion cell axons. A failure in choroid fis-
sure formation usually affects both processes (See Introduction Fig.6 and Lupo et al., 2011). 
To determine whether the defects caused by Cdon knock-down interfered with the proper for-
mation of the ventral retina, we injected control and CdonMO in different reporter lines. The 
control CdonMO
nr
l
nr
l
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nr
l nrl
C
Fig. 14. Failure of choroid fissure closure in Cdon 
morphants is associated with navigation defects of 
the RGC axons and with abnormal vascularization. 
Zebrafish transgenic reporter lines were injected with 
control MO or CdonMO, fixed at 36 hpf or 48 hpf and 
visualized by fluorescence (A-F) or in bright field (G, 
H). Lateral views of the eye of transgenic βactin::mGFP 
embryos injected with control and CdonMO (A, B). The 
ventral retina remains open in Cdon morphants (32/50 
embryos) (B). Frontal views of the ath5::GFP reporter 
line injected with control MO (C) or CdonMO (D). 
Cdon morphants show defects in the outgrowth of the 
GFP positive RGCs axons that leave the eye cup in ec-
topic locations (54/80) (D white arrow). Lateral views 
of the eye of the endothelial reporter fli1a:EGFP em-
bryos injected with control (E) or CdonMO (F). Cdon 
morphants exhibit a thickening of the vasculature in the 
eye (27/30 embryos) (F white arrow) in comparison to 
controls (E white arrow). The pericardial cavity is also 
expanded in Cdon morphants (G, H red arrows). Scale 
bars: 100 µm. l, lens; nr, neural retina; OC, optic chiasm.
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reporter transgenic line ath5::gap-gfp drives GFP under the control of an enhancer-promoter 
from the Ath5 gene specifically in the RGCs (Zolessi et al., 2006). This strain was injected 
with CdonMO or control MO and visualized at 48 hpf. In control eyes, retinal axons form a 
compact bundle at the optic nerve head and project contralaterally at the midline, where the 
two optic nerves meet to form the optic chiasm (Fig. 14C). In Cdon morphants the axons pro-
jected aberrantly and exited the eye in ectopic locations (Fig. 14D). Note that differentiation 
of the RGCs could be affected in Cdon morphants (Fig14D). In order to visualize the vascu-
lature of the retina, the endothelial cell reporter fli1a::EGFP (Lawson and Weinstein, 2002) 
was injected with CdonMO or control MO. The blood vessels in the eye of Cdon morphants 
were thicker than those of control embryos (Fig. 14E, F). The pericardial membrane was also 
expanded. The enlarged pericardial cavity in Cdon morphants could be caused by a poorly 
developed vascular system, which could result in an accumulation of fluid in the pericardial 
cavity (Fig. 14G, H).
Cdon was expressed also in neural crest cells. Developmental abnormalities in neural 
crest cells may result in ventro-ocular malformations (Ozeki et al., 1999; Lupo et al., 2011). 
To determine whether the neural crest cells presented abnormal characteristics or distribution 
after interference with Cdon expression, we injected the MOs in a sox10::EGFP reporter line 
that label neural crest–derived cells (Hoffman et al., 2007). The results of these experiments 
suggest that the eye phenotype is not associated with neural crest defects (data not shown).
The abnormal eye development displayed by Cdon morphants suggested that the ex-
pression pattern of region specific eye molecular markers could be affected. To addresss this 
issue we analyzed the expression pattern of different genes by ISH. Vax1, Fgf8a and Pax2.1 
are expressed in the optic stalk and contribute to its development (Macdonald et al., 1995; 
Take-uchi et al., 2003; Lupo et al., 2005). Vax1 expression did not seem to be affected in 
Cdon morphants (data not shown).  Fgf8a expression in the brain was mainly detected at the 
midbrain-hindbrain boundary (MHB), dorsal diencephalon, telencephalon and optic stalks 
(Fig. 15A-A´´, E). In Cdon morphant, Fgf8a expression was highly expanded caudally in the 
optic stalk and dorsal telencephalon (Fig. 15B-B´´, E). The boundary between the hypothala-
mus and telencephalon, which was negative for Fgf8 expression, was reduced or absent in 
Cdon morphants (Fig. 15B). Pax2.1 was mainly expressed in the optic stalk, MHB and along 
the hindbrain (Fig. 15C-C´´, F). In Cdon morphants Pax2.1 was also abnormally expanded in 
the optic stalk region (Fig. 15D-D´´, F). In contrast to its expansion in the optic stalk, Pax2.1 
was strikingly reduced in the hindbrain region of many CdonMO injected embryos (Fig. 
15D). In conclusion, Pax2.1 and Fgf8a expression were clearly increased in the optic stalk of 
Cdon morphants, whereas Vax1 expression was unaltered. 
In order to rule out the possibility that the phenotype of Cdon morphants could be 
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Fig. 15. Fgf8a and Pax2.1 expression patterns are altered in Cdon morphants. In situ hybridization analysis of 
the expression pattern of two optic stalk markers, Fgf8a (A-B´´) and Pax2.1 (C-D´´) at 24 hpf and 28 hpf respectively. 
Embryos are shown in lateral (l), dorsal (d) and frontal (f) views. The expression pattern of both genes is schematically 
represented in E and F. In Cdon morphants, Fgf8a expression is expanded caudally and laterally in the optic stalk (B, 
B´´ arrowhead and dotted lines) as well as in the telencephalon (B-B´´) when compared to control embryos (A, A´´ ar-
rowhead and dotted lines) (93/112). Pax2.1 expression is also dorsally expanded in the optic stalk of Cdon morphants 
(D, D´´ brackets) in comparison to controls (A-A´´) (124/140). Scale bars: 100 µm. di, diencephalon; mes, mesencepha-
lon; MHB, midbrain-hindbrain boundary;  os, optic stalk; rh, rhombencephalon; tel, telencephalon.
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an outcome of unspecific effects produced by the CdonMO, Cdon translation was blocked 
with a different MO. MOs can block translation of a mRNA, by modifying the pre-mRNA 
splicing. We designed a MO (spl8MO) that targeted the intron splice junction of exon 8 of 
the Cdon pre-mRNA, thus inducing a frameshift of the corresponding mRNA and leading 
to a truncated translation product. Zebrafish embryos were injected at 1-2 cells stage with 
spl8MO and analyzed at 28 hpf by RT-PCR or ISH (Fig. 16). Spl8MO induced exon 8 skip-
ping in Cdon mRNA as determined by RT-PCR with primers targeting exons 7 and 9 (Fig. 
16A). Note that spl8MO altered just a fraction of Cdon mRNA. ISH showed that Pax2.1 
expression was expanded in spl8MO injected embryos (Fig. 16B-E) as observed with the 
initial CdonMO.
As CdonMO, spl8MO morphants presented coloboma (Fig. 16F, G). Curiously, many 
CdonMO and spl8MO injected embryos showed an ectopic spot of Pax2.1 expression lo-
cated in the dorsal midline (Fig. 16H-J). The position of the spots was variable along the ven-
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Fig. 16. The Cdon splicing spl8MO reproduces the 
phenotype of Cdon morphants. Validation of the splice 
blocking activity of the spl8MO by PCR (A) and Pax2.1 
in situ hybridization of the expression pattern of Pax2.1 
analysis in spl8MO injected embryos or controls (B-E, 
H-J). Bright field images are used to show the presence 
of coloboma in spl8MO morphants (F, G). PCR using 
two primers complementary to regions of exon 7 and 9 of 
Cdon, amplified a region of ~700pb in wild type cDNA. 
An additional band of ~400pb was observed in the cDNA 
of spl8MO morphants. The band corresponds to the ex-
pected product if exon 8 is removed (A). In spl8MO 
injected embryos Pax2.1 expression is expanded in the 
optic stalk and in the retina (35/64) (C, E arrowheads) 
in comparison to controls (B, D). At 48 hpf the choroid 
fissure is closed in control embryos (F) and remains open 
in embryos injected with spl8MO (17/40 embryos) (G). 
Dorsal view of control and CdonMO or spl8MO inject-
ed embryos hybridized with Pax2.1 probe (H-J). Mor-
phants display similar phenotypes. Note the presence of 
an ectopic spot of Pax2.1 in the dorsal midline of some 
Cdon morphants (I, J arrows) in comparison to control 
(H). The asterisks in D-G indicate the position of the op-
tic fissure. Scale bars: 100 µm. lv, lens vesicle; oc, optic 
cup; os, optic stalk. 
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tro-dorsal or anterior-posterior axis (data not 
shown). The coincidence of these phenotypes 
indicates that the defects are specially caused 
by the knock-down of Cdon.
Coloboma phenotypes can arise be-
cause of impaired dorso-ventral patterning of 
the eye (Chang et al., 2006). We thus examined 
the expression of eye polarity markers in Cdon 
knocked down embryos at 28 hpf. The expres-
sion of the ventral retina markers VSP (gift 
of Gaia Gestri), the zinc finger protein NLZ 
that has been associated to coloboma (Brown 
et al., 2009) and Rdh10a (retinol dehydroge-
nase 10a) a retinoic acid pathway gene, were 
enlarged in the eyes of CdonMO injected em-
bryos (Fig. 17B, D, F) in comparison to that 
of control embryos (Fig. 17A, C, E). In con-
trast, Cdon morphants showed no appreciable 
defects in the expression of the dorsal retinal 
marker Tbx5.1 (Fig. 17G, H). These results 
suggest that Cdon is necesary for ventral pat-
terning of the eye.
Defects in neural crest–derived peri-
ocular mesenchymal cells are also associated 
with the failure of the choroid fissure closure 
or in some cases with more severe morphoge-
netic alterations of the ventral optic cup (Mc-
Mahon et al., 2009). Because Cdon was also 
expressed in the presumptive neural crest, we 
asked if the expression of FoxC1a, a neural 
crest–derived periocular mesenchyme (POM) 
marker, was abnormal in Cdon morphants. 
The expression appeared normal in Cdon mor-
phants (Fig. 17I, J). This is in agreement with 
the result obtained with CdonMO injection in 
the sox10::GFP transgenic line. This suggests 
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Fig. 17. Cdon knock down increases the expression 
of ventral ocular markers in the retina. ISH analy-
sis of specific ventral retina markers, VSP, NLZ and 
Raldh10a (A-F) of the dorsal retina marker Tbx5.1 
(G-H) and of the periocular cell marker Foxc1a (I-J). 
Ventral retina markers VSP (B) (28/54 embryos), NLZ 
(D) (39/60 embryos) and Raldh10a (F) (32/44 em-
bryos) are expanded in CdonMO injected embryos in 
comparison to controls (A, C, E). The dorsal retina (H) 
(62 embryos) and periocular cells derived from neural 
crest (J) (24 embryos) do not show evident alterations 
in CdonMO injected embryos in comparison to controls 
(G, I). The dashed line marks the retina and the asterisk 
the position of the optic fissure. Scale bar: 100 µm.
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that the neural crest is not responsible for the eye phenotype of Cdon morphants.
Cdon has been associated to HPE in mice and humans (Cole and Krauss, 2003; Bae 
et al., 2011). Eye coloboma is sometimes a consecuence of midline defects (Gongal et al., 
2011). Because Cdon is expressed in both the eye and the axial midline at neural plate stage 
(See Fig.9 B´, O) lack of Cdon at the midline could interfere with Shh gradient formation, 
leading to an expansion of Pax2 expression. Alternatively, Cdon expression in the optic ves-
icle itself could be necessary for correct proximo-distal patterning of the eye. We decided to 
test the latter possibility. For this purpose, we performed heterochronic transplants in zebraf-
ish (Fig. 18). Cells from GFP-labeled donors at 50% epiboly were injected with CdonMO 
and then transplanted in the region fated to become the eye field in shield stage embryos (Fig. 
18A) (Woo and Fraser, 1995). Transplants that were well localized in the eye field caused 
eye anomalies when compared to the non-transplanted eye (Fig. 18B-E). The defects were 
confirmed by ISH with the VSP marker, which is expanded in Cdon morphants (See Fig. 
non-transplanted transplanted
]vr]vr
donor host host
A
transplanted eye
B C
D E
F G
VSP VSP
Fig. 18.  Transplant experiments indicate 
that Cdon expression in the presumptive 
neural retina prevents optic stalk expan-
sion. A) Embryos at mid-blastula stage co-
injected with CdonMO and GFP were used 
as donors and cells were transplanted to early 
gastrula stage hosts (55%–65% epiboly) in the 
region fated to become the eye field. Manipu-
lated embryos were let develop until 28 hpf 
and then either prepared for live imaging (B, 
C) or fixed and mounted for microscope im-
aging (D, E) and ISH (F, G). The transplanted 
eye (C) show alteration of the ventro-nasal 
region in comparison to the non-transplanted 
eye (4 embryos) (B). The transplant is visual-
ized by GFP expression (D). The frontal view 
shows that the VSP marker is expanded in the 
transplanted right eye (6/7 embryos) (G) in 
comparison to controls (F). Red dashed line 
marks the lens vesicle and the blue dashed 
line outline the retina. Scale bars: 100 µm.
81
Results
17A, B). In wild type embryos the VSP marker was symmetrically expressed in both eyes 
(Fig.18F). When Cdon knocked-down cells were transplanted only in one eye, VSP signal 
was increased in that eye, but not in the contralateral one (Fig. 18G). For technical reasons 
this experiment could not be repeated in a large number of embryos, making statistical analy-
sis difficult. Nonetheless these findings supported the idea that Cdon expression specifically 
in the eye could be responsible of ventral defects seen in Cdon morphants directly. 
To test this hypothesis further, it was necessary to interfere with Cdon expression in a 
timely and spatially controlled manner. Therefore we turned to the chicken embryo, in which 
such a control can be achieved. We designed a specific MO to block chick Cdon expression. 
This MO (cCdonMO) and the control MO (cctlMO) were designed with a carboxyfluorescein 
tag,  in order to directly visualize the distribution of the MO after electroporation (Voiculescu 
et al., 2008). We forced cCdonMO by electroporation in HH9 embryos when Cdon is not yet 
expressed in the eye primordium (Fig. 19A) and then fixed the embryos at the optic vesicle 
stage (HH14) when the entire retina expresses Cdon (Fig. 19B). We succeeded to perform 
focal electroporations in the optic vesicle (Fig. 19C). To test the translation blocking capabil-
ity of cCdonMO, chicken embryonic eyes were electroporated with cCdonMO or cctlMO 
(Fig. 19D) collected 24h later and processed for Western blot analysis. Mouse �-Cdon anti-
body crossreacted with the chicken protein detecting a single band of around 110 Kda (Fig. 
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Fig. 19. cCdonMO efficiently interferes 
with chick Cdon expression. Cdon ex-
pression at HH9 and HH14 stages (A, B). 
Carboxyfluorescein conjugated chicken 
Cdon MO (cCdonMO) and control MO, 
were electroporated in the chicken presump-
tive eye approximately at HH8-9 stages 
and analized at HH14 (C, D). The interfer-
ence efficiency of the MO was determined 
by Western blot with an antibody against 
mouse Cdon normalized using �-tubulin ex-
pression (N.D.V, normalized density values)
(E, F). Analysis of Cdon expression by ISH 
reveals that at HH9 Cdon is not expressed in 
the primitive optic vesicles (ov) (A)  but it 
is expressed at HH14 in the early optic cup 
(oc) (B). Chicken embryos at HH8-9 stage 
were electroporated with cCdonMO or con-
trol MO specifically in the eye (C). At HH14 
the electroporated eyes were dissected (D) 
and collected.  The cCdonMO decreased the 
levels of Cdon relative to �-tubulin levels in 
the electroporated eyes. Scale bars: 200 µm. 
lv, lens vesicle; nr, neural retina.
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19E). The intensity of the band was reduced in cCdonMO electroporated eyes in comparison 
to those electroporated with cctlMO (Fig. 19E). The protein levels were normalized using 
�-tubulin levels (Fig. 19E, F). This demonstrates that cCdonMO effi ciently reduced the lev-
els of Cdon protein in chicken embryos. 
Because Pax2 was the most informative molecular marker to follow the effect of 
Cdon abrogation in zebrafish, electroporated chicken embryos were also hybridized with a 
Pax2 probe. cCdonMO electroporated embryos showed expansion and increased intensity of 
the Pax2 signal in the retina (Fig. 20B) in comparison with cctlMO electroporated embryos 
(Fig. 20A). This effect was better appreciated when the cCdonMO was electroporated only 
in one of the eyes (Fig. 20C, D, E). 
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Fig. 20. Knock-down of Cdon in optic vesicles induces an expansion of the optic stalk at the expenses of the optic 
cup. Carboxyfluorescein conjugated chicken Cdon MO (cCdonMO) and control MO, were electroporated in one or 
both vesicles of chick embryos (A, B,C-G´) at HH8-9 stages. The embryos were fixed at HH14, analyzed by ISH with 
a Pax2 probe (blue signal) and by immunohistochemistry with anti-fluorescein antibodies (brown signal) (A-F, G). 
Pax6 immunohistochemistry was performed on cryostat sections of electroporated embryos (F´, G´). Frontal (A, B) 
and lateral (C, D) views of embryos electroporated with control (A) or cCdonMO (B-D). In electroporated eyes, Pax2 
expression is expanded in the entire optic vesicle of cCdonMO treated embryos (7 embryos) (B) in comparison with 
control MO (6 embryos) (A). Ventral (E) and lateral (C,D) views of chicken electroporated embryos with cCdonMO 
in one eye (brown signal). Pax2 expression is clearly expanded in the electroporated optic vesicle (6/9 embryos) (D,E) 
in comparison with the non-electroporated eye (C,E). Frontal cryostat sections of a cCdonMO electroporated eye (G, 
G´) and a control eye (F, F´). The electroporated eye shows Pax2 expansion and Pax6 reduction in the retina (G, G´) 
in contrast to a normal condition (F, F´). The optic vesicles (ov) are outlined with a black dashed line. Black arrows in 
C and D indicate Pax2 expression in the optic vesicle.  Scale bar: 50 µm. ov, optic vesicle.
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The closure of the optic fissure occurs fairly late in chick embryos since it begins 
around E6-E8 (Adler and Belecky-Adams, 2002). Although we let develop some embryos 
up to this stage we failed to observe coloboma in the embryos. Likely, this is a consequence 
of MO dilution. Indeed, at this stage we were unable to detect the fluorescent signal in the 
electroporated embryos. The knockdown analysis both in zebrafish and chicken suggest that 
Cdon function in the eye is conserved and that the eye phenotype of Cdon morphants is not 
produced by midline defects.
There is convincing evidence that the two paired box transcription factors Pax2 and 
Pax6  regulate each other’s activity,  establishing the boundary between the optic stalk and 
the optic cup (Schwarz et al., 2000). Consistent with this notion, Pax2 overexpression in the 
cCdonMO electroporated eye (Fig. 20F, G) was associated with a reduction of Pax6 expres-
sion (Fig. 20F´, G´). This distribution is consistent with the phenotype described for the gain 
of Hh signaling function from the midline (Macdonald et al., 1995; Sanek et al., 2009). This 
suggests that Cdon expression in the retina may prevent the expansion of Shh signaling from 
the midline.
Cdon function in the retina is linked to Shh signaling.
If Cdon expression in the retina 
may prevent the expansion of Shh sig-
naling from the midline, inactivation of 
Hh signaling should rescue Cdon loss of 
function phenotype. To test this hypoth-
esis we interfered with Hh signaling in 
Cdon morphants by incubating the em-
bryos with cyclopamine (Cya), a drug 
that binds Smo and therefore blocks 
Hh signaling transduction. CdonMO 
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Fig. 21. Gain of Hh function is responsible of the optic stalk expansion observed in Cdon morphants. Analysis 
by ISH of the expression pattern of Pax2.1 at 28 hpf in control or CdonMO injected embryos threated from 90% 
epiboly with Cyclopamine (Cya). Lateral views of embryos threated with Cya (100uM) (B, D) or DMSO (A, C). In-
jection of CdonMO induces an expansion of the optic stalk region (B) in comparison with control (A). Cya at 100uM 
abolished Pax2.1 expression in the optic stalk in wild type embryos (C). In CdonMO injected embryos, Cya treatment 
reduced the Pax2.1 overexpression observed in CdonMO injected embryos to wild type levels (34/35 embryos) (D). 
The lens is indicated by a black dashed line and the body perimeter of the embryo by a white dashed line. Arrows 
indicate the extension of the Pax2.1 expression in the optic stalk. Scale bar: 100 µm. MHB, midbrain hindbrain 
boundary; os, optic stalk. 
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was injected in zebrafish embryos, which were let develop from epiboly stage until 28 hpf 
in medium (E3) containing Cya. Embryos were fixed and Pax2.1 expression was analyzed 
(Fig. 21). As expected, in wild type embryos, Cya treatment at 100µM, strongly reduced 
Pax2.1 expression in the optic stalk (Fig. 21A, C). In contrast, Cya administration counter-
acted Pax2.1 expansion normally observed after Cdon knock-down (Fig. 21B), generating 
embryos with a nearly normal Pax2.1 expression in the optic stalk (Fig. 21D). In contrast, 
the injection of CdonMO in the Shh mutant line syutbx392 could not rescue the Cdon pheno-
type (data not shown). However, the proximo-distal specification of the eye in these mutant 
embryos is not affected suggesting that the lack of Shh is compensated by the Shh homolog, 
Twhh as already proposed in Schauerte et al., 1998.  
Fig. 22. MOs designed against splice sites efficiently remove the exons coding the Ptc1 and Shh binding domains 
of Cdon. A) The cartoon depicts the mechanism of exon removal by splice blocking morpholinos. The color boxes 
represent exons and the black line the introns. The lightblue line depicts normal splicing and the violet dashed line the 
exon skipping induced by the morpholino (yellow box). Right panel shows the outcome of the MO activity; the non-
spliced mRNA and the spliced mRNA. The MO activity can be assessed by RT-PCR with two primers complementary 
to the flanking exons (black arrows). A successful splice-modification appears as a change in the RT-PCR product. B) 
Graphic representation of cdon exon distribution and of the Cdon protein with its domain composition.  C) RT-PCR of 
embryos injected with spl11MO and spl14MO. Splice Blocking MOs block pre-mRNA splicing inducing exon removal 
by targeting the exon-intron boundary. (C). The position of the morpholinos used in this study is depicted in B, the 
boxes represent Cdon exons. Exons can be removed with (red boxes) or without (green box) frameshift changes. The 
Cdon domains are aligned with the respective coding exons. Removal of exon 11 or 14 produce a deletion in fibronectin 
III (FnIII) 2 (Ptch binding site) or FnIII 3 (Shh binding site) respectively without frameshift modifications. 
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These experients support the idea that the phenotype of Cdon morphants is a conse-
quence of gain of Hh signaling function. As Cdon can interfere with Hh signaling by binding 
to Shh or Ptch (Yao et al., 2006; Izzi et al., 2011) we asked whether both interactions were rel-
evant to Cdon function in the eye. According to the published data Cdon binds Shh through 
its Fn3 domain (Yao et al., 2006; McLellan et al., 2008) and Ptch through its Fn1-2 domains 
(Izzi et al., 2011). By aligning of the protein sequence of the zebrafish and human Cdon, we 
verified that the residues involved in Ptch and Shh binding are conserved among vertebrates 
(see supplementary material). In fact, the protein sequence of Fn2 and Fn3 domains are well 
conserved from Humans to Xenopus 
(data not shown). By analysis of the 
Cdon genomic (NC_007129.5) and 
protein (Q1L8D0) sequences we es-
tablished that skipping of exon 11 or 
exon 14, which encode the Fn2 and 
Fn3 domains, respectively, would 
not alter the reading frame. Removal 
of exons can be achieved in vivo by 
MOs that can block nuclear process-
ing events like pre-mRNA splicing. 
Targeting exon-intron boundaries is a 
method to generate an exon skipping 
(Fig. 22A) (Draper et al., 2001). In 
order to generate truncated forms of 
Cdon lacking the Ptch or Shh bind-
ing domains in vivo, splicing MO 
(spl11MO and spl14MO respective-
ly) were designed (Fig. 22B) and in-
jected in zebrafish embryos at 1 cell 
stage.  The efficiency of the spl11MO 
and spl14MO was determined by RT-
PCR of MO injected embryos using 
primers complementary to regions in 
the adjacent exons. Amplifications 
detected a band of  molecular weight 
lower than that observed in controls 
(Fig. 22C). Thus in both cases, MOs 
modified the splicing of the respec-
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Fig. 23. Removal of the Shh binding domain of Cdon, but not 
that of Ptc1 phenocopies the effects of CdonMO. ISH analysis of 
the expression pattern of Pax2.1 in controls (A, C), spl11MO (B) 
and spl14MO (D) injected embryos at 28 hpf. Bright field lateral 
views of control (E) and spl14MO (F) injected embryo at 48 hpf. 
In spl11MO morphant embryos, the expression of Pax2.1 appears 
normal (130/130 embryos) (A, B). Spl14 morphants show an ex-
pansion of Pax2.1 expression (58/86 embryos) (D). Some embryos 
show ventral defects in the eye at 48 hpf (F) not observed in con-
trols (C, E). Red asterisks indicate the position of the optic fissure. 
Dashed lines indicate the lens and the body perimeter of the em-
bryos. Scale bars: 100 µm.
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tive targeted exons.
Spl11 morphants did not show evident 
changes in Pax2.1 expression at 28 hpf (Fig. 
23A, B), at least when embryos were injected 
in a 100uM to 600uM range of MO concentra-
tion. In contrast, spl14MO injected embryos 
exhibited an expansion of Pax2.1 expression 
in the optic stalk region comparable to the 
Pax2.1 overexpression obtained in Cdon mor-
phants (Fig. 23C, D). At 48 hpf, some of the 
embryos failed to close the optic fissure (Fig. 
23E, F). These results suggest that Cdon inter-
action with Shh, but not with Ptch, is critical 
for Cdon function in the optic cup. This is in 
agreement with the observation that Cdon and 
Ptch (referred as Patched1 (Ptc1) in zebrafish) 
are expressed in a complementary and non-
overlapping distribution in the eye (Fig. 24).
Nevertheless we cannot completely rule out the possibility that skipping of exon 14 
Cdon Ptc1
A B
A´ B´
Fig. 24. Cdon and Ptc1 expression pattern in zebraf-
ish embryos. Dorsal (A, B) and lateral (A´-B´) views 
of zebrafish embryos hybridized in toto with specific 
probes for Cdon (A, A´) and for Ptc1 (B, B´) at 20 so-
mites. The expression patterns of both molecules are 
complementary and donot overlap. Dashed lines out-
line the lens and the embryo body.  Scale bar: 100 µm.
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Fig. 25. Deletion of fibronectin domains of Boc does not affect protein stability or localization in transfected cell 
culture. A) HEK cells transfected with Boc-GFP or deleted versions of the fusion protein as indicated in the panels. 
Note that GFP signal is always detected at the cell membrane. E) Western Blot analysis of lysates from cells transfected 
with Boc-GFP or its derivatives. The asterisk indicates the position of the band corresponding to Boc-GFP. Scale bar: 
2 µm.
87
Results
may give rise to an unstable Cdon form affecting its turnover. Due to the lack of cross-reac-
tivity of the Cdon antibody in zebrafish, we could not test this possibility directly. However, 
individual deletions of the fibronectin domains of the Cdon homolog Boc did not appear to 
affect the stability of the protein. Indeed, we deleted the fibronectin domains from a fusion 
construct of Boc-GFP (Boc-GFP). Transfection of the Boc-GFP plasmid or of its mutant vari-
ants (BocΔFn1-3) in Human Embryonic Kidney (HEK293) cells, revealed that all constructs 
were localized at the plasma membrane (Fig. 25A-D). Furthermore the translation and integ-
rity of the different truncated peptides appeared normal by Western Blot analysis (Fig. 25E).
Studies in vertebrates have suggested that Cdon forms with Ptch an heterodimeric 
receptor (Bae et al., 2011). The normal phenotype of Spl11 morphants and the lack of over-
lapping expression of the two molecules suggest that Cdon in the eye acts with a Ptch inde-
pendent mechanism.
Cdon binds all mammalian Hh proteins (Kavran et al., 2010). The phenotype of Cdon 
morphants is similar to the phenotype produced by Shh overexpression at the midline (Mac-
donald et al., 1995). We thus hypothesized that Cdon may act by controlling the diffusion of 
Shh secreted from the axial midline. To address this question Cdon was overexpressed in the 
neural tube close to the floor plate, an endogenous source of Shh. A complete mouse Cdon 
coding sequence cloned into the pCAG expression vector (pCAG-Cdon). HEK293 cells were 
transfected with the pCAG-Cdon DNA and 48h later the cells were collected and the proteins 
α-Cdon
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Fig. 26. Mouse Cdon is efficiently expressed 
in chicken neural tube. A) Chicken embryos 
were electroporated with a construct carrying 
mouse Cdon cDNA in half of the neural plate 
at HH5 and the embryos were selected by GFP 
expression at HH11. B) Cdon expression in the 
electroporated neural tube (green cells) was 
verified by IHC with a Cdon antibody (red 
cells, arrows) C) The plasmid carrying Cdon 
cDNA was transfected in HEK cells and the 
cell lysate was analyzed by WB with a Cdon 
antibody. Mouse telencephalon was used as a 
positive control. The lysate of Cdon transfected 
cells shows the expected band corresponding to 
the mouse Cdon. Yellow dashed line indicates 
the midline and white dashed line outlines the 
CNS. Scale bar: 5 µm. FB, forebrain; HB, hind-
brain; MB, midbrain; ov, optic vesicles. 
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Fig. 27. Cdon enhances Shh diffusion in vivo. Chicken embryos were electroporated with a construct carrying mouse 
Cdon cDNA and GFP (D-F) or GFP alone (A-C). The embryos were sectioned and Shh localization was determined 
by IHC (B, E). Sections were counterstained with DAPI (C, F).  The electroporated half of the neural tube is showed 
in A) and D). Shh localizes to the floor plate (indicated by red dotted lines) (B, E). In the presence of Cdon Shh seems 
to accumulate (E, red bracket) in cells with high Cdon expression (D, red bracket). Scale bar: 50 µm. FP, floor plate; 
Nc, notochord.
extracted in lysis buffer to perform a WB analysis using Cdon antibodies, to verify that the 
construct was well translated. The WB showed that Cdon was expressed correctly compared 
to mouse telencephalon lysate, which served as a positive control (Fig. 26C). Embryos were 
then electroporated at HH5 in a half of the neural plate and were let develop until HH11, 
when they showed an electroporated hemitube (Fig. 26A). Embryos were immunostained 
with Cdon antibodies to determine if the construct was well expressed and the protein well 
localized. A specific signal was localized at the plasma membrane of the cells (Fig. 26B). 
The chicken embryos were co-electroporated with the pCAG-Cdon construct and a GFP as a 
tracer or a GFP alone. Only GFP positive embryos were selected, sectioned, inmunostained 
with antibodies against Shh (Fig. 27A-F). The images of the sections were captured with a 
confocal microscope. In the non-electroporated half of the neural tubes or in control embryos 
electroporated with GFP alone, Shh signal was detected only in floor plate cells (Fig. 27A, 
B, D, E). Interestingly, in the Cdon electroporated half of the neural tube, Shh signal was 
detected away from the endogenous source of Shh, in cells with high levels of ectopic Cdon 
expression (Fig. 27D, E). This indicates that Cdon binds Shh secreted from the midline, sug-
gesting that Cdon could modify Shh diffusion and therefore its signaling capability. 
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FGF signaling acts downstream of Cdon.
In Xenopus embryos FGF signaling ventralizes the eye, expanding the optic stalk and 
the ventral retina (Lupo et al., 2005). In the MHB Fgf8 maintains, but does not initiate, the 
expression of Pax2.1 (Reifers et al., 1998) . In Cdon morphants Fgf8 was expanded in the 
optic stalk and telencephalon domains as shown in Fig.7 A-B´´. 
We thus hypothesize that Fgf8 could at least in part mediate the expansion of the optic 
stalk caused by Cdon knock down. If this is the case inactivation of FGF signaling should res-
cue the Cdon-loss-of-function phenotype. To test this hypothesis we interfered with FGF sig-
naling in Cdon morphants incubating the embryos with SU5402, a drug that interferes with 
the tyrosine kinase activity of the FGF receptors and thus inhibits the signal (Mohammadi et 
al., 1997). Zebrafish embryos injected with CdonMO were let develop in medium contain-
ing SU5402 from epiboly stage until 28 hpf. Embryos were fixed and Pax2.1 expression was 
analyzed (Fig. 28). In wild type embryos, FGF treatment at 1µM slightly reduced Pax2.1 
expression in the optic stalk 
region (Fig. 20A, C). Instead 
SU5402 counteracted the ex-
pansion of Pax2.1 expression 
observed in Cdon morphants 
(Fig. 28B), giving rise to em-
bryos with a basically normal 
phenotype (Fig. 28D). This re-
sult suggests that FGF signal-
ing acts downstream of Cdon 
mediating the optic stalk phe-
notype of Cdon morphants.
The developing retina 
is highly sensitive to FGF 
signal. Previous studies have 
showed that Fgf8, 3 and 24 
cooperate to control naso-
temporal patterning of the 
neural retina. Increased Fgf8 
expression is associated with 
an expansion of the ventral 
and nasal retina (Picker and 
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Fig. 28. FGF signaling acts downstream of Cdon to control proximo-
distalization of the eye. Analysis by ISH of the expression pattern of Pax2.1 
at 28 hpf in control or CdonMO injected embryos threated from 90% epiboly 
with SU5402 inhibitor. Lateral views of embryos treated with SU5402 at 
1uM (B, D) or DMSO (A, C). Injection of CdonMO induces Pax2.1 expan-
sion in the optic stalk region (B) in comparison with control (A). SU5402 
administration at 1uM slightly reduces Pax2.1 expression in the optic stalk of 
wild type embryos (C). In CdonMO injected embryos, SU5402 treatment re-
duces the Pax2.1 overexpression otherwise observed in CdonMO morphants 
(38/41 embryos) (D).  MHB, midbrain hindbrain boundary; os, optic stalk. 
The lens is indicated by a black dashed line and the body embryo is outlined 
with a white dashed line. Arrows indicate the extension of the Pax2.1 expres-
sion in the optic stalk. Scale bar: 100 µM.
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Brand, 2005; Picker et al., 2009). We therefore tested whether the observed Fgf8 expansion 
in Cdon morphants was also followed by defects in the naso-temporal patterning of the retina. 
The CdonMO was injected in the transgenic line Claudin::GFP (cldnb::GFP) which 
expresses GFP in the nasal portion of the retina (Fig. 29A). In Cdon morphants,  GFP expres-
sion driven by the Claudin enhancer was detected in both the nasal and the ventral-temporal 
quadrant of the retina (Fig. 29B). ISH with an Efn5a probe, which normally marks the nasal 
retina (Fig. 29C) was also expressed abnormally in the ventral-temporal region of the eye 
(Fig. 29D). In line with an expansion of the nasal region of the retina, the expression of the 
temporal marker FoxD1 was absent from the ventral-temporal retina of Cdon morphants 
(Fig. 29F), as compared to control embryos (Fig. 29E). The gain of Efn5a-positive nasal fate 
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Fig. 29. Cdon is required for the naso-tempo-
ral patterning of the retina. The transgenic line 
cldnb::GFP, which express GFP in the nasal re-
gion of the retina, was injected with CdonMO (A, 
B). Analysis by in situ hybridization of nasal (N) 
(Efn5a) and temporal (T) (Foxd1) markers of the 
retina (C-F). Transgenic embryos injected with 
CdonMO show ectopic GFP expression in the tem-
poral region of the retina (B) (16/30 embryos) in 
comparison with control embryos (A). The same 
defect is observed with the nasal marker Efn5a (C, 
D arrow). The temporal marker Foxd1 is absent in 
the ventral-temporal quadrant of the retina in Cdon 
morphants (F arrow) in comparison to control (E). 
Quantification of the changes in Efna5a (wt=14 
embryos, MO=11 embryos, blue) and FoxD1 (wt=8 
embryos, MO=15 embryos, red) expression, deter-
mined by measuring the extent of the staining  in 
degrees. The optic fissure was considered 0º. The 
standard deviation is in yellow. The nasal retina is 
expanded at the expenses of the temporal retina in 
Cdon morphants (H, G). The yellow dotted line de-
picts the division between the nasal and temporal 
half of the retina. The lens is outlined in white and 
the retina in red. Scale bar: 50 µM.
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Fig. 30. Fgf8 acts downstream of Cdon in naso-temporal patterning of the retina. ISH analysis of a nasal retina 
marker (Efn5a) (A-D) in wild type and Fgf8a-/- mutants (ace) injected with or without CdonMO. CdonMO injected em-
bryos show expanded Efn5a expression in the retina (B) in comparison to control (A) and ace mutants show a reduction 
of Efn5a (C). Note the reduction of Efna5a in ace mutants injected with CdonMO (14 embryos) (D) in comparison to 
wild type injected embryos (B). Quantification of Efn5a expression in the eye, shows that in ace mutants the extent of 
Efn5a expression domain produced by Cdon knock-down is smaller than that of non-mutant CdonMO injected embryos 
(n=14 for each condition) (E). ** p < 0.01, *** p < 0.001 according to one-way ANOVA. The red dotted line depicts 
the division between the nasal (N) and temporal (T) half of the retina. The lens is indicated by a white dashed line. 
Scale bar: 100 µM.
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at the expenses of the temporal marker FoxD1 is plotted in figure 21G, H. Notably, the ex-
pression of the nasal marker Foxg1 and of the temporal marker Epha4b  did not seem to be 
affected (data not shown).
To corroborate that the increase of the nasal domain of the retina observed in Cdon 
morphants is a specific consequence of Fgf8 overexpression (see Fig. 15), CdonMO was 
injected in the Fgf8 mutant embryos (ace) (Reifers et al., 1998) at 1 cell stage. At 28 hpf 
the embryos were fixed and hybridized for the nasal marker Efn5a. In ace mutants Efn5a 
expression domain is reduced (Fig. 30A, C and (McMahon et al., 2009; Picker et al., 2009)) 
whereas in CdonMO it is expanded (Fig. 30B). Notably, ace mutants injected with CdonMO 
showed a wild type phenotype (Fig. 30D, E) indicating that Fgf8 mediates, at least in part, 
the naso-temporal alterations observed in Cdon morphants. From these experiments, we con-
clude that Fgf8 acts downstream of Cdon during the process of naso-temporal patterning of 
the retina.
Analysis of the regulatory elements that control Cdon expression.
Cdon expression pattern during development is very dynamic and complex but there 
is little information regarding the regulatory regions that control its expression. Cdon expres-
sion seems to be negatively regulated by Hh signaling in early mammalian embryos (Tenzen 
et al., 2006; Bergeron et al., 2011) supported by the abnormal levels of Cdon expression 
found in the limb buds of Gli3 mutant embryos (McGlinn et al., 2005). 
Recently, a medaka fish Cdon GFP reporter line was generated using the sequence 
localized at chr13:4420609-4421119 of the medaka genome. This line expresses GFP only 
in the proliferative regions of the CNS (Ramialison et al., 2012). The lack of GFP expres-
sion in the axial midline, the retina or the dorsal neural tube indicates that other elements 
regulate Cdon expression in these regions. In order to identify and characterize these ele-
ments we aligned the Cdon locus of different vertebrate species including the sequences 
~200kb up and downstream of the Cdon coding sequence. We found little conservation out-
side the Cdon coding region between zebrafish and the other vertebrates (data not shown). 
Because this alignment was not informative, we aligned ~500kb of the zebrafish genome 
(chr18:42,238,809-42,745,581), containing the Cdon gene, with the corresponding sequenc-
es of Tetraodon nigroviridis, Takifugu rubripes, Oryzias latipes and Gasterosteus aculeatus. 
The alignment was performed with the Mulan software using the default settings (Ovcha-
renko et al., 2005) and with the “MultiZ Alignment & Conservation” track, available in the 
genome.ucsc.edu website. The alignment indicated the existence of several high conserved 
non-coding elements (Fig. 31A and data not shown). We selected nine sequences that com-
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plied with the following criteria: more than 50% of sequence conservation among species 
and low degree of repeated sequences. These nine sequences were named A-I (Fig. 31A). 
The A and B sequences are localized downstream of Cdon coding region. The C, D and E 
sequences are instead found within the Cdon introns whereas the sequences F, G, H and I are 
upstream of Cdon coding region (Fig. 31A).
The sequences A-I were amplified by PCR from zebrafish DNA and were cloned by 
Gateway technology in the Zebrafish Enhancer Detection (ZED) vector (Bessa et al., 2009) 
which harbors the GFP gene as reporter of the cloned putative regulatory elements. The nine 
constructs (A-I) were co-injected with a transposase RNA in 1-cell stage embryos. The de-
veloping embryos were followed with a fluorescent stereo microscope to detect the onset of 
GFP expression. Sequences A, D, H and I drove GFP expression in the eye, telencephalon 
and dorsal neural tube at 24 hpf respectively in a proportion of the injected embryos. The 
most reproducible enhancer activity was observed in fishes injected with the D sequence, 
which drove GFP expression in the telencephalon of F0 injected embryos. The F1 progeny 
showed expression in the telencephalon (Fig. 31C) and in some cases in the retina and lens 
(Fig. 31B). The F2 generation will be fully analyzed to establish in detail the activity of this 
tel
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Fig. 31. Analysis of the Cdon regulatory regions. A) Organization of exons (blue boxes), introns and non-coding 
regions of the Cdon gene. Nine conserved sequences were selected as putative regulatory elements; the graphic shows 
their position relative to Cdon (red boxes, A-I). Each one of the sequences was cloned in ZED (Zebrafish Enhancer 
Detection), a vector designed for transgenic enhancer assay. The alignment of zebrafish, medaka, fugu, tetraodon and 
three-spined stickleback Cdon regions shows the conservation of the nine selected elements in fishes (gray boxes). B) 
The enhancer D F1 embryos drove GFP expression in the telencephalon (n=19, 3 independent lines and n=271 in tran-
sient lines). C) An F1 line drove GFP expression in the retina, lens and telencephalon (n=2). l, lens; lv, lens vesicle; nr, 
neural retina; r, retina; tel, telencephalon.
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element. 
To further localize regulatory regions that are not highlighted by the criteria of con-
servation among vertebrates, we analyzed histones marks in the human CDON gene through 
the ENCODE database available at www.genome.ucsc.edu. Histone H3 acetyl Lys27 anti-
body (H3K27AC), which marks active regulatory elements may distinguish active enhancers 
and promoters from their inactive counterparts. Human CDON gene displays a region that is 
marked by the H3K27AC, upstream of the promoter region, localized in the first intron (Fig. 
32A). This data suggests that the first intron of CDON harbors regulatory elements.  
The histone H3K27AC profile determined at various stages of zebrafish development 
(kindly provided by Prof. J. L. Gómez-Skarmeta) confirmed that the sequences D and E are 
chr18:42,501,500-42,530,202
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Fig. 32. Cdon first intron contains putative regulatory regions. A) Organization of exons and introns in CDON 
gene. H3K27ac signature marks active regulatory elements in the promotor region and the first intron of CDON (green 
box). B) The H3K27ac signature which marks active regulatory elements is depicted in purple, whereas the H3K4me3 
signature which marks regulatory elements primarily associated with the promoters/transcription start sites, is depicted 
in green. The enhancers D and E are indicated with red boxes. A medaka homolog enhancer sequence is indicated with 
a blue box and three other putative regulatory elements are marked with green boxes. Multiple Alignment of zebraf-
ish, medaka, fugu, tetraodon and three-spined stickleback Cdon regions shows the conservation among fishes of the 
selected and putative regulatory elements (gray boxes). 
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strong candidates to be regulatory elements. The D sequence appears to be active from 80% 
epiboly at least until 48 hpf (Fig. 32B). The E sequence appears to be active at dome stage 
and later on appears to be inactive (Fig. 32B). In addition to the D and E sequences, four other 
sequences within the first intron of Cdon are marked by H3K27ac and are thus putative regu-
latory elements (Fig. 32B, green and blue boxes). One of these sequences (chr18:42,508,500-
42,509,000) (Fig. 32B, blue box) is in fact homologous to the Cdon enhancer isolated in 
medaka embryos (Ramialison et al., 2012). Together these data points to the presence of 
different regulatory elements that could control Cdon expression. Future studies will confirm 
their relevance and spatial-temporal activity in the regulation of Cdon expression.
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The CNS is highly regionalized along the antero-posterior and dorso-ventral axes. 
Hh signaling plays a key role in specifying ventral cell types throughout the neuroectoderm. 
Other molecular pathways, including nodal, retinoic acid and FGF signaling, have been also 
identified as important cues for the ventral patterning of the spinal cord, the telencephalon 
and the eye (Lupo et al., 2006). The organogenesis of the vertebrate eye is a multistep process 
that requires Hh signaling at different time points (Amato et al., 2004). Shh secreted from 
the midline is critical to establish and maintain the proximo-distal patterning of the eye, by 
controlling the balanced expression of Pax2/Pax6 in the optic stalk and retina domains, re-
spectively (Macdonald et al., 1995; Take-uchi et al., 2003). Shh is also necessary to confer 
ventral identity to the retina (Huh et al., 1999; Zhang and Yang, 2001; Sasagawa et al., 2002). 
We thus propose that the Shh binding molecule, Cdon, can act as a negative modulator of Hh 
signaling in vertebrates. Cdon expressed in the retina acts to protect the optic cup from Shh 
activity by binding and preventing Shh diffusion. This function is needed to establish a cor-
rect proximo-distal patterning of the eye. In the absence of Cdon, the Shh gradient becomes 
expanded to more distal regions enlarging the optic stalk domain at expense of the retina 
promoting ventral eye defects (Fig. 33).
This model adds a novel function to Cdon, opposite from what has been so far pro-
posed in vertebrates. In fact, in vertebrates, Cdon acts as a positive modulator of Hh signaling 
during development. Cdon KO mice present a microform of HPE, which partially resemble 
the phenotype of Shh-/- mice (Cole and Krauss, 2003; Zhang et al., 2006a; Allen et al., 2007; 
Hong and Krauss, 2012). Human patients with mutations in CDON display HPE (Bae et al., 
2011). Shh expression and its target genes are downregulated in Cdon mutants (Tenzen et 
al., 2006; Zhang et al., 2006a; Allen et al., 2011; Zhang et al., 2011). In vitro experiments 
demonstrated that in Cdon absence, Hh signaling is impaired (Zhang et al., 2006a; Bae et al., 
2011) and ectopic expression of Cdon promotes Shh-dependent cell fate specification in the 
neural tube (Tenzen et al., 2006). In Drosophila the Cdon homologs Boi/Ihog are necessary 
for Hh signaling activation (Lum et al., 2003; Yao et al., 2006; Camp et al., 2010). However, 
Boi/Ihog can also act as negative modulators of Hh signaling in some contexts, participating 
in the secretion and titration of Hh ligand limiting long-range signaling (Hartman et al., 2010; 
Yan et al., 2010; Callejo et al., 2011; Bilioni et al., 2012). 
In Drosophila, these functions were revealed thanks to the distinct advantages of this 
model organism that includes an efficient control of time and tissue specific transgene expres-
sion or amenable techniques to generate knockout and gene replacement. In mice instead a 
conditional Cdon knock-out is not yet available. Therefore to avoid possible masking effects 
of an earlier phenotype, we addressed the study of Cdon function using zebrafish and chicken 
embryos, in which it is possible to interfere with gene expression in a controlled manner.
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Fig. 33. Model of the proposed function of Cdon in early eye development. The cells of the ventral forebrain are 
represented in yellow (vF), those of the optic stalk (OS) in light blue and those of the neural retina (NR) in red.  A) Cdon 
expressed in the retina binds Shh secreted from the midline thus restraining its diffusion and protecting the retina from 
signaling activation during the establishment of the proximo-distal patterning of the eye. B) In absence of Cdon, the 
ligand spreads to more distal region. C) Consequently, the optic stalk domain is expanded giving rise to ocular defects.
In our knock-down model in zebrafish, the levels of Cdon expression are reduced 
rather than being completely depleted. Nevertheless, we expected to observe an eye phe-
notype consistent with the loss of Hh signaling: that is to say a reduction of the proximal 
structures, the optic stalk, and a cyclopic phenotype produced by the fusion of the retinas at 
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the midline. Unexpectedly, the eye phenotype of Cdon knock-down was compatible with an 
opposite scenario: a gain of Hh signaling. Indeed in both, zebrafish and chick embryos we 
always observed an expansion of the optic stalk and ventral retina domain visualized by an 
expanded Pax2 expression. These results contrast with the proposed function of Cdon as a 
positive modulator of Hh signaling (Tenzen et al., 2006; Zhang et al., 2006a). 
Several lines of evidence indicate that the transcription factor Pax2 is a direct Shh 
target. Pax2 expression in the optic stalk and choroid fissure is dependent on Shh  (Chiang et 
al., 1996; Varga et al., 2001; Zhang and Yang, 2001; Perron et al., 2003) and Shh overexpres-
sion is sufficient to induce the expression of Pax2 in more distal optic vesicle territories, from 
which it is normally absent (Ekker et al., 1995; Macdonald et al., 1995; Zhang and Yang, 
2001; Perron et al., 2003). Pax2 in turn is required to establish the proximo-distal patterning 
of the eye. 
The development of the eye in the teleost fish Astyanax mexicanus is the clearest ex-
ample of the consequence of an expansion of Hh signaling from the midline. In their natural 
environment, these fishes exist in two forms: a surface dwelling river morph and a cave-
living blind morph (cavefish). One of the most surprising characteristic of the cavefish is that 
the anterior expression domain of Shh (and that of Twhh) at the embryonic ventral midline is 
expanded throughout forebrain development (Yamamoto et al., 2004; Menuet et al., 2007). 
This expansion of Hh signaling results in hyper activation of downstream genes like Pax2 
during optic vesicle and optic cup stages and also in the lack of the ventral quadrant of the 
retina that leads to eye degeneration (Yamamoto et al., 2004). Our observations are in line 
with this scenario and strongly suggest that Hh signaling is expanded in Cdon morphants. 
The evidence described above and the experiments in which the optic stalk phenotype was 
counteracted by blocking Hh signaling further support the critical role of Hh signaling in the 
observed Cdon phenotype.
In Cdon morphants the repositioning of the boundary between the optic stalk and the 
neural retina is associated with ventral eye defects and the presence of coloboma due to a 
failure in optic fissure closure. Other studies in fishes are consistent with the idea that Hh sig-
naling overactivation is responsible of similar defects. In fact, blowout mutants (Ptc1-/-) (Lee 
et al., 2008), uta1 mutants (Ptc2-/-) (Lee et al., 2012), Zic2a morphants (Sanek et al., 2009), 
the uncharacterized aussicht (aus) mutant (Heisenberg et al., 1999) and Shh overexpression 
(Ekker et al., 1995; Macdonald et al., 1995) are all characterized by an expansion of Hh sig-
naling that leads to Pax2 overactivation in the optic stalk and by optic coloboma formation. 
The consequence of Shh overexpression in chicken is similar. Optic cups infected with a vi-
rus that leads to Shh ectopic expression, display microphthalmia at E6. This is accompanied 
by a loss of ventral retina, abnormal folding of the retina and/or pigmented epithelium, ab-
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normal ciliary margins, and a widened optic fissure (Zhang and Yang, 2001). Notably in ovo 
electroporation of Pax2 in the ventral optic cup results in the formation of coloboma (Sehgal 
et al., 2008). By contrast loss of Pax2 function leads to optic nerve hypoplasia and coloboma 
in humans and in a number of animal models (Sanyanusin et al., 1995; Torres et al., 1995; 
Macdonald et al., 1997; Otteson et al., 1998). Interestingly, the presence of coloboma have 
been described in patients with a deletion in the human SHH gene (Schimmenti et al., 2003). 
In summary, an unbalanced expression of the signals responsible for the proximo-distal pat-
terning of the optic vesicle, modifies the position of the boundary between the optic stalk and 
the retina, thus affecting the closure of the optic fissure.
In the zebrafish mutant strain syu (Shh-/-), there are no obvious abnormalities of Pax2 
or Pax6 expression in the developing eye. This indicates that the lack of Shh alone does not 
affect proximo-distal fates in the developing eye of the zebrafish (Schauerte et al., 1998), 
possibly because Twhh may compensate Shh activity. In fact, in zebrafish Twhh expression 
and function are similar to those of Shh in proximo distal patterning of the eye (Ekker et al., 
1995). This suggests that Cdon may bind other Hh ligands in zebrafish. In line with this idea 
and the fact that Hh signaling mediates the phenotype of Cdon morphants, the downregula-
tion of Cdon in syu mutants did not rescue the optic stalk expansion.
If Hh signaling is altered in Cdon morphants, targets of the pathway should be modi-
fied, either in its expression level or distribution. However, we could not detect any evident 
change in the expression of different readouts of the Hh pathway in Cdon morphants. The 
expression pattern of Ptc1, Shh, Nkx2.1, Nkx2.2, Gli2, Gli2b, Gli3, Boc and Cdon itself ap-
peared normal in Cdon knock-down embryos (data not shown). However, ISH is a poorly 
sensitive technique and subtle changes might have gone unappreciated. Other studies report-
ing similar phenotypic consequences associated to a gain of Hh function have not described 
evident alterations in the expression of Hh pathway components. One example is the zebrafish 
aus mutant, carrying a mutation in a regulator of Fgf8 expression (Heisenberg et al., 1999). 
Its phenotype includes the overexpression of Fgf8 and Pax2.1, the incomplete closure of the 
optic fissure and nasal retina expansion, with little if any Shh ectopic expression (Heisen-
berg et al., 1999). Zic2a morphants present a phenotype similar to that of aus mutants. The 
phenotype could be rescued in a Smo-/- background or by blocking Hh signaling with Hhip 
mRNA injection, although the expression of Hh signaling targets was not analyzed (Sanek 
et al., 2009). We thus believe that the changes of Hh signaling in these and our studies might 
be very subtle and possibly restricted in space and time so that variations might be buffered 
by the regulation of the pathway itself. We propose that in absence of Cdon the Shh gradi-
ent becomes modified. Verifying this modification requires the visualization of Shh protein 
in fishes. Unfortunately and despite the many attempts, we did not succeeded in performing 
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this experiment. Therefore to address if Cdon knock down affects the Hh pathway, we plan 
to perform MO injections in the Hh signaling reporter zebrafish line ptc1::KAEDE (Huang et 
al., 2012), in the hope to have a better resolution. 
Aberrant Shh signaling is one of the leading causes of HPE. Individuals suffering 
from mild forms of HPE are also affected by coloboma. Given the overlap in mutational 
etiology, HPE and coloboma are likely to represent in some cases severe and mild mani-
festations of the same phenotypic spectrum. To avoid the effect that the abrogation of Cdon 
expression in the midline could generate, we blocked the expression of Cdon specifically in 
the retina of chicken embryos by the electroporation of a specific MO. When Cdon was down 
regulated in the retina, Pax2 was overexpressed in the optic stalk and retina domains suggest-
ing that these phenotypes are independent of midline defects. 
In mice and in zebrafish, Cdon is expressed transiently in the prechordal plate mesen-
doderm and notochord and in the ventral structures that produce and respond to Shh. In this 
structure Cdon functions as a positive regulator of the Shh pathway, necessary for proper 
patterning of the ventral telencephalon and floor plate of the neural tube (Tenzen et al., 2006; 
Kang et al., 2008; Oh et al., 2009). Cdon deficiency in mice results in HPE with strain-
specific severity due to defective Shh signaling in and ⁄ or from the prechordal plate (Cole 
and Krauss, 2003; Zhang et al., 2006a). Additionally, Cdon mutant mice display multiple 
anomalies of eye development, including the disruption of ventral patterning, coloboma and 
defective lens (Zhang et al., 2009). Notably, eye anomalies displayed by Cdon morphants are 
similar to those described for Cdon mutant mice, however the expression pattern of some 
molecular markers are affected in a distinct manner. Cdon-/- embryos present a downregula-
tion of ventral (Pax2.1, Vax2) and dorsal (Tbx5 and Bmp4) patterning genes (Zhang et al., 
2009). This difference  may be explained by  the primary cause  of the Cdon-/- mouse phe-
notype likely linked to Cdon function in axial midline. In Cdon morphants instead we did 
not observed midline defects. It is possible that a possible overlap of Cdon with either Boc, 
Gas1 or LRP2 expression could compensate Cdon knock down. Alternatively, the remaining 
Cdon levels in zebrafish morphants are sufficient to allow correct embryo development at 
early stages.  By contrast eye development may require high Cdon levels. In absence of these 
levels Shh signaling becomes expanded, promoting Pax2 upregulation.
Although it has been suggested that Cdon and Ptch act in concert in Shh signaling 
(Bae et al., 2011), we have shown by ISH that there are many contexts during development in 
which the expression patterns of both molecules do not overlap. Cdon expression in the retina 
or in the dorsal neural tube does not overlap with that of Ptc1, suggesting that Cdon has Ptch 
independent functions. Our experiments using splicing blocking MO´s demonstrated that 
removal of the Shh binding domain (FNIII 3) domain of Cdon (Okada et al., 2006; Tenzen 
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et al., 2006; McLellan et al., 2008)  induced a phenotype similar to that of CdonMO injected 
embryos. However removal of the Ptch binding domain (FNIII 2) of Cdon, resulted in em-
bryos with a wild type phenotype. These observations are consistent with a mechanism in 
which Cdon acts on Hh signaling independently of its interaction with Ptch. Notably, all the 
mutations in the CDON gene that cause HPE in humans falls outside the Shh binding domain 
and the resulting CDON variants still present effective Shh binding. In contrast, wild-type 
CDON associates with PTCH1 but the mutated variants are less efficient (Bae et al., 2011). 
This indicates that normally Cdon plays an important role in the axial midline likely by bind-
ing to both Shh and Ptch and thus acting as a positive modulator of Hh signaling. By contrast, 
Cdon interaction with Shh but not with Ptch could be important for the development of a nor-
mal eye.  These results support the idea that Cdon could have multiple, independent functions 
in Hh signaling during development depending on the biological context. 
Besides its role in Hh signaling, Cdon can also interact with N-cadherin, activating 
p38�/β MAPK signaling (Kang et al., 2003; Lu and Krauss, 2010). We cannot totally exclude 
that this Cdon interaction might be also relevant to eye development, because N-cadherin 
zebrafish mutants present eye defects (Yamaguchi et al., 2010). Furthermore, Cadherin-
mediated cell adhesion is critical for the closure of the mouse optic fissure (Chen et al., 
2012). N-cadherin restricts cell proliferation in the dorsal region of the zebrafish neural tube, 
regulating cell-cycle length. Enhanced proliferation in N-cadherin mutants is mediated by 
ligand-independent activation of Hh signaling (Chalasani and Brewster, 2011). Considering 
that Cdon-/- mice also display dorsal CNS phenotypes, including defects in proliferation and 
differentiation of cortical neural precursors (Zhang et al., 2006b), it might be interesting to 
investigate if Cdon and cadherins could act together during CNS development.
Our experiment showing ectopic expression of Cdon in the chick neural tube suggests 
that Cdon binds Shh with high efficiency. In this assay, we detected an accumulation of Shh 
in the cells that expressed high levels of Cdon close to the floor plate, a source of Shh, but 
not in cells with similar Cdon expression levels located more dorsally. Similar results were 
obtained by the electroporation of Boc in the neural tube (unpublished data of the laboratory). 
A possible explanation for this observation is that Cdon (and Boc), could act as Shh “sinks” 
(for instance, by endocytosis and degradation of the ligand). This mechanism is similar to 
that described for Glypican-3 (Capurro et al., 2008), Patched (Chen and Struhl, 1996; Lee et 
al., 2008) or Hhip (Chuang and McMahon, 1999) which bind Shh and restrict its diffusion 
and thus the activation of the pathway. 
Besides Hh ligands, glypicans and Xhip can regulate the activity of Wnt and FGF li-
gands (Song et al., 1997; Tsuda et al., 1999; Grisaru et al., 2001; Cornesse et al., 2005). How 
the context-specific interplay among different signaling pathways produces distinct temporal 
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and spatial outcomes is an open question in the field of developmental biology. Whether 
Cdon interferes with the activity of other secreted signaling molecules is unknown. It is also 
unexplored whether Cdon has additional binding partners. These are open questions that 
might be important to address in the future.
FGF and Hh signaling act in positive feedback loop in different developmental con-
texts (Brewster et al., 2000), including forebrain development (Bertrand and Dahmane, 
2006). In line with this observation, in Cdon morphants, the FGF pathway appears upregu-
lated. Cdon depletion could affect Shh signaling as a consequence of the expression of Fgf8. 
The participation of Fgf8 in the molecular cascade of eye development was dem-
onstrated in cavefish. Fgf8, expressed in the rostral forebrain is activated 2 hours earlier in 
cavefish embryos than in their surface counterparts. This occurs in response to the higher Shh 
signaling levels present in the cavefish. It has been proposed that this crucial heterochrony 
is responsible for morphogenesis defects of the eye in the cavefish (Pottin et al., 2011). Al-
though we have not tested it, it is possible that a similar heterochrony could be present in 
Cdon morphants. This issue could be addressed with a detailed analysis of the onset of Fgf8 
expression and/or with a time course of the inhibition of FGF signaling with pharmacological 
treatment. It will be also interesting to test whether Cdon expression is modified in cavefish 
embryos. 
Fgf8 is expanded not only in the optic stalk but also in the telencephalon of Cdon 
morphants. Results obtained in chick, mouse and zebrafish highlight the role of the Hh and 
FGF pathways and a cross-regulation between the two pathways at distinct and precise times 
during telencephalon ventralization (Bertrand and Dahmane, 2006; Rash and Grove, 2011). 
Notably, Cdon is expressed in the dorsal telencephalon, opening the possibility that Cdon 
might has a similar role here.
Knock-down of Cdon in ace (Fgf8-/-) mutant embryos did not lead to mayor altera-
tions in patterning of the nasal retina, as instead observed in wild type embryos, supporting 
that Fgf8 acts downstream of Cdon. In contrast, other aspects of retinal patterning were not 
affected in CdonMO injected ace mutants suggesting that Cdon function is mediated by addi-
tional proteins. For example, other FGF might mediate Cdon function, since there are several 
examples in in which multiple Fgf ligands seems to control tissue development including 
several examples in sensory organs (Picker 2009; Martinez-Morales 2005; Zelarayan et al., 
2007). Therefore, the analysis of the expression pattern of other FGF family members in 
Cdon morphants is an important issue for future research.
In this study, we did not analyze whether Wnt signaling components are altered in 
Cdon morphants. Ablation of canonical Wnt signaling during early eye development causes 
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coloboma and microphthalmia (Pinson et al., 2000; Stump et al., 2003). It has been proposed 
that the Wnt and Hedgehog pathways exhibit reciprocal inhibition in the Xenopus retina 
(Borday et al., 2012). As in fishes, adult amphibians produce retinal neurons from a pool of 
neural stem cells localized in the CMZ. The Wnt pathway restrains Hh activity in the CMZ 
by regulating the expression of transcriptional repressor Gli3. In turn, Hh signaling nega-
tively regulates Wnt activity in the CMZ by transcriptional activation of Secreted Frizzled 
Related Protein 1 (Sfrp1), an antagonist of Wnt signaling (Borday et al., 2012). Cdon ex-
pression localize to the CMZ at later stages of in zebrafish development. Furthermore, Cdon 
can be regulated in a positive manner by Gli3 (McGlinn et al., 2005). It is thus possible that 
Cdon could be an important factor in the proposed crosstalk between Hh and Wnt pathways. 
Recently, in Drosophila the secreted protein Shifted (Shf), a member of Wnt inhibitory factor 
1 (WIF1) family and its vertebrate ortholog WIF1 have been shown to interact with the Hh 
co-receptor Ihog (Avanesov and Blair, 2012; Bilioni et al., 2012). Whereas vertebrate WIF1 
blocks Wnt signaling (Hsieh et al., 1999; Hunter et al., 2004), Drosophila WIF1 (Shifted 
(Shf)) regulates only Hh distribution and spreading through the extracellular matrix (Glise et 
al., 2005; Gorfinkiel et al., 2005). This specificity is conferred by the WIF domain of those 
proteins (Sanchez-Hernandez et al., 2012). Notably, Ihog can increase the Wnt-inhibitory 
activity of vertebrate WIF1; this result raises the possibility of the existence of an interac-
tion between WIF1 and Cdon or Boc (Avanesov and Blair, 2012), which would support our 
hypothesis. 
At the moment there is little information about the precise regulation of Cdon or is 
homolog Boc. Cdon and Boc seem to be negatively regulated by Hh signaling in early verte-
brate embryos (Tenzen et al., 2006; Bergeron et al., 2011) as also supported by the abnormal 
levels of Cdon expression found in the limb buds of Gli3 mutant embryos (McGlinn et al., 
2005). We have isolated a number of non-coding conserved sequences on the Cdon locus that 
could have enhancer activity. Only one sequence (D) showed a clear enhancer activity. To 
establish if the other sequences have enhancer activity we need to analyze the F1 stable trans-
genic embryos of the different isolated elements. However these conserved sequences could 
have other regulatory functions, e.g. silencers. Another possibility is that these sequences 
require to act in coordination with other genetic elements and therefore they need to be tested 
in more details to establish their possible function in Cdon regulation.
We isolated possible regulatory sequences based on their conservation among 
different species. However, there is additional information obtained with the analysis of his-
tone marks in the zebrafish genome at four developmental stages (Gómez-Skarmeta lab, 
unpublished data). The integration of the different histone modification information can be 
used systematically to assign functional attributes to genomic regions (Hon et al., 2009). This 
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information points with more precision to the sequences that are potential regulatory ele-
ments at different stages of development. Using this information, we have detected that the 
first intron of zebrafish Cdon seems to harbor a cluster of conserved non-coding sequences, 
which are likely regulatory elements. Further studies of the elements inside the first intron of 
Cdon will be important to understand Cdon regulation.
The analysis of these elements may also give hints on the possible trans-acting fac-
tors. The transgenic lines carrying the different elements, can be analyzed through pharmaco-
logical treatments with inhibitors, injection of RNAs or MOs to dissect the regulatory control 
of Cdon.
Conclusion
We propose here that Cdon is able to act as a negative modulator of Hh signaling in 
vertebrates at least in the context of eye development. This proposed mechanism improves 
our understanding of the dynamic Hh signaling network and may have implications in other 
cellular and pathological contexts, included for instance in cancer (Stecca and Ruiz, 2010). If 
Cdon plays a similar role in other developmental contexts is still an open question. 
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1. Cdon mRNA expression pattern in the developing eye is conserved from teleost 
to mammals.
2. Downregulation of Cdon causes ventral eye defects and expansion of the optic 
stalk domain in zebrafish.
3. Cdon expression in the presumptive retina prevents optic stalk expansion.
4. Hh signaling mediates the enlargement of the optic stalk observed in Cdon mor-
phants. 
5. Cdon interaction with Shh (but not with Ptc) is critical for the proper positioning 
of the boundary between the optic stalk and the neural retina. 
6. Neuroepithelial cells that ectopically express Cdon accumulate Shh protein se-
creted from the floor plate.
7. Cdon acts as a negative modulator of Hh signaling in vertebrate eye formation.
8. FGF signaling mediates the enlargement of the optic stalk in Cdon morphants. 
9. Cdon is required for proper naso-temporal patterning of the retina.
10. Fgf8 acts downstream of Cdon during naso-temporal patterning of the retina. 
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Supplementary Materials
Sequences.
The information about Cdon exon and intro regions was obtained from the Nation-
al Center for Biotechnology Information (NCBI). Reference Sequence: Chromosome: 18; 
NC_007129.5 (chr18:42,454,187-42,530,202). 
Cdon sequences from Mouse, Human and Zebrafish (Q32MD9, Q4KMG0 and 
Q1L8D0 respectively) were obtained from Uniprot (Consortium, 2012). The locations and 
sequences of the fibronectin type-III 2 and 3 domains were obtained from UniProt (Consor-
tium, 2012)
Alignment among human, mouse and zebrafish Cdon sequences.
The Cdon Danio Rerio sequence is not annotated in UniProt database, therefore ze-
brafish Cdon sequence of Danio Rerio was aligned with the fibronectin type-III 2 (purple) 
and 3 (green) of Mus musculus and Homo sapiens using Clustal Omega (Goujon et al., 2010; 
Sievers et al., 2011).
Q4KMG0 (CDON_HUMAN)
>sp|Q4KMG0|CDON_HUMAN Cell adhesion molecule-related/down-regulated by 
oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2
MHPDLGPLCTLLYVTLTILCSSVSSDLAPYFTSEPLSAVQKLGGPVVLHCSAQPVTTRIS
WLHNGKTLDGNLEHVKIHQGTLTILSLNSSLLGYYQCLANNSIGAIVSGPATVSVAVLGD
FGSSTKHVITAEEKSAGFIGCRVPESNPKAEVRYKIRGKWLEHSTENYLILPSGNLQILN
VSLEDKGSYKCAAYNPVTHQLKVEPIGRKLLVSRPSSDDVHILHPTHSQALAVLSRSPVT
LECVVSGVPAPQVYWLKDGQDIAPGSNWRRLYSHLATDSVDPADSGNYSCMAGNKSGDVK
YVTYMVNVLEHASISKGLQDQIVSLGATVHFTCDVHGNPAPNCTWFHNAQPIHPSARHLT
AGNGLKISGVTVEDVGMYQCVADNGIGFMHSTGRLEIENDGGFKPVIITAPVSAKVADGD
FVTLSCNASGLPVPVIRWYDSHGLITSHPSQVLRSKSRKSQLSRPEGLNLEPVYFVLSQA
GASSLHIQAVTQEHAGKYICEAANEHGTTQAEASLMVVPFETNTKAETVTLPDAAQNDDR
SKRDGSETGLLSSFPVKVHPSAVESAPEKNASGISVPDAPIILSPPQTHTPDTYNLVWRA
GKDGGLPINAYFVKYRKLDDGVGMLGSWHTVRVPGSENELHLAELEPSSLYEVLMVARSA
AGEGQPAMLTFRTSKEKTASSKNTQASSPPVGIPKYPVVSEAANNNFGVVLTDSSRHSGV
PEAPDRPTISTASETSVYVTWIPRANGGSPITAFKVEYKRMRTSNWLVAAEDIPPSKLSV
EVRSLEPGSTYKFRVIAINHYGESFRSSASRPYQVVGFPNRFSSRPITGPHIAYTEAVSD
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TQIMLKWTYIPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSY
DIKMQCFNEGGESEFSNVMICETKVKRVPGASEYPVKDLSTPPNSLGSGGNVGPATSPAR
SSDMLYLIVGCVLGVMVLILMVFIAMCLWKNRQQNTIQKYDPPGYLYQGSDMNGQMVDYT
TLSGASQINGNVHGGFLTNGGLSSGYSHLHHKVPNAVNGIVNGSLNGGLYSGHSNSLTRT
HVDFEHPHHLVNGGGMYTAVPQIDPLECVNCRNCRNNNRCFTKTNSTFSSSPPPVVPVVA
PYPQDGLEMKPLSHVKVPVCLTSAVPDCGQLPEESVKDNVEPVPTQRTCCQDIVNDVSSD
GSEDPAEFSRGQEGMINLRIPDHLQLAKSCVWEGDSCAHSETEINIVSWNALILPPVPEG
CAEKTMWSPPGIPLDSPTEVLQQPRET
Q32MD9 (CDON_MOUSE)
>sp|Q32MD9|CDON_MOUSE Cell adhesion molecule-related/down-regulated by 
oncogenes OS=Mus musculus GN=Cdon PE=1 SV=2
MHPDLGPLWTLLYVLVILCSSVSSDLAPYFISEPLSAVQKLGRPVVLHCSAKPVTARISW
LHNGKRLDRNTEQIKIHRGTLTILSLNPSLSGCYQCVANNSVGAVVSGPATVSAAALGDF
DSSTMHVITAEEKNTGFIGCRVPESNPKAEVRYKIRGKWLKHSTGNYIILPSGNLQVLNV
SSKDKGSYKCAAYNPVTSELKVEPTGRKLLVSRPSSNGFHILHPALSQALAVLPHSPVTL
ECVVSGVPASQVYWLKDGQDAVAGSNWRRLYSHLATASIDPADSGNYSCVVGNKSGDVKH
VTYMVNVLEHASISKGLHDQKVSLGATVHFTCDVHGNPAPNRTWFHNAQPIHPSSRHLTE
GNVLKITRVVMEDSGLYQCVADNGIGFMQSTGRLQIEQDSGWKPVIVTAPANIEVMDGDF
VTLSCNATGVPVPVIHWYGRHGLITSHPSQVLRSKPRKSHLFRPGDLDLEPVYLIMSQAG
SSSLSIQAVTLEHAGKYTCEATNKHGSTQSEAFLTVVPFETNTKAESVTPSEASQNDERD
PQDGSESSLLNLFPVKVHPSGVELPAERNASVPDAPNILSPPQTHMPDTYNLVWRAGRDG
GMPINAYFVKYRKLDDGSGAVGSWHTVRVPGSENELHLTELEPSSLYEVLMVARSAVGEG
QPAMLTFRTSKEKMASSKNTQASFPPVGVPKRPVTAEASNSNFGVVLTDSSRHSGVPEAP
DRPTISMASETSVYVTWIPRANGGSPITAFKVEYKRMRTSDWLVAAEDIPPSKLSVEVRS
LEPGSIYKFRVIAINHYGESFRSSASRPYQVAGFPNRFSNRPITGPHIAYTEAVSDTQIM
LKWTYVPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHTIGHLQPETSYDIKM
QCFNEGGESEFSNVMICETKVKRVPGASDYPVKELSTPPSSSGNAGNVGPATSPARSSDM
LYLIVGCVLGVMVLILMVFIALCLWKSRQQSTIQKYDPPGYLYQGSEINGQMVEYTTLSG
AARINGSVHGGFLSNGCSHLHHKGPSGVNGTLSGNINGGLYSAHTNSLTRACVEFEHPHH
LVNSGGVYTAVPQMDPLECINCRNCRNNNRCFTKTNSPLPVVPVVASYPQGGLEMKPLNA
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MKVPVCPASTVPDHGQLPDDCVKDSVAPIPTQHTCCQDNISDINSDSTEDTAEFSRGDSS
GHSEAEDKVFSWNPLILSPVLEDCGEKTARSPPGPPLDGLSVVLQQAQET
Alignment among mouse and human Cdon FNIII 2 sequences with Cdon ze-
brafish sequence.
Cdon_Danio_rerio          MEDGGLRLLSAVLCVCHTLLLNCPTVLSFSFRAEPLSAILKQGSSVHLHCTTHPATARIS
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          WLFQGQPLDPSHHSGVELSQDSLSLSNLQPALTGSYQCSARSETGSIISRHARVTIADIE
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          EFAETHRRSFTVNKGDTAVIECPLPRSNPPALPRFRIRGKWLEQSTDEYLILPSGNLQIV
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          SVSSEHQGMYKCGAYNPLTRETRVEAHGTKLLVKDSESSSPVRIVYPITPRSLTVDQSGS
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          LTLECVVSGSLSSKVKWMKNGAELSLSSKRMLSHSNLVLNDIQPGDGGHYSCSVPTDRGA
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          VVSVNYTVNVLAHVSILRGLSDQAAVAGSSVRFTCAASGNPTPNITWLLNAAPLSSSPRL
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
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Cdon_Danio_rerio          KISGTSLLISSTTLQDQGIYQCMFDNGISSAQSTGRLSIQSEPQSSSISAVPVKTQPSVH
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          PIQSDEGDELFLSMGEAALGETVGPPTERIGDRPTPEAPIIISPPQTHKPNMYDLEWRAG
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          RDWGIAIIAYFVKYRKVDDMGNVVGSWHTVRVPGSEKSLPLSELEPSSLYEVLMVARSAA
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          GEGQPAMLTFRTGKERASPNKNPSKAPIVSLPEKTPEDKTTNTYYGVVIHDRVPEAPDRP
FnIII_2_Mus_musculus      -----------------------------------------------------PEAPDRP
FnIII_2_Homo_sapiens      -----------------------------------------------------PEAPDRP
                                                                               *******
Cdon_Danio_rerio          TISMATESSVYVTWIPRANGGSPITAFRVEYRKQGRNGDWIIAADNISPLKLSVEVRNLE
FnIII_2_Mus_musculus      TISMASETSVYVTWIPRANGGSPITAFKVEYKRM-RTSDWLVAAEDIPPSKLSVEVRSLE
FnIII_2_Homo_sapiens      TISMASETSVYVTWIPRANGGSPITAFKVEYKRM-RTSDWLVAAEDIPPSKLSVEVRSLE
                          *****:*:*******************:***::  *..**::**::* * *******.**
Cdon_Danio_rerio          PGSTYRFRVIAMNNYGESPASATSRPYQVSMSSSPVSNRPVTGPHISSTDAVSDTQILLR
FnIII_2_Mus_musculus      PGSIYKFRVIAINHYGESFRSSASRPY---------------------------------
FnIII_2_Homo_sapiens      PGSIYKFRVIAINHYGESFRSSASRPY---------------------------------
                          *** *:*****:*.****  *::****                                 
Cdon_Danio_rerio          WTYTPSSNNNTPIQGFYIYYRPTDSDNDSDYKKDVVEGFKFWHMIGELQPETSYDIKMQC
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
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Cdon_Danio_rerio          YNDGGESEYSNVMICETKARQPPGVPSLRPITPPGFYPADTPSQPGGLLYLIVGCVLGVM
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          VLILLVFIVMCLWRNRQQNSMHKYDPPNYIYQSAEMNGHVLDYSALPGSSHVNGSVHTGC
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          GHTAPMMPQTCHHLHHKLPNGLALLNGSGGLYPAGHPHAHDTSLHQNNMEYEHPSPHHLH
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          NGGGIYTALPQNDSSDCMSCQNFCNNNRCYTKTNGTFSGGTLPLMHRVAARQPDGLEMMP
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          LNPILSRCHGRDSPQLNGCQDRDSVQQAEEGNVPPLSHNSPCLPVETKSSLEQQRGVQQV
FnIII_2_Mus_musculus      ------------------------------------------------------------
FnIII_2_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          QHEDSEGPVVCWERLGLDLDCKEKTAWISTGSLTGDLIQPTVQEI
FnIII_2_Mus_musculus      ---------------------------------------------
FnIII_2_Homo_sapiens      ---------------------------------------------
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Alignment among mouse and human Cdon FNIII 3 sequences with Cdon ze-
brafish sequence.
Cdon_Danio_rerio          MEDGGLRLLSAVLCVCHTLLLNCPTVLSFSFRAEPLSAILKQGSSVHLHCTTHPATARIS
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          WLFQGQPLDPSHHSGVELSQDSLSLSNLQPALTGSYQCSARSETGSIISRHARVTIADIE
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          EFAETHRRSFTVNKGDTAVIECPLPRSNPPALPRFRIRGKWLEQSTDEYLILPSGNLQIV
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          SVSSEHQGMYKCGAYNPLTRETRVEAHGTKLLVKDSESSSPVRIVYPITPRSLTVDQSGS
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          LTLECVVSGSLSSKVKWMKNGAELSLSSKRMLSHSNLVLNDIQPGDGGHYSCSVPTDRGA
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          VVSVNYTVNVLAHVSILRGLSDQAAVAGSSVRFTCAASGNPTPNITWLLNAAPLSSSPRL
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
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Cdon_Danio_rerio          KISGTSLLISSTTLQDQGIYQCMFDNGISSAQSTGRLSIQSEPQSSSISAVPVKTQPSVH
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          PIQSDEGDELFLSMGEAALGETVGPPTERIGDRPTPEAPIIISPPQTHKPNMYDLEWRAG
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          RDWGIAIIAYFVKYRKVDDMGNVVGSWHTVRVPGSEKSLPLSELEPSSLYEVLMVARSAA
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          GEGQPAMLTFRTGKERASPNKNPSKAPIVSLPEKTPEDKTTNTYYGVVIHDRVPEAPDRP
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          TISMATESSVYVTWIPRANGGSPITAFRVEYRKQGRNGDWIIAADNISPLKLSVEVRNLE
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          PGSTYRFRVIAMNNYGESPASATSRPYQVSMSSSPVSNRPVTGPHISSTDAVSDTQILLR
FnIII_3_Mus_musculus      ---------------------------------------PITGPHIAYTEAVSDTQIMLK
FnIII_3_Homo_sapiens      ---------------------------------------PITGPHIAYTEAVSDTQIMLK
                                                                 *:*****: *:*******:*:
Cdon_Danio_rerio          WTYTPSSNNNTPIQGFYIYYRPTDSDNDSDYKKDVVEGFKFWHMIGELQPETSYDIKMQC
FnIII_3_Mus_musculus      WTYVPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHTIGHLQPETSYDIKMQC
FnIII_3_Homo_sapiens      WTYIPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSYDIKMQC
                          *** ****************************:***** * ** **.*************
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Cdon_Danio_rerio          YNDGGESEYSNVMICETKARQPPGVPSLRPITPPGFYPADTPSQPGGLLYLIVGCVLGVM
FnIII_3_Mus_musculus      FNEGGESEFSNVMICET-------------------------------------------
FnIII_3_Homo_sapiens      FNEGGESEFSNVMICET-------------------------------------------
                          :*:*****:********                                           
Cdon_Danio_rerio          VLILLVFIVMCLWRNRQQNSMHKYDPPNYIYQSAEMNGHVLDYSALPGSSHVNGSVHTGC
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          GHTAPMMPQTCHHLHHKLPNGLALLNGSGGLYPAGHPHAHDTSLHQNNMEYEHPSPHHLH
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          NGGGIYTALPQNDSSDCMSCQNFCNNNRCYTKTNGTFSGGTLPLMHRVAARQPDGLEMMP
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          LNPILSRCHGRDSPQLNGCQDRDSVQQAEEGNVPPLSHNSPCLPVETKSSLEQQRGVQQV
FnIII_3_Mus_musculus      ------------------------------------------------------------
FnIII_3_Homo_sapiens      ------------------------------------------------------------
                                                                                      
Cdon_Danio_rerio          QHEDSEGPVVCWERLGLDLDCKEKTAWISTGSLTGDLIQPTVQEI
FnIII_3_Mus_musculus      ---------------------------------------------
FnIII_3_Homo_sapiens      ---------------------------------------------
Consensus symbols
* (asterisk) indicates positions which have a single, fully conserved residue. 
: (colon) indicates conservation between groups of strongly similar properties - scoring > 0.5 
in the Gonnet PAM 250 matrix. 
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. (period) indicates conservation between groups of weakly similar properties - scoring =< 
0.5 in the Gonnet PAM 250 matrix. 
 
Zebrafish Cdon fibronectin type-III 2 and 3 sequences obtained from the alignment 
with mouse and human Cdon fibronectin type-III  2 and 3 sequences.
Q1L8D0 (Q1L8D0_DANRE)
>tr|Q1L8D0|Q1L8D0_DANRE Cell adhesion molecule-related/down-regulated by 
oncogenes OS=Danio rerio GN=cdon PE=2 SV=2
MEDGGLRLLSAVLCVCHTLLLNCPTVLSFSFRAEPLSAILKQGSSVHLHCTTHPATARIS
WLFQGQPLDPSHHSGVELSQDSLSLSNLQPALTGSYQCSARSETGSIISRHARVTIADIE
EFAETHRRSFTVNKGDTAVIECPLPRSNPPALPRFRIRGKWLEQSTDEYLILPSGNLQIV
SVSSEHQGMYKCGAYNPLTRETRVEAHGTKLLVKDSESSSPVRIVYPITPRSLTVDQSGS
LTLECVVSGSLSSKVKWMKNGAELSLSSKRMLSHSNLVLNDIQPGDGGHYSCSVPTDRGA
VVSVNYTVNVLAHVSILRGLSDQAAVAGSSVRFTCAASGNPTPNITWLLNAAPLSSSPRL
KISGTSLLISSTTLQDQGIYQCMFDNGISSAQSTGRLSIQSEPQSSSISAVPVKTQPSVH
PIQSDEGDELFLSMGEAALGETVGPPTERIGDRPTPEAPIIISPPQTHKPNMYDLEWRAG
RDWGIAIIAYFVKYRKVDDMGNVVGSWHTVRVPGSEKSLPLSELEPSSLYEVLMVARSAA
GEGQPAMLTFRTGKERASPNKNPSKAPIVSLPEKTPEDKTTNTYYGVVIHDRVPEAPDRP
TISMATESSVYVTWIPRANGGSPITAFRVEYRKQGRNGDWIIAADNISPLKLSVEVRNLE
PGSTYRFRVIAMNNYGESPASATSRPYQVSMSSSPVSNRPVTGPHISSTDAVSDTQILLR
WTYTPSSNNNTPIQGFYIYYRPTDSDNDSDYKKDVVEGFKFWHMIGELQPETSYDIKMQC
YNDGGESEYSNVMICETKARQPPGVPSLRPITPPGFYPADTPSQPGGLLYLIVGCVLGVM
VLILLVFIVMCLWRNRQQNSMHKYDPPNYIYQSAEMNGHVLDYSALPGSSHVNGSVHTGC
GHTAPMMPQTCHHLHHKLPNGLALLNGSGGLYPAGHPHAHDTSLHQNNMEYEHPSPHHLH
NGGGIYTALPQNDSSDCMSCQNFCNNNRCYTKTNGTFSGGTLPLMHRVAARQPDGLEMMP
LNPILSRCHGRDSPQLNGCQDRDSVQQAEEGNVPPLSHNSPCLPVETKSSLEQQRGVQQV
QHEDSEGPVVCWERLGLDLDCKEKTAWISTGSLTGDLIQPTVQEI
 The homolog residues important for Cdon function in Hh signaling (in the Ptch 
binding domain) are highlighted in blue (Bae et al., 2011). The homolog residues important 
for Shh binding are highlighted in red (McLellan et al., 2008).
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Enhancer Detection.
 For the enhancer analysis alignments we used the following sequences obtained from 
UCSC Genome Browser website. The sequences A-I were amplified by PCR from zebrafish 
DNA using the primers listed in table IX.
Danio rerio, chr18:42,238,809-42,745,581
Tetraodon nigroviridis; chr16:5,282,323-5,169,430
Takifugu rubripes; chr11:8,230,678- 8,132,445
Oryzias latipes; chr13:4,271,233-4,579,683
Gasterosteus aculeatus; chr1:15,349,426-15,539,451
Table IX. List of primers to amplify the possible Cdon regulatory elements. 
Enh Primer F Primer R start end
A TAGAAAAACCAACTCTATAGA-
CACC
GGAGTCAAAGACATTATAGCAT-
TAC
42419960 42420318
B GAGTCTTTTTCGCCGACTGGGG CTTGTGTTTCGGTGGAGCAGCT 42424126 42424445
C AGCCAACATTTGGAAAAGAC TGAGAAGGCTGTGAGTGTGA 42499655 42500039
D TCTACAGAGTGTAGGTGACCTT GTGTAGCATGCATCGTAGATGT 42516402 42517273
E TGGCCATGTATTGATTCAAA CATCGGTTATCCAGTACAGA 42522330 42522663
F GTCCTGGTAATAGGAAGTGC-
GGGGC ACGACCTGATTGAGGCCCGA
42548364 42548712
G CACTTCTGGTTTAGTTTCAGTT ATCTATCCTGCCTTGTATCAAC 42567249 42568543
H TTTTAAAGTGTGTGAGAGAG-
TATGC CATTTTTCTGTCATGATCCG
42574828 42575312
I AAGAGTAGAGACATATGGAACG TTCTGTGCTATAAATTACCC 42586581 42586840
 The histone profile data of H3K27AC of zebrafish Cdon was kindly provided by Dr. 
Jose Luis Gómez-Skarmeta (unpublished data).
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Cdon and Boc, and theirDrosophilahomologues Ihog and Boi, are evolutionary conserved transmembrane
glycoproteins belonging to a subgroup of the Immunoglobulin superfamily of cell adhesion molecules
(CAMs). Initially isolated in vertebrates as CAMs that link cadherin function with MAPK signaling in
myoblast differentiation, they have thereafter been shown to act as essential receptors for the Hedgehog
(Hh) family of secreted proteins. They associate with both ligand and other Hh receptor components,
including Ptch and Gas1, thus forming homo- and heteromeric complexes. In Drosophila, they are also
involved in ligand processing and release from Hh producing cells. Cdon/Boc and Ihog/Boi can substitute
one another and play redundant functions is some contexts. In addition, Boc, but not Cdon,mediates axon
guidance information provided by Hh in speciﬁc neuronal populations, whereas mutations in the CDON
cause holoprosencephaly, a human congenital anomaly deﬁned by forebrainmidline defects prominently
associated with diminished Hh pathway activity.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Cell to cell communication is at the basis of coherent organ
development and tissue homeostasis. There are several different
ways in which cells interact with one another but cell adhesion
and activation of signaling cascades by extracellular molecules are
twoprominentmechanisms. Cdon (cell adhesionmolecule-related,
down-regulated by oncogenes, also noted as Cdo) and Boc (Brother
of Cdon), the two molecules here on focus, are emerging as impor-
tant mediators of both functions.
The Cdon gene was isolated out of a screening designed to iden-
tify novel transformation suppressor genes using a cDNA library
derived from a rat ﬁbroblast cell line, resistant to oncogene-
induced anchorage-independent growth (Kang et al., 1997). The
corresponding gene product was characterized as a cell surface
glycoprotein of the Immunoglobulin (Ig)/ﬁbronectin type III-like
(FNIII) family and soon after implicated in myogenic differentia-
tion (Kang et al., 1998). Low stringency screening of a human fetal
brain cDNA library with a rat Cdon probe lead to the identiﬁcation
of a related gene named Boc, which encoded a protein with sim-
ilar effects on myoblast differentiation (Kang et al., 1998, 2002).
∗ Corresponding author at: Centro de Biología Molecular Severo Ochoa, CSIC-
UAM, Universidad Autónoma de Madrid, c/ Nicolás Cabrera, 1, 28049 Cantoblanco,
Madrid, Spain. Tel.: +34 91 196 4718 (ofﬁce); +34 91 196 4720 (lab);
fax: +34 91 196 4420.
E-mail address: pbovolenta@cbm.uam.es (P. Bovolenta).
1 These authors contributed equally to this work.
Both genes are highly conserved among vertebrateswhereas, in the
Drosophila counterparts, a highdegreeof conservation is foundonly
in the region predicted to encode the extracellular domain (Kang
et al., 2002). The Drosophila homologues were thereafter indepen-
dently identiﬁed in a RNA interference screening in tissue culture
cells for newcomponents of theHh signaling pathway and received
the name of ihog (interference hedgehog) and boi (brother of ihog)
(Lum et al., 2003). Both vertebrate and invertebrate proteins were
shown to bind the N-terminal and biologically active Hh (HhN) or
Shh (ShhN) peptides (Yao et al., 2006), prompting the investigation
on Cdo/Boc and ihog/boi function in different directions.
2. Structure and interactions
The human CDON gene maps to the minus strand of a gene rich
genomic region on chromosome 11q24.2 and is composed of 20
exons. Although data base predictions identify different alterna-
tive transcription start sites, only two transcripts have been so far
described encoding isoforms of 1287 and 1264aa. The shorter iso-
form has received the most attention. BOC similarly localizes to a
gene-rich region but to the plus strand of chromosome 3q13.2. Its
20 exons encode an 1114aa protein that shares 34% identity with
CDON (Kang et al., 2002).
Cdon and Boc proteins have been characterized as cell surface
glycoproteins belonging to a subgroup of the Immunoglobulin (Ig)
superfamily of cell adhesion molecules (CAMs), that also includes
the Robo axon-guidance receptors. Their ectodomain respectively
contains ﬁve and four Ig-like domains, followed by three FNIII
1357-2725/$ – see front matter © 2012 Elsevier Ltd. All rights reserved.
doi:10.1016/j.biocel.2012.01.019
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repeats (Fn1-3), a single trans-membrane domain and a divergent
intracellular region of variable length (Fig. 1A), whichmay account
for some of their functional differences (Kang et al., 2002; Mulieri
et al., 2002). The presence of four Ig domains and only two FNIII
repeats (Fn1, 2) distinguished the Drosophila Ihog and Boi from
their vertebrate homologues (Fig. 1A) (Kang et al., 2002; Yao et al.,
2006). Sequence analysis reveals that Cdon/Boc Fn2 and Fn3 are
respectively homologous to the Fn1 and Fn2 of Ihog/Boi (Kang et al.,
2002).
Boc and Cdon form homophilic and heterophilic complexes in
cis by interaction of the ecto- and intracellular domains (Kang
et al., 2002) (Fig. 1B–D). Cdon has also been shown to interact with
Neogenin (Kang et al., 2004), an Ig/FnIII CAM family member that
acts as receptor for the axon guidance cue Netrin. Furthermore,
during myoblast and neuronal differentiation, cis-interaction of N-
CadherinwithFn1 (Kangetal., 2003; LuandKrauss, 2010)promotes
binding of the Cdon intracellular domain to Bnip-2 and JLP, two
proteins that function as scaffolds for small GTPases and p38 path-
way components, respectively (Kang et al., 2008; Takaesu et al.,
2006; Oh et al., 2009). The Cdon–Bnip-2 complex furthers interacts
with Cdc42 and stimulates its activity, which, in turn, is required
for p38-dependent differentiation (Fig. 1B). Activation of the same
pathway has been also observed after Cdon association with the
non-receptor tyrosine kinase Abl (Bae et al., 2009) (Fig. 1B).
Cdon/Boc and Ihog/Boi bind members of the Hh family with
high-afﬁnity, but, notably, with different and evolutionary non-
conserved modes (Okada et al., 2006; Tenzen et al., 2006; Yao
et al., 2006; McLellan et al., 2008). Biochemical, biophysical, and
X-ray structural studies demonstrated that Shh-Cdon interaction
is calcium dependent and involves a previously unappreciated bin-
uclear calcium-binding site on ShhN (McLellan et al., 2008) and
the Cdon/Boc Fn3 (Tenzen et al., 2006; Yao et al., 2006; McLellan
et al., 2008). This interaction mode is conserved for all vertebrate
Hh proteins (Kavran et al., 2010). Instead, and despite the general
extensive homology between invertebrate and vertebrate Hh pro-
teins, the HhN surface that binds Ihog is different (a single common
residue) from that implicated Shh/Cdon interaction (McLellan et al.,
2008). Furthermore, HhN-Ihog binding is heparin-dependent and
involves the Ihog/Boi Fn1,which is nothomologous to theCdon/Boc
Fn3 (Yao et al., 2006) (Fig. 1A, B). The Cdon-like binding mode is
conserved in vertebrates and the Ihog-likemode in arthropods, but
how interaction occurs in other species remains to be determined
(McLellan et al., 2008).
Besides ligandbinding, Ihog/Boi can forma complexwith theHh
receptorPatched (Ptch) and thisheteromeric interaction is required
for both high-afﬁnity ligand binding and presentation of Ptch at the
cell surface, providing initial indications that Ihog or Boi are obli-
gate co-receptors for efﬁcient Hh reception (Zheng et al., 2010).
This requirement is conserved in vertebrates (Fig. 1B, C), where an
additional Hh binding protein, Gas1, can substitute Cdon or Boc
function in speciﬁc contexts as demonstrated by genetic inactiva-
tion studies in mice (Bae et al., 2011; Izzi et al., 2011; Allen et al.,
2011). Notably, Cdon has also been shown to associate with Gas1
(Fig. 1D).
The relevance of simultaneous interaction of Cdon/Boc with
both ligand and other Hh receptor proteins is supported by muta-
tion analysis. A mutation in Cdon that does not interfere with Shh
binding, but weakens interaction with Ptch and Gas1, is associated
with low Shh signaling activation (Bae et al., 2011). Conversely, a
pointmutation in theHh protein that interfereswith Boc, Cdon and
Gas1 but not with Ptch binding prevents Shh signaling activation
(Izzi et al., 2011).
3. Expression, activation and turnover
Boc and CdonmRNAswere initially localized to cells of themyo-
genic lineages (Kang et al., 1998, 2002; Mulieri et al., 2002) but
their distribution has been thereafter detected from gastrulation
stages in many tissues of different vertebrate species. In general,
their expression is mostly associated to domains of proliferating
andundifferentiated cellswhere both genes are co-expressed, indi-
cating cooperative activities (Mulieri et al., 2002). Both genes have
also unique sites of expression that may explain the so far speciﬁc
function of Boc (Connor et al., 2005; Fabre et al., 2010; Okada et al.,
2006) and Cdon (Ming et al., 1998; Cole and Krauss, 2003) as we
will detail later. In Drosophila, ihog and boi are widely distributed
at embryonic and larva L3 stages (http://ﬂybase.org).
At early stages of vertebrate embryonic development, Boc and
Cdon are abundantly expressed in the head folds, somites, the
developing lungs, primitive gut and tracheal mesenchyme, the
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Fig. 1. Schematic diagram representing the structure and protein interactions of Boc and Cdon. (A) Comparison of the domain organization of Boc and Cdonwith that of their
Drosophila homologs, Boi and Ihog. Numbers indicate the position of each Fibronectin type III (FnIII) domain. (B) Cdon forms homo- and heteromeric complexes binding to
Neogenin and N-cadherin and interacts with the cytosolic proteins JLP, Abl, Bnip-2. Within the Shh signaling pathways Cdon (B) and Boc (C) associate with Shh, Dhh, Ihh and
Ptch1. (D) Boc and Cdon can interact in cis and bind Gas1. Arrows and dotted lines depict protein interactions. Ig, Immunoglobulin domain. FnIII, Fibronectin type III domain.
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digestive tract and urogenital system, the limb buds, the dorsal
aspect of the entire neural tube and sensory organs, including the
inner ear, the olfactory apparatus and the developing eye (Kang
et al., 2002; Mulieri et al., 2000, 2002; Connor et al., 2005; McGlinn
et al., 2005; Bergeron et al., 2011). Later on, Boc and Cdon have
been also detected in the cortical progenitors of the telencephalon,
the prospective hippocampus, the dorsal thalamus and epithala-
mus and the dorsal superior and inferior coliculi (Aglyamova and
Agarwala, 2007).
In mice Cdon mRNA is also transiently expressed at low lev-
els in the notochord (Tenzen et al., 2006), whereas Boc has been
transiently detected in the zebraﬁsh ventral spinal cord prior to
expression in the dorsal neural tube, in the branchial arches and
in the hypothalamus and hindbrain (Bergeron et al., 2011). As the
central nervous systemdevelops, Boc, but not Cdon, localizes to the
differentiated commissural neurons of the spinal cord (Okada et al.,
2006; Tenzen et al., 2006) and to the ipsilaterally projecting reti-
nal ganglion cells (RGCs) (Fabre et al., 2010; Sanchez-Camacho and
Bovolenta, 2008), inﬂuencing the axon outgrowth of both types of
neurons.
At the moment there is little information regarding the precise
regulation of Cdon/Boc and ihog/boi expression and the turnover
of the respective encoded proteins. Cdon and Boc both seem to be
negatively regulated by Hh signaling in early vertebrate embryos
(Tenzen et al., 2006; Bergeron et al., 2011) as also supported by
the abnormal levels of Cdon expression found in the limb buds of
Gli3mutant embryos (McGlinn et al., 2005). However, there is also
evidence for Shh-mediated Boc upregulation in cerebellar granule
cell precursors (Lee et al., 2010). Nevertheless, the ﬁnal levels of
receptors at the membrane might be tightly regulated by a com-
plex feed-back regulatory mechanism as in both vertebrates and
invertebrates Cdo/Boc and ihog/boi participate in Hh pathway acti-
vation (Lum et al., 2003; Okada et al., 2006; Tenzen et al., 2006;
Yao et al., 2006; Izzi et al., 2011; Allen et al., 2011) and regulate the
extracellular Hh distribution, likely restricting its range of action
(Yan et al., 2010; Hartman et al., 2010; Callejo et al., 2011) (Fig. 2A).
4. Biological functions
As already mentioned, Cdon/Boc and iHog/Boi are cell adhesion
molecules and important regulators of Hh signaling in different
contexts. As such, they have been shown to regulate different
developmental and homeostatic events with Hh-independent and
dependentmechanisms. The studies exploring the function of both
proteins in different species are rapidly growing. Below we high-
light a few prominent aspects of their activities.
Speciﬁcation and differentiation of skeletalmyocytes are tightly
regulated and require the activity of transcription factors such as
myogenic regulatory factors (MRF) and myocyte enhance factor-
2 (MEF2). MRF and MEF2 are in turn controlled by the p38/
mitogen-activated protein kinase (MAPK) signaling pathway and
p38 deﬁciency impairs myoblast differentiation (Krauss, 2010).
Cell adhesion mediated by cadherins, including N-, R- and M-
cadherins, is also a key factor in skeletal muscle differentiation
(Krauss, 2010). Cdonacts at the interfacebetween these twoevents.
Asmentionedabove, Cdonassociates at theplasmamembranewith
N- and M-cadherins. Upon interaction, the intracellular region of
Cdon undergoes a change and stably associates with Bnip-2/Cdc42
and JLP/p38/, leading to p38 activation and thus myogenic dif-
ferentiation (Fig. 1B). These changes do not occur when Cdon binds
Shh, thus Cdon acts as a non-ligand-binding signaling co-receptor
for N-cadherin in this context (Lu and Krauss, 2010). Similarly,
CdonassociateswithNeogenin, andbothmolecules are required for
Netrin-mediated activation of FAK and ERK signaling in myoblasts
(Bae et al., 2009). In line with these multiple functions, Cdon−/−
mice present delayed skeletal muscle development (Cole et al.,
2004).
Cdon, Boc, Cadherins andNeogeninare co-expressed indifferent
tissues, but whether their functional interaction is muscle speciﬁc
or occurs in other tissues needs to be explored. Indeed, most of
the currently known, additional functions of Cdon and Boc can
be explained by their participation in the Hh signaling pathway,
forming a functional receptor with Ptch in several tissues and/or
Ptch1 Smo
Ihog/Boi
Boc/Cdon
Ihog
APICAL
BASAL
RECEIVING CELLSPRODUCING CELLS
BA
Ihog/Boi
Hh Shh
Hh
Hh Hh Hh
Hh
Hh Hh
Hh
Hh Hh
Hh
Hh
Hh
Fig. 2. Schematic diagram of the proposed functions for Cdon/Boc and Ihog/Boi in the Hh signaling. (A) Ihog and Boi can titrate Hh levels in the extracellular space, acting
as molecular sinks. (B) In the Hh producing cell, Hh undergoes apico-basal recycling in the wing imaginal disc epithelium. Ihog in the latero-basal membrane contributes to
processes of Hh release and membrane attachment. In the receiving cell, Ihog, Boi, Boc and Cdon associate with both Hh ligands and Patched (Ptch) receptor increasing the
Hh signaling response. Pathways activation further involves release of Smoothened (Smo) inhibition and transcription activation of target genes.
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cell types (Fig. 2B). Notably, their function appears redundant in
different contexts. For example, Boc and Gas1 can substitute one
another in the cerebellum and both of them can associate with the
Ptch receptor tomediate Shh-dependent proliferation of cerebellar
granule neuron progenitors. Consequently, only combined genetic
inactivation of the two molecules impairs cerebellar development
(Izzi et al., 2011). Similarly, Boc, Gas1 as well as Cdon play over-
lapping and essential roles during early Hh-dependent patterning
of the mammalian ventral neural tube and further contribute the
speciﬁcation of different neural progenitors (Allen et al., 2011).
Only embryos deﬁcient in the three genes die before birth and are
characterized by a phenotype similar to that in Shh null embryos,
with severe holoprosencephaly (HPE) – a phenotype deﬁned by
forebrainmidline defects – cyclopia, heart and limbmalformations
(Allen et al., 2011; Izzi et al., 2011). This overlapping activity does
not seem to be conserved in zebraﬁsh, where loss of Boc function,
that characterizes the umleitung (uml)mutant, is sufﬁcient to cause
defects in patterning of the ventral neural tube, somites and upper
jaw.Mechanistically, Boc seems required tomaximize the response
of cells exposed to high Hh concentrations; in its absence, cells no
longer express genes that are normally activated by high Hh levels
(Bergeron et al., 2011).
Boc, but not Cdon, has also been implicated in mediating axon
guidance information provided by Shh. Both spinal cord commis-
sural and RGC axons respond to Shh secreted by ventral midline
cells, the ﬂoor plate and the pre- and post-optic areas, respec-
tively. Their response is however different. Floor plate-derived Shh
attracts Boc-positive commissural axons from the dorsal spinal
cord toward the midline, whereas the growth of contralateral pro-
jecting RGC axons is suppressed by Shh, which, expressed at the
chiasm borders, funnels the growth of axons to the contralateral
side of the brain (rev. in Sanchez-Camacho and Bovolenta, 2009).
Genetic inactivation of Boc prevents commissural axons to reach
the ﬂoor plate (Okada et al., 2006), with a mechanism that seems
to involve a Src-kinase dependent non-canonical pathway (Yam
et al., 2009). In contrast to commissural neurons, contralaterally
projecting RGCs do not express Boc, suggesting that Shh-mediated
repulsion involves a different receptor complex. Notably however,
Boc localizes to the small population of ipsilaterally projecting
RGCs, the axons of which respond positively to Shh stimulation
(Sanchez-Camacho and Bovolenta, 2008). In Boc null embryos, the
number of ipsilateral projecting axons is reduced, leading to the
hypothesis that Boc contributes to the segregation visual axons at
theoptic chiasm (Fabre et al., 2010). Further supporting thatBochas
a relevant function in axon guidance, knock-down of Boc function
in zebraﬁsh causes defects in the trajectory of the dorso-ventrally
projecting supraoptic and epiphyseal tracts,which aberrantly grow
toward the anterior and postoptic commissure, respectively. In
addition, axons of the posterior commissure were defasciculated
and ectopically extended toward rostro-dorsal regions (Connor
et al., 2005). Whether all these defects are Hh-dependent or may
alternatively imply the cell adhesion properties of Boc needs to be
investigated.
In contrast to Boc−/− mice that are characterized by axon guid-
ance defects, Cdon deﬁcient mice display different forms of HPE
with strain-speciﬁc severity that goes from mild facial defects
to brain and eye malformations (Cole and Krauss, 2003; Zhang
et al., 2006, 2009), suggesting that Cdon has some spatio-temporal
unique function during embryonic development. Underscoring a
unique function during mammalian development, mutations in
CDONhave been found in patients affected byHPE (Bae et al., 2011).
Nevertheless, defects of Cdon−/− embryos aggravate in absence of
Boc. Indeed,Cdo−/−;Boc−/− animals display severe brain defects and
strong craniofacial anomalies, associated to reduced expression of
Shh and its target genes (Zhang et al., 2011). The phenotype of
double-mutant mice is however milder than that of Shh-null mice,
likely owing to the compensating expression of Gas1 (Allen et al.,
2011; Izzi et al., 2011).
In Drosophila, loss of either boi or ihog function has no conse-
quences in the development of the imaginal discs that are normally
strongly dependent on Hh signaling. Their combined inactivation
however recapitulates hh loss of function, suggesting that Boi and
Ihog play a redundant function in Hh pathway activation (Zheng
et al., 2010; Camp et al., 2010). Notably, Ihog and Boi have been
also related to the formation of the Hh gradient, as both proteins
can sequester and titrate the amount of ligand available for Ptch
binding, thus limiting long-range signaling (Yan et al., 2010; Zheng
et al., 2010; Hartman et al., 2010).
As in vertebrates, speciﬁc independent functions for Ihog and
Boi have been also described. Indeed, Boi, but not Ihog, is expressed
in apical cells of the Drosophila ovary where it suppresses follicle
stem cell proliferation by binding to and sequestering Hh on the
apical cell surface, thereby controlling Hh long-range distribution
(Hartman et al., 2010). Ihog instead together with Dally-like (Dlp),
an additional protein previously implicated in Hh reception, has
been shown to act as a key component of Hh secretion from the
producing cells (Fig. 2B). Ihog and Dlp both interact with Ptc during
Hh reception (Yao et al., 2006; Yan et al., 2010) and both interact
withDispatchedduringHh release fromtheproducing cells (Callejo
et al., 2011). In the Drosophila wing imaginal disc epithelium, Hh
undergoes apico-basal recycling in the producing cells to form a
basolateral gradient. Ihog anchors Hh to the basolateral plasma
membranes, where it binds to Ptch localized to the baso-lateral
side of the responding cells and activates the downstream signal-
ing cascade (Callejo et al., 2011). Whether Boi has a similar role
and what makes Ihog acquire different functions in the produc-
ing and receiving cells are still unanswered questions that deserve
attention.
5. Possible medical applications
Mutations in CDON have already been associated with human
HPE and BOC may represent a silent HPE modiﬁer gene (Zhang
et al., 2011). However, besides HPE, alterations in Shh signaling
cause other severe pathological conditions including Carpenter,
Ellis-van Creveld, Smith-Lemli-Opitzl and Pallister-Hall Diseases,
Greig Cephalopolysyndactyly or the Gorlin syndrome. Search for
possible implications of Cdon and Boc in these conditions is thus a
necessary step toward the understanding of the possible medical
implication of these molecules. The important role of Cdon in eye
formation and that of Boc in RGC axon guidance are also reasons to
consider these genes as possible candidates for inborn ocular mal-
formations. The fundamental role of Cdon and Boc in Hh signaling
suggests also that they might be relevant targets for therapy in Hh
dependent tumors.
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Abstract
During development, the mechanisms that specify neuronal subclasses are coupled to those that determine their axonal
response to guidance cues. Pax6 is a homedomain transcription factor required for the specification of a variety of neural
precursors. After cell cycle exit, Pax6 expression is often shut down in the precursor progeny and most postmitotic neurons
no longer express detectable levels of the protein. There are however exceptions and high Pax6 protein levels are found, for
example, in postmitotic retinal ganglion cells (RGCs), dopaminergic neurons of the olfactory bulb and the limbic system in
the telencephalon. The function of Pax6 in these differentiating neurons remains mostly elusive. Here, we demonstrate that
Pax6 mediates the response of growing axons to SFRP1, a secreted molecule expressed in several Pax6-positive forebrain
territories. Forced expression of Pax6 in cultured postmitotic cortical neurons, which do not normally express Pax6, was
sufficient to increment axonal length. Growth was blocked by the addition of anti-SFRP1 antibodies, whereas exogenously
added SFRP1 increased axonal growth of Pax6-transfected neurons but not that of control or untransfected cortical
neurons. In the reverse scenario, shRNA-mediated knock-down of Pax6 in mouse retinal explants specifically abolished RGCs
axonal growth induced by SFRP1, but had no effect on RGCs differentiation and it did not modify the effect of Shh or Netrin
on axon growth. Taken together these results demonstrate that expression of Pax6 is necessary and sufficient to render
postmitotic neurons competent to respond to SFRP1. These results reveal a novel and unexpected function of Pax6 in
postmitotic neurons and situate Pax6 and SFRP1 as pair regulators of axonal connectivity.
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Introduction
The selective response of axons to elongation and guidance cues
encountered along their paths enables the precise formation of
neuronal circuits and the formation of topographic maps. During
development, mechanisms that specify neuronal subclasses are
coupled to those that specify their axonal response through the
selective expression of transcription factors.
Pax6 is a homeodomain transcription factor expressed in several
territories of the developing nervous system, mostly in the
proliferative regions containing neural precursors [1]. The vast
majority of the neural progeny of these precursors including
neurons of the dorsal cortical plate or neural stem cell (NSCs)
derived neurons, shut down Pax6 expression upon exiting the cell
cycle. Consequently, very few postmitotic populations express
Pax6. Notable examples are the retinal ganglion cells (RGCs), the
dopaminergic neurons of the olfactory bulb and certain neurons in
the basal telencephalon and midbrain [2,3,4,5]. While the role of
Pax6 in neural precursors has been widely explored, revealing a
central function in cell fate specification and cell cycle regulation
[5,6,7,8,9], less attention has been paid to its functions in
postmitotic neurons, with the major exception of a recent study
demonstrating that Pax6 is needed for the survival of dopaminer-
gic neurons in the olfactory bulb [10].
RGCs are one of the best-characterized postmitotic populations
that express Pax6 [11]. Pax6 expression in both developing and
mature RGCs is graded, with higher levels in the ventro-temporal
distal cells and lower in the proximal domains [11]. These two
differentially expressing Pax6 populations project to distinct non-
overlapping and complementary topographic regions of the
superior culliculus and lateral geniculate nucleus (LGN), which
suggests that Pax6 may contribute to control axon targeting.
Indeed, RGCs of mice overexpressing Pax6 show disrupted axonal
trajectories and abnormal bundle formation [12], whereas changes
in Pax6 expression in the RGCs correlate with axonal regener-
ation in the optic nerve of lizards and zebrafish [13]. Still, there is
no information on whether Pax6 is directly involved in the control
of axon growth and what guidance cues, if any, depend upon its
activity.
Secreted Frizzled-Related Protein 1 (SFRP1) is one of the
factors known to stimulate the directional growth of RGCs axons
in Xenopus and chick retina. This activity is independent of Wnt
signaling and modulated by extracellular matrix molecules
[14,15]. Mouse Sfrp1 is expressed in several structures of the
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embryonic and adult eye and brain, including the pigmented
retina, cornea, ciliary bodies, lens epithelium, the prospective
thalamus and the proliferative regions of the telencephalon
[14,16,17,18,19]. The SFRP1 distribution often coincides with
that of Pax6 or decorates the axonal pathways of Pax6 expressing
neurons [14,16,17,18,19], raising the possibility of a functional
relationship between the two molecules.
Here we show that expression of Pax6 in neuronal postmitotic
populations is necessary and sufficient to confer neurons with a
positive response to SFRP1. Over-expression of Pax6 rendered
cultured cortical neurons competent to respond to endogenous
and exogenous SFRP1. Conversely, knock-down of Pax6 in mouse
retinal explants abolishes RGC axonal growth induced by SFRP1
without affecting RGC differentiation or their axonal response to a
different guidance cue like sonic hedgehog (Shh) or Netrin. These
results suggest that Pax6 and SFRP1 are pair regulators of axonal
connectivity in the retina and reveal a new function of Pax6 in the
postmitotic populations.
Results
1. Pax6 induces axonal growth in postmitotic neurons
The majority of postmitotic neurons, including those derived
from telencephalic Pax6 positive precursors, such as cerebral
cortical neurons or neurons derived from cortical neural stem cells
(NSCs), do not express Pax6 [2] (Fig. S1a). To test the
consequences of Pax6 expression in postmitotic populations, we
forced its expression in neurons derived from mouse NSCs. NSCs
grown as neurospheres were nucleofected with CAG-empty vector
or CAG-Pax6, together with a CAG-GFP that allowed the
visualization of transfected cells. GFP staining demonstrated
efficient transfection by FACs cytometry (Fig. S1b) and immuno-
staining of plated cells confirmed that cells transfected with CAG-
Pax6, but not those transfected with the empty vector, had nuclear
Pax6 protein expression (Fig. S1a). Plated transfected cells were
then allowed to differentiate for 9 days to analyze their
differentiation and morphology. GFP neurons identified by b-
tubulin III expression show an advance differentiated asymmet-
rical polarized morphology, both in control and Pax6 transfected
cells (Fig. 1 c), and the longer neurite was identified as the axon by
MAP1b staining (not shown), a selective marker of the distal part
of the growing axon [24]. Overexpression of Pax6 alone was
sufficient to promote axonal extension compared to control
neurons (Fig. 1a). Quantitative analysis of b-tubulin III positive-
projections confirmed a significant increment of the axonal length
from neurons transfected with CAG-Pax6 both at 6 and 9 days of
culture (Fig. S2 and Fig. 1a, respectively). Similar results were
obtained upon quantification of MAP1b projecting axons (not
shown). The total number and extension of the additional neurites
was not affected (Figure S1c).
Several reports have shown that Pax6 over-expression induces
precursor cells to exit the cell cycle and differentiate [9,25]. To
discard the possibility that increased axonal length was a
consequence of a premature exit from cell cycle and, thus, of an
extended time of differentiation, we restricted our study to those
cells that were leaving the cell cycle at similar times. To visualize
cohorts of nascent neurons, BrdU was added on the second day of
culture and extensively washed after 12 h. Analysis of BrdU-
positive neurons on the ninth day of culture confirmed that the
axons of the Pax6 expressing population were significantly longer
than those of cells transfected with mock vector (Fig. 1b and c).
Restricting to this cohort of BrdU neurons correlated with a higher
increment in axonal length as expected from the analysis of a more
homogenous population (compared Fig. 1a and b). This
demonstrates that the effect in axonal growth is unrelated to an
early exit from the cell cycle. To strengthen this conclusion, we
over-expressed Pax6 in non-proliferating primary cortical neurons
and quantified the length of MAP1b projections, obtaining similar
results (Fig. 1d and e), although the increment of outgrowth was
less evident than that observed in NCSs, likely owing to the
heterogeneity of primary differentiating neurons. Together, these
experiments demonstrated that Pax6 expression in differentiated
neurons stimulates process elongation by a cell cycle independent
mechanism.
2. Pax6 mediates the axonal response to SFRP1
SFRP1 is expressed by the neural precursors of the ventricular
zone (VZ) of the dorsal telencephalon, which give rise to both
cortical neurons and NSCs [2]. We confirmed that neural
precursor cells cultivated in vitro also express detectable levels of
the SFRP1 protein (Fig. 2a). We therefore postulated that SFRP1
produced and secreted in the culture by undifferentiated cells was
responsible for the selective axonal growth of Pax6-transfected
neurons. Addition of antibodies against SFRP1 to the culture
media two days after NSCs transfection completely blocked Pax6-
induced axonal growth, leading to processes with a length
undistinguishable from that of control cells (Fig. 2b). This result
was specific since addition of control unrelated antibodies had no
effect (Fig. 2b). This data indicated that Pax6 stimulated the
growth of NSCs derived neurons in response to endogenous
SFRP1 produced in the in vitro culture.
To support this conclusion, we next assayed the effects of
exogenously added SFRP1 upon forced expression of Pax6 in
primary cortical neurons or neurons derived from NSCs. Purified,
recombinant SFRP1 was added to the neuronal culture after
transfection and the early axonal response was evaluated after two
or three days in cortical neurons and NSCs, respectively. Notably,
addition of exogenous SFRP1 to control neurons had no effect on
the length of their axons, but stimulated, in a dose dependent
manner, the elongation of those belonging to Pax6-positive
neurons (Fig. 2c, d and Fig. S3). Therefore, Pax6 appears to be
necessary and sufficient to confer cortical neurons with the
competence to respond to SFRP1 of exogenous or endogenous
origin.
Postmitotic RGCs express Pax6 [4] and their axons respond to
SFRP1 [14]. We therefore asked whether this response was
similarly dependent on Pax6. To this end we decided to knock-
down Pax6 using shRNA lentiviral constructs. Effective knock-
down of the Pax6 protein by the shRNA lentiviral constructs was
first evaluated in cultured mammalian CHO cells transfected with
Pax6 (See Methods and Fig. S1d). Selected constructs were
thereafter targeted to the retina of E13.5 embryos by in utero
electroporation. A CAG-GFP plasmid was co-electroporated to
visualize targeted cells and their axons. The expression of Pax6
and the fate of the targeted cells were analyzed at E19.5 in
histological sections. In retinas targeted with either control or Pax6
shRNA, the majority of GFP-positive cells were located in the
inner layers, corresponding with the normal location of RGCs
(Fig. 3a and b). Double staining with anti-Pax6 and -GFP
antibodies demonstrated strong expression of Pax6 in GFP-
positive control cells but undetectable levels in the majority of cells
electroporated with the Pax6-shRNA (Fig. 3a). Quantification of
the number of GFP and Pax6 positive cells demonstrated that the
selected shRNA resulted in efficient down-modulation of Pax6 in
the mouse retina cells (Fig. 3a, graph). No significant changes were
observed in the number of apoptotic, Caspase3-positive cells [26]
(Fig. 3a). Because Pax6 is involved in cell fate decisions and cell
cycle exit [4,9,27] we next analyzed the molecular identity of the
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GFP electroporated cells using two RGC specific markers: Islet-1/
2, that marks most of RGCs [28], and Brn3, which labels only a
subpopulation [29]. In control retinas, an important proportion of
GFP positive cells showed expression of Islet-1/2 and Brn3, with
the expected pattern. Down-regulation of Pax6 did not block RGC
generation but somehow favored the increase of the number of
Islet-1/2 positive cells, which was less clearly correlated with that
of Brn3 positive cells (Fig. 3b). This moderated shift in the
proportion of RGCs cells might be associated to the reported
effects in cell cycle exit [4,9,27], rather than on selective cell death,
which was invariant (Fig. 3a).
Given that shRNA-mediated knock-down of Pax6 in E13.5
retinal precursors did not interfere with RGC generation and
organization, we examined the response of Pax6 deficient RGCs to
SFRP1 [14]. Explants from E13.5 retinas electroporated ex vivo
with control shRNA or shRNA constructs targeting Pax6 were
seeded on laminin-coated coverslips, stimulated with SFRP1 and
fixed 24 h after. Staining with anti-b-tubulin III confirmed that, as
in chick and Xenopus [14], SFRP1 stimulated axonal outgrowth
and extension from control mouse retinas, increasing the
proportion of axons longer than 900 mm (Fig. 4a). Similarly,
addition of SFRP1 to control electroporated retinal explants
doubled the proportion of GFP-positive electroporated RGCs with
axons longer than 200 mm (Fig. 4b), although the average length
was appreciably shorter than that of axons from non-electropo-
rated retinas (compare Fig. 4a and 4b). Likely, this is because
Figure 1. Ectopic expression of Pax6 stimulates axonal growth in cortical neurons. NSCs were nucleofected with CAG-empty vector or
CAG-Pax6 and co-electroporated with CAG-GFP. a) The graph shows the percentage of nucleofected neurons with respect to their axonal length after
9 days of differentiation. Over-expression of Pax6 increments the axonal length compared with control neurons. b) The graph shows quantification of
the axonal length of a cohort of BrdU positive neurons. c) Nucleofected neurons were identified by the specific expression of b-tubulin III and GFP.
BrdU staining allowed us to compared neurons of similar birth dates. The effect in axonal growth is unrelated to an early exit from the cell cycle.
Arrows point to BrdU stained nuclei. Bar indicates 50 mm. d) Cortical primary neurons were also transfected with CAG-empty vector or CAG-Pax6, and
with CAG-GFP. Transfected primary axons were identified by GFP and MAP1b staining. Arrows indicate the distal part of the axon stained by MAP1b.
Bar indicates 70 mm. e) The graph shows the percentage of primary neurons with respect to their axonal length. Data are expressed as the mean 6
SD. (*) p,0.05; (**) p,0.01.
doi:10.1371/journal.pone.0031590.g001
Figure 2. SFRP1 secreted by cortical cells in vitro is responsible for the axonal growth observed in Pax6 over-expressing neurons. a)
Immunofluorescence shows expression of SFRP1 (red) in differentiating, NSCs cultured for 5 days. Cells were double labeled with anti-nestin, GFAP
and b-tubulin III. SFRP1 expression is found in the cytoplasma of Nestin-positive cells or in some with a low GFAP expression (arrowheads). No SFRP1
expression was found in cell with high GFAP levels or in b-tubulin III-positive cells. Bar represents 20 mm. b) The graphs show the percent of axons
longer than 100 mm upon Pax6 overexpression in NSCs when cultured in the presence or absence of control or anti-SFRP1 antibodies. Note that
antibody against SFRP1 blocks axonal growth stimulated by the ectopic expression of Pax6. c, d) Response to increasing concentrations of purified
recombinant SFRP1 in neurons derived from NSC c) or primary cortical neurons (d). NSCs (c) and primary neurons (d) were transfected with control
empty CAG and CAG-Pax6 vectors and stimulated with different concentrations of SFRP1.Addition of recombinant SFRP1 only stimulates the growth
and elongation of axons of neurons ectopically expressing Pax6. Data are expressed as the mean 6 SD. (*) p,0.05; (**) p,0.01; (***) p,0.001.
Number of axons per condition .50 (n = 3).
doi:10.1371/journal.pone.0031590.g002
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targeted cells only account for newly generated RGCs [30].
Knock-down of Pax6 in RGCs prevented their response to SFRP1
(Fig. 4b) but did not interfere with axonal initiation because the
total number of axons per explants was not significantly different
in control and Pax6 shRNA electroporated retinas in the presence
or absence of SFRP1 (not shown). Furthermore, in non-stimulated
explants, the length of GFP positive axons was similar in both
control and Pax6 shRNA electroporated retinas (Fig. 4b). Notably,
axonal growth was restored when knock-down was attempted in
the presence of a silent mutant form of Pax6 resistant to shRNA,
excluding off-target effects of the shRNA constructs (not shown).
Furthermore, Pax6 knock-down had no effect on the response of
dorsal retinal explants to exogenously added Shh (Fig. 5a and 5b)
or Netrin1 (Fig. 5c), additional axon guidance cues known to
modify RGC axon growth [23,31,32]. These results indicated that
the expression of Pax6 in mouse RGCs prompt axon extension
Figure 3. Knock-down of Pax6 in the embryonic retina does not interfere with the generation of RGCs. Frontal cryostat sections of E19.5
retinas after electroporation at E13.5 with shRNAs constructs control and targeting Pax6 and immunostained (red) for Pax6 and Caspase 3 (a) or Islet-
1/2 and Brn3 (b) as indicated in the panels. Electroporated cells are visualized with GFP (green). The graphs show the quantification of the proportion
of the double positive cells for the indicated marker. Note that shRNA efficiently target Pax6 without inducing cell death (a) or changes in expression
of markers for postmitotic RGCs (b). Bar indicates 10 in (a) and 40 mm in (b). Data are expressed as the mean6 SD. (*) p,0.05; (**) p,0.01. Number of
axons per condition .60 (n = 3). INL, inner layer; VZ, ventricular zone.
doi:10.1371/journal.pone.0031590.g003
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specifically in response to SFRP1, whereas it does not influence the
response to Shh and Netrin1.
The Fz2 receptor appears to mediate the axonal response to
SFRP1 in RGCs [14]. Thus, the selective induction of the
expression of this receptor appeared as possible feasible mecha-
nism of the action of Pax6. However, equal expression of Fz2
protein was detected in the axons of RGCs electroporated with
either control or shRNAs targeting Pax6. Similarly quantitative
PCR analysis did not reveal significant differences in the mRNA
levels of Fz2 from control and Pax6 overexpressing neurospheres
or primary neurons (Fig. S4). Similarly, there were no significant
changes in the expression of other members of the Frizzled
receptor family expressed in the retina, [33], including Fz3, Fz5,
Fz6 and Fz7 (Fig. S4). We therefore consider the possibility that
Pax6 could regulate the expression of members of the family of
Unc receptors, Unc5a, Unc5b, Unc5c and Unc5d, that contain
SFRP1 binding domains [34] or that of other receptors implicated
in axonal guidance like Neuropilin1 or PlexinD1 [35]. However,
Pax6 overexpression in primary cortical cells did not induce
significant changes in the expression of any of these genes (Fig. S4),
suggesting that other factors might be involved.Hence, the
regulation of the expression any of these receptors does not
underlie the specific response to SFRP1 triggered by Pax6.
Altogether, our results demonstrate that Pax6 is necessary and
sufficient to confer postmitotic differentiating neurons with the
competence to respond to SFRP1, revealing a novel non
neurogenic function of this pleiotropic transcription factor.
Discussion
Pax6 expression is crucial for dorsal-ventral and anterior-
posterior patterning of the neural tube and controls neural
precursor proliferation and fate decisions [13,36,37]. We herein
demonstrated that expression of Pax6 in postmitotic neurons is
necessary and sufficient to provide axons with the competence to
respond to SFRP1, a secreted molecule that can control growth
Figure 4. Knock-down of Pax6 blocks SFRP1 stimulated growth of retinal axons. a) Low magnification images (a) and confocal micrographs
(b) of explants from control (a) or electroporated retinal explants (b) seeded onto laminin coated coverslip and cultured in the absence or presence of
recombinant SFRP1 as indicated in the panels. Explants in (a) were stained with b-tubulin III whereas those in (b) were co-electroporated with CAG-
GFP and shRNA control or shRNA targeting Pax6 and axons were visualized by GFP expression. Graph shows quantification of the proportion of total
axon longer than 900 (a) or 200 (b) mm. Note that knocking-down Pax6 inhibits the axonal response stimulated by SFRP1. Bar indicates 300 (a) and
150 mm (b). Data are expressed as the mean 6 SD. (*) p,0.05 comparing stimulated populations; (**) p,0.01 and (***) p,0.001 compared with
control.
doi:10.1371/journal.pone.0031590.g004
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cone movements [14]. This conclusion is based on the observation
that abrogation or activation of Pax6 expression in neuronsthat,
respectively, normally do or do not express Pax6, correlates with
the response of their axons to SFRP1. This novel activity adds up
to the very limited examples of Pax6 functions in postmitotic
neurons, namely the control of dopaminergic neuron survival via
the regulation of Crystallin aA [10]. In progenitors, other recent
studies have also pointed out non-neurogenic roles of Pax6, such
as the downregulation of the neurotrophin receptor p75NTR [38].
Together, these studies consistently highlight alternative functions
of this pleiotropic factor.
Although much progress has been made in defining the
mechanisms directing the formation of brain circuitry, there is
still much to learn about the precise coordination between axonal
connectivity and the acquisition of neuronal identities, which,
through the selective expression of certain specific transcription
factors, specifies the interpretation of these signals. Indeed, the
reported number of such transcription factors is still limited and
needs to be expanded to obtain a truly comprehensive landscape
of the determinants of neuronal connectivity. Moreover, the
mechanisms that accurately synchronize acquisition of neuronal
subtype identity with guidance molecule expression deserve
further elucidation. Examples of this coordination are offered by
the LIM homeodomain protein control of EphA receptor and
ephrin-A ligand expression during motor neuron innervation of
limb muscle [39]. Similarly, Lhx2/9 in the dorsal spinal cord
directly regulates the expression of Rig-1 [40], a divergent member
of the Robo family, required for midline crossing of commissural
axons [41]. In the retina, expression of Zic2 in the ventro-temporal
retina determines ipsilateral identity of RGCs [42] and controls
the behavior of their axons likely by regulating the expression of
EphB1 [43], a specific guidance receptor implicated in ephrinB2-
mediated repulsion of uncrossed axons at the optic chiasm midline
[44]. However, genetic control of receptor expression is not always
an evident explanation, and there are also multiple transcription
factors shown to be critical in directing axonal trajectories by still
unknown or alternative pathways. In the cerebral cortex for
example, Ctip2, and Satb2, determine the final targets of
corticospinal motor neurons and callosal projecting neurons,
respectively [45,46,47,48,49] and recent studies report that these
two cell populations differentially respond to Sema3A, a potent
repellant of cortical axons [50]. Surprisingly, similar levels of
Sema3A receptors are found in cells expressing Satb2 or Ctip2,
and the selective response is proposed to be dependent on the
control of the receptor’s endocytic and signaling pathway [51].
In this scenario, our data provide an additional example of a
transcription factor that selectively controls the response to axon
guidance cues. Although we clearly demonstrated a relationship
between Pax6 expression and response to SFRP1 in different
neurons, we did not found an obvious mechanism to explain this
relationship. In chick and Xenopus, SFRP1 binds to Fz2 to mediate
axonal response [14]. Our experiments indicate the unlikely
involvement of the Fz2 receptor and suggest other unknown
mechanisms that we have been so far unable to decipher. There
are several possible scenarios. Other yet undefined SFRP1
receptors or co-receptors might be involved. Pax6 might also
control the expression of other molecules involved in the pathway
downstream of SFRP1 response. Alternative Pax6 may regulate
the expression of ECM molecules known to be needed to control
SFRP1 response, such as laminin and fibronectin [14]. Previous
microarray analysis of Pax6 mutants and cells over-expressing
Pax6 makes way to these possibilities and have shown regulation of
guidance molecules receptors such as the Netrin receptor Unc5h,
PlexinA2 and EphA5, signal transduction molecules of the Wnt
pathway such as Gpc3, or cell adhesion molecules such as tenascin
C or cadherin 11 [52,53]. Notably, the screening of a phage
display peptide library revealed that SFRP1 binds with high
affinity to the peptide motif L/V-VDGRW-L/V, which is present
Figure 5. Knock-down of Pax6 does not affect the response of
retinal axons to Shh or Netrin 1. a) Micrographs show confocal
images of GFP positive axons of retina explants co-electroporated with
CAG-GFP and control shRNA or shRNA targeting Pax6. Explants were
seeded onto laminin coated coverslip in the presence or absence of
recombinant Shh. Bar indicates 100 mm. b) Graph shows quantification
of the proportion of GFP positive axons longer than 100 mm in the
presence or absence of recombinant Shh. c) Graph shows quantification
of the proportion of GFP positive axons longer than 200 mm in the
presence or absence of recombinant Netrin 1. Data are expressed as the
mean 6 SD. (*) p,0.05; (**) p,0.01.
doi:10.1371/journal.pone.0031590.g005
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in Unc5H3 [34], although, whether the two proteins actually
interact is still unknown.
Understanding the role of Pax6 and SFRP1 in the selective
connectivity of neuronal subclasses may contribute to untangle a
piece of the puzzle of brain circuits. In particular, in the retina,
developing RGCs express different levels of Pax6 protein [11] and
their axons travel in the vicinity of several anatomical domains of
expression of SFRP1 that may serve as cue to establish their
connectivity [15,18,54,55]. In regard to other Pax6 positive
postmitotic populations in the brain, as the ones referred above,
Sfrp1 expression patterns would be consistent with a possible role
of the Pax6-SFRP1 pair in circuit formation [16,19]. However,
although Sfrp1 knock out mice have been generated and are viable,
defects in axonal connectivity have not yet been investigated [16]
and will require attention in the future, especially in relation to
Pax6, as our results indicate.
Besides axon guidance, an additional interesting implication of our
study is raised by the blocking experiments using anti-SFRP1
antibodies. Our data evidenced the secretion of endogenous SFRP1
by NSCs and differentiating primary cortical cells, which is consistent
with the reported Sfrp1 expression patterns in the developing and
adult brain [19,56]. NCS express Pax6 both in vivo and in vitro, which
suggests possible roles for the coordinated functions of both molecules
in the physiology of NSCs and neural niches.
Methods
Animals
All animal procedures were approved by the National Center
for Biotechnology Animal Care and Use Committee, in compli-
ance with National and European Legislation (ID 080016).
C57BL6 mice were obtained from Harlan Laboratories, Inc.
(Indianapolis, US). Morning of the day of the appearance of the
vaginal plug was defined as embryonic day (E) 0.5.
Antibodies, immunohistochemistry, histology
Mouse embryos were fixed with 4% paraformaldehyde (PFA) in
0.1 M phosphate-buffered saline (PBS; pH 7.4) and cryoprotected
in 30% sucrose in PBS. 10–20 mm horizontal sections were
produced and mounted on Superfrost plus microscope slides
(Fisher Scientific, Pittsburgh, PA). Inmunostaining of tissue
sections and explants, or cell cultures was performed as described
[20] using the following antibodies: rabbit anti-GFP (Molecular
probes, Eugene, OR, 1:500), mouse anti-b-tubulin III (Sigma-
Aldrich, ST Louis, MO, 1:1000), rat anti-Bromodeoxiuridine
(BrdU) (BD Biosciences, San Jose, CA, 1:250), mouse anti-Islet-1/
2 (39.4D5 1:10) developed by T. Jessell and the monoclonal
antibody anti-Nestin (Rat 401, 1:100) developed by S. Hockfield,
were obtained from the Development Studies Hybridoma Bank
developed under the auspices of the NICHD and maintained by
The University of Iowa, Department of Biological Sciences, Iowa
City, IA 52242, rabbit anti-SFRP1 (Abcam, Cambridge UK,
1:500), goat anti-Brn3 (C-13) (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, 1:250), rabbit anti-Caspase3 (Cell Signaling Tech
Inc, Danuers, MA, 1:500), rabbit anti-Pax6 (Covance, Princeton,
NJ, 1:500), mouse anti-MAP1b (Covance, Princeton, NJ, 1:500),
rabbit anti-Fz2 (Abcam, Cambridge, UK, 1:200), mouse anti-
GFAP (Sigma-Aldrich, ST Louis, MO, 1:400), and Alexa Fluor
488-, 594- or 647-conjugated fluorescent secondary antibodies
(Molecular probes, Eugene, OR, 1:500).
Epifluorescece and confocal microscopy
Confocal microscopy was performed with a TCS-SP5 (Leica
Microsystems GmbH, Welzlar, Germany) Laser Scanning System.
Tissue sections of 50 and 20 mm were analyzed by taking 0.2 mm
serial optical sections with the LASAF v2.2.1 software (Leica
Microsystems GmbH, Welzlar, Germany). Fluorescence micros-
copy was performed with a Leica DMRXA and images were
captured with Leica CW4000 FISH Version V1.2 software.
DNA constructs and recombinant proteins
The hairpin sequences targeting Pax6 were: TRCN0000075
377:ICCGGCCTGAAGCAAGAATACAGGTACTCGAGTACC-
TGTATTCTTGCTTCAGGTTTTTG; ITRCN0000075376:ICC-
GGCATGGCAAACAACCTGCCTATCTCGAGATAGGCAG-
GTTGTTTGCCATGTTTTTG;ITRCN0000075375:ICCGGGA-
CGGCATGTATGATAAACTACTCGAGTAGTTTATCATAC-
ATGCCGTCTTTTTG;ITRCN0000075374:ICCGGCCACTTC-
AACAGGACTCATTTCTCGAGAAATGAGTCCTGTTGAAG-
TGGTTTTTG.
Pax6 and green fluorescence protein (GFP) cDNAs were under
the cytomegalovirus enhancer, chicken b-actin promoter, and
rabbit b-globin poly (A) signal (CAG) (cytomegalovirus [CMV] and
beta-actin) promoter. For knock-down experiments, a mixture of
the selected shRNA lentiviral constructs (1 mg/ml) and pCAG-GFP
(1 mg/ml) was used. For testing off-target effects, we co-electropo-
rated a construct driving expression of a silent resistant form of
Pax6 (1 mg/ml; CAG-mutPax6; see Text S1) and shRNA targeting
Pax6 (1 mg/ml) plasmids. Pax6 lentiviral shRNA constructs were
obtained from Sigma-Aldrich Inc. (St. Louis, MO). Purified
recombinant SFRP1 protein was generated as previously de-
scribed [21] and recombinant purified N-Shh (2.5 mg/ml) was a
kind gift from Dr. Sebastian Pons [22].
In utero and ex vivo electroporation
In utero and ex vivo electroporations were performed as described
previously [23]. E13.5 pregnant C57BL6 female mice were
anesthetized by continuous inhalation of Isoflurane (Baxter.
Deerfield, US). The abdomen was opened and the uterine horns
exposed. The DNA solution containing 0.03% fast green in PBS
was injected into one eye of each embryo using a pulled glass
micropipette. The head of each embryo was placed between
tweezer type electrodes (CUY 650 P5 Nepa GENE, Chiba, Japan)
and five square electric pulses (38V, 50 ms) were passed at 1 sec
intervals using an Electro Square Porator ECM 830 (BTX,
Harvard Apparatus, Holliston, MA, USA). The wall and skin of
the abdominal cavity were sutured and the embryos were allowed
to develop normally until E16-P0. For the ex vivo electroporation
the head of the E13.5 embryos were transfer to a dissecting dish
where they were electroporated with the above conditions. Then,
electroporated retinas were dissected and incubated in DMEM-
F12 (Gibco, Invitrogen, Carlsbad, CA) supplemented with N2
(Gibco, Invitrogen, Carlsbad, CA) medium at 37uC, 5% CO2 for
24 hours.
Retinal explants and analysis of axonal growth
Dorsal retinal microexplants were plated on glass coverslips
coated with poly-D-Lys (50 mg/ml; Sigma-Aldrich, Co. St. Louis,
MO) and laminin (10 mg/ml; Invitrogen, Carlsbad, CA) and
grown for 24 hours in DMEM-F12 medium supplemented with
N2 in the presence or absence of SFRP1 (2 ng/ml) or N-Shh
(1 ng/ml). After 24 hours, explants were fixed in 4% PFA at RT
for 30 minutes and immunostained with anti-b-tubulin III and
anti-GFP antibodies. Axonal length was determined in confocal
images employing LaserPix v.4 image software (Bio-Rad). In non-
electroporated explants, axonal length was estimated by counting
the number of b-tubulin III positive axons crossing 600 and
900 mm radius circumferences of a minimum of 100 axons in each
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of three independent experiments (n = 3). For electroporated
explants, we measured the length of each individual GFP positive
axon from the edge of the explant up to the distal tip of the growth
cone. Knock-down of Pax6 in RGCs did not interfere with axonal
initiation because the number of total axons per explants was not
significantly different in control and Pax6 shRNA electroporated
retinas (not shown). It was also not affected by treatment with
SFRP1, Netrin1 or Shh. For SFRP1 experiments at least 50 axons
per condition in each independent experiments (n = 6) or 60
neurons per condition (n= 4) in Shh and Netrin1 experiments. We
chose to specifically study SFRP1 response in dorsal explants
because this population expresses high levels of Pax6 and is
homogeneously composed of contra-laterally projecting axons
facilitating the analysis of SFRP1 response.
Neurosphere culture and nucleofection
Dorsal telencephalons of E13.5 WT embryos were dissected and
cells were dissociated employing trypsin and a flamed-tip, glass
Pasteur pipette. Dissociated cells were cultured in DMEM-F12
supplemented with N2 (Gibco, Invitrogen, Carlsbad, CA),
heparin, recombinant human basic fibroblast growth factor
(FGF-2) (10 ng/ml; R&D Systems, Minneapolis, MN), and
epidermal growth factor (EGF; 10 ng/ml; Gibco, Invitrogen,
Carlsbad, CA). Neurosphere cultures were passage every 3 days by
mechanical dissociation. Dissociated cells were transfected using
the nucleofector (Amaxa Biosystems, Gaithersburg, MD) with 5 mg
of a 1:1 mixture of CAG-GFP and CAG-Pax6 or CAG- empty
vector. Nucleofection efficiency and GFP positive cells were
analyzed by flow cytometer (Coulter Epix XL) and data were
analyzed with the Win MIDI software. Nucleofected neurospheres
were seeded on glass coverslips coated with poly-D-Lys and
cultured in DMEM-F12 supplemented with N2, heparin and 1%
fetal calf serum (FCS). Cells were fixed in 4% PFA at RT for
30 minutes, then immunostained with anti-b-tubulin III and anti-
GFP antibodies. Axonal length was determined with the LaserPix
v.4 image software (Bio-Rad, Richmond, CA) over images taken
with a fluorescence microscopy Leica DMRXA. For analysis of the
effects of Pax6, cells were fixed after 6 or 9 days in culture. To
compare neurons that exit at the same time from the cell cycle,
postmitotic neurons were labeled with a 12 h pulse of Bromo-
deoxiuridine (BrdU, Sigma-Aldrich, ST Louis, MO) (0.5 ng/ml) in
the media and subsequently extensively washed. For blocking the
endogenous SFRP1 activity a mix of anti-SFRP1 antibodies (4 mg/
ml dialyzed in PBS): rabbit anti-SFRP-1 and goat anti-SFRP-1 (H-
90 and C-19; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or
a control IgG (4 mg/ml, dialyzed in PBS; rabbit anti-p-aPAK Ser
199/204; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were
added to the culture media after nucleofection. For stimulation
experiments, SFRP1 was added to the media 24 h after the
nucleofection and the early axonal growth measured 3 days after
the addition of SFRP1.
Primary neurons culture and transfection
Dissociated cells from the dorsal telencephalon of E13.5
embryos were seeded onto 24 well Poly-D-Lys coated plates in
Neurobasal media supplemented with B27 complement (Gibco,
Invitrogen, Carlsbad, CA) and BrdU (0.5 ng/ml) to test
proliferation. 24 h after seeding, cells where co-transfected with
CAG-Pax6 or the empty CAG- vector and CAG-GFP using
lipofectamine 2000 (Invitrogen, Carlsbad, CA) and following
manufacture procedure. Three days after transfection, cells were
fixed with PFA 4%, and immunostained with anti-b-tubulin III
and anti-GFP antibodies to measure their axonal length as
describe next. GFP positive neurons did not incorporate BrdU
demonstrating an effect on posmitotic neurons independent of cell
cycle exit. As mentioned, SFRP1 was added to the media 24 h
after transfection and the axons measured 2 days after the addition
of the protein.
Quantification of axonal length
In neurons differentiated from NSC or primary neurons, we
identified the axon by morphological criteria and the specific
staining of MAP1b, selectively localized to the distal part of axonal
projections [24], but not in neurites. As illustrated in Fig. 1d,
staining with MAP1b allowed us to identify the axon in primary
neurons, while GFP staining reveals transfected cells. In neurons
derived from NSCs after 6 and 9 days of differentiation, a long
projection neurite was always clearly observed (Fig. 1c) and
quantified as an axon. Specific staining with MAP1b demonstrated
that the axon was always the longest neurite projection (99%
Map1b positive projections were the longest neurite in the cell
(.100 cells counted). Accordingly, experiments in which we
measure MAP1b or the morphological identified neurite gave
equivalent results (compared results shown in Fig. 1e and Fig. 2).
We measured the axonal length from the nucleus of the neurons to
the distal end of the axon where the growth cone is localized. We
analyzed a minimum of 50 axons per condition in four
independent experiments (n = 4).
Statistical analysis
Quantitative results are expressed as the mean 6 SD. Axonal
length distributions of each population were compared using a
Chi-square test. Differences in gene expression was analyzed were
compared with Student’s two-sample t test. P values are indicated
in figure legends.
Supporting Information
Figure S1 Efficiency of Pax6 overexpression and inhi-
bition. a) Transfection of pCAG-Pax6 in NSCs results in efficient
overexpression of Pax6 proteins in NSC derived neurons. Pax6
proteins are not expressed normally in GFP positive CAG-control
targeted neurons, but are ectopically expressed (yellow) in cells
transfected with CAG-Pax6 plasmid. Bar indicates 20 mm. b)
Fluorescent-activating cell sorting (FACs) analysis demonstrates
more than 20% transfection efficiency. c) Ectopic Pax6 expression
in NSCs does not alter the total number of secondary and primary
neurites per cell. The number of neurites, excluding the axon, was
quantified 9 days after transfection. d) Transfection of shRNA
lentiviral constructs efficiently suppresses the ectopic expression of
Pax6 in CHO cells. CHO cells co-trasfected with CAG-Pax6;
control shRNA and CAG-GFP show expression of Pax6 protein
(red). Pax6 is down-modulated in cells transfected with CAG-Pax6
and shRNAs targeting Pax6. Number of cells .100 (n= 3). Bar
indicates 30 mm. Graph represents the proportion of GFP positive
cells expressing Pax6 protein. Data are expressed as the mean 6
SD. (***) p,0.001.
(TIF)
Figure S2 Ectopic expression of Pax6 stimulates axonal
growth in cortical neurons. NSCs were nucleofected with
CAG-empty vector or CAG-Pax6 and co-electroporated with
CAG-GFP. Graph shows the percentage of nucleofected neurons
with respect to their axonal length after 6 days of differentiation.
Results are equivalent to those obtained at 9 days. Over-
expression of Pax6 increments the axonal length compare with
control neurons. Data are expressed as the mean 6 SD. (**)
p,0.01.
(TIF)
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Figure S3 SFRP1 stimulated axonal response in Pax6
over-expressing neurons but not in the control popula-
tion. Graph represents the population distribution of neurons
with axons longer than 100 mm or more. Data are expressed as the
mean 6 SD. (**) p,0.01; (***) p,0.001.
(TIF)
Figure S4 Knock-down of Pax6 did not affect the
expression of Fz2 receptor. a) Micrographs show confocal
images of GFP positives axons in retina explants that were
electroporated with shRNA control or shRNA targeting Pax6, and
with CAG-GFP. Both populations present low levels of Fz2
expression and a positive dotted pattern of Fz2 staining. GFP
negative mature axons presented a stronger signal. Bar indicates
3 mm. b) Q-PCR detection of the relative expression of the mRNA
of Fz1, Fz3, Fz5, Fz6, Unc5a, Unc5b, Unc5c, Unc5d, Neuropilin1
and PlexinD1 from primary cultured neurons. Expression levels
are relative to GAPDH transcript and normalized to one control
sample (see Text S2). There are no differences in the relative
mRNA expression of these receptors in control and Pax6
transfected cells.
(TIF)
Text S1 cDNA sequence for the silent mutant form of
Pax6 resistant.
(DOCX)
Text S2 Methods for real-time quantitative RT-PCR (Q-
PCR).
(DOCX)
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During embryonic development, Notch and Wnt signaling orchestrate 
cell proliferation and cell fate decisions in a wide variety of tissues. 
The functional relationship between the two signaling pathways is 
intricate, and complementary or mutually exclusive activation has 
been reported during processes such as myogenesis, hematopoiesis 
and neurogenesis of the telencephalon or neural tube1.
Notch and Wnt signaling are also required for the development 
of the vertebrate neural retina. This structure develops from a 
neuroepithelium composed of multipotent progenitors, which go 
through a series of competence states to give rise to six neuronal 
and one glial cell types2. As progenitor cells produce the various 
cell types, Notch through lateral inhibition maintains neighboring 
cells in a multipotent, proliferative state, ensuring that sufficient 
numbers of progenitors are retained for consecutive waves of neuro-
genesis. Thus, downregulation of Notch is a prerequisite for retinal 
neuronal differentiation2.
Wnt–β-catenin signaling has also been implicated in the 
 proliferation of vertebrate retinal precursors. However, in the mouse 
embryonic neural retina this function is limited to progenitor cells 
located in the periphery3,4. Wnt–β-catenin signaling is not active 
in the central retina, and cell proliferation and differentiation pro-
ceed normally in mice with conditional deletion of β-catenin in 
the neural retina, although retinal lamination is altered5. Similarly, 
retina-specific inactivation of Fzd5, a noncanonical Wnt receptor, 
mostly influences retinal vasculature formation but has no effect on 
neurogenesis6. Although these results do not strongly implicate Wnt 
signaling in retinal differentiation, Sfrp1 and Sfrp2, two members 
of a family of postulated Wnt antagonists, are strongly expressed in 
the neural retina throughout neurogenesis7—raising the question of 
whether their function is related to Wnt signaling.
Sfrps (1–5 in mammals) are a family of secreted factors that fold 
in two independent domains. The cysteine-rich domain (CRD) at 
the N terminus shares similarities with the extracellular domain of 
the Wnt receptors Frizzled (Fzd) and ROR8. The C-terminal domain 
contains instead a netrin-related motif (NTR), which characterizes 
a number of unrelated proteins including Netrin-1, tissue inhibi-
tors of metalloproteinases (TIMPs), complement proteins and type I 
procollagen C–proteinase enhancer proteins (PCOLCEs)8. Owing to 
their homology to the extracellular portion of Fzd receptors, Sfrps 
were first described and generally accepted as Wnt antagonists that 
bind and sequester Wnt ligands, thereby preventing signal activation. 
Gain of Sfrp1 or Sfrp2 function has supported this idea, as excess Sfrp 
function antagonizes Wnt signaling in a variety of contexts8. Loss of 
Sfrp function instead points to two additional important features. 
First, Sfrp function might be redundant, because genetic inactivation 
of individual family members in mice seems to have little effect on 
embryonic development9,10. Double inactivation of Sfrp1 and Sfrp2, 
by contrast, causes a variety of alterations9,11,12, some of which are 
worsened by the additional inactivation of Sfrp5 (refs. 9,11). Second, 
Sfrps have Wnt-independent functions9,12, as Sfrp-null phenotypes 
are only partially explained by overactivation of Wnt–β-catenin 
signaling11 or alterations in the noncanonical Wnt-PCP (planar cell 
1Centro de Biología Molecular “Severo Ochoa”, Consejo Superior de Investigaciones Científicas (CSIC)–Universidad Autónoma de Madrid, Madrid, Spain.  
2Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain. 3Instituto Cajal, CSIC, Madrid, Spain. 4Vall d’Hebron Institute of Oncology, 
Barcelona, Spain. 5Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain. 6Institució Catalana de Recerca i 
Estudis Avançats, Barcelona, Spain. 7Cancer Science Institute of Singapore, National University of Singapore, Singapore. Correspondence should be addressed to  
P.E. (pesteve@cbm.uam.es) or P.B. (pbovolenta@cbm.uam.es).
Received 22 December 2010; accepted 2 March 2011; published online 10 April 2011; doi:10.1038/nn.2794
SFRPs act as negative modulators of ADAM10 to 
regulate retinal neurogenesis
Pilar Esteve1–3, Africa Sandonìs1–3, Marcos Cardozo1–3, Jordi Malapeira4–6, Carmen Ibañez1,  
Inmaculada Crespo1–3, Severine Marcos1–3, Sara Gonzalez-Garcia1, Maria Luisa Toribio1, Joaquin Arribas4–6, 
Akihiko Shimono7, Isabel Guerrero1 & Paola Bovolenta1–3
It is well established that retinal neurogenesis in mouse embryos requires the activation of Notch signaling, but is independent 
of the Wnt signaling pathway. We found that genetic inactivation of Sfrp1 and Sfrp2, two postulated Wnt antagonists, perturbs 
retinal neurogenesis. In retinas from Sfrp1−/−; Sfrp2−/− embryos, Notch signaling was transiently upregulated because Sfrps 
bind ADAM10 metalloprotease and downregulate its activity, an important step in Notch activation. The proteolysis of other 
ADAM10 substrates, including APP, was consistently altered in Sfrp mutants, whereas pharmacological inhibition of ADAM10 
partially rescued the Sfrp1−/−; Sfrp2−/− retinal phenotype. Conversely, ectopic Sfrp1 expression in the Drosophila wing imaginal 
disc prevented the expression of Notch targets, and this was restored by the coexpression of Kuzbanian, the Drosophila ADAM10 
homolog. Together, these data indicate that Sfrps inhibit the ADAM10 metalloprotease, which might have important implications 
in pathological events, including cancer and Alzheimer’s disease.
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polarity) pathway. Consistent with this notion, several studies have 
implicated individual Sfrps in the Wnt-independent regulation of 
other cell signaling mechanisms. For example, Sfrp1 can interact 
with and inhibit the activity of RANKL, a member of the tumor 
necrosis factor (TNF) family that is involved in osteoclast forma-
tion8. Sfrp2 specifically binds to tolloid metalloproteinases and 
thereby regulates procollagen processing during myocardium infarc-
tion13,14. Sfrp2 also interacts with an integrin–fibronectin complex 
that modulates apoptosis8. Furthermore, Sizzled (a member of the 
family that is not present in mammals) acts as a negative feedback 
regulator of bone morphogenetic protein (BMP) signaling by binding 
to BMP1-Tolloid, a metalloprotease that normally degrades the BMP 
antagonist chordin15,16.
By analyzing the functional consequences of compound inactiva-
tion of Sfrp1 and Sfrp2 during mouse retinal neurogenesis, we found 
that Sfrps have a Wnt-independent role in the regulation of Notch 
signaling. We explain this finding by demonstrating that Sfrps can 
bind to and downregulate the activity of ADAM10, a metalloprotease 
with multiple substrates, including Notch, N-cadherin and amyloid 
precursor protein (APP).
RESULTS
Sfrp1 and Sfrp2 are essential for proper eye development
Sfrp1 and Sfrp2 are expressed during murine eye development with a 
complementary pattern that includes all eye structures7. Sfrp1 tran-
scripts are localized to the optic cup periphery and the retina pig-
mented epithelium from embryonic day 10.5 (E10.5), whereas Sfrp2 
is predominant in the neural retina (Supplementary Fig. 1).
Despite restricted mRNA expression, Sfrp 
proteins efficiently diffuse in the extracellular 
space17 and Sfrp1 was also immunodetected, 
albeit at low levels, in the neural retina 
(Supplementary Fig. 1), supporting the pro-
posed functional redundancy of Sfrps9,11,12. 
Accordingly, the eyes of Sfrp1 or Sfrp2 single-
null embryos appeared histologically normal. 
By contrast at E16.5, the latest viable stage, the 
eyes of Sfrp1−/−; Sfrp2−/− compound mutants 
(n = 20) were smaller than those of control 
littermates (n = 30) with visible morphological alterations, including 
dorsal peripheral defects, reduction in lens size, abnormal cornea 
and eye lid formation, increased thickness of the neural retina and 
abnormal vitreal accumulation of mesenchyme-derived angioblasts 
that normally form the hyaloid artery, the major vascular structure 
of the embryonic eye (Supplementary Fig. 2).
Inactivation of Sfrp1 and Sfrp2 alters retinal neurogenesis
Multipotent progenitors in the neural retina generate neurons and 
one type of glia with an established temporal order. The first cells 
to be generated are retinal ganglion cells (RGCs), followed by ama-
crine and cone photoreceptors, and bipolar neurons and Müller glial 
cells are the last2. Although Wnt signaling does not seem to partici-
pate in retinal neurogenesis4,5, the neural retina of Sfrp1−/−; Sfrp2−/− 
embryos was abnormally thick and had vascular defects, as shown 
by immunohistochemistry with endothelial and pericyte-specific 
markers (Supplementary Fig. 2). At E16.5, the number of Islet1+, 
Pax6+ RGCs, Islet1+ and Pax6+ amacrine cells and Otx2+ early-born 
photoreceptors (74 ± 5.72 versus 52 ± 3.70 in controls) was greater 
in the neural retina of Sfrp1−/−; Sfrp2−/− embryos than in wild-type 
embryos, whereas PKCα+ bipolar progenitors were virtually absent 
(2.33 ± 0.408 versus 29 ± 3.417 in controls) (Fig. 1a–h).
This increased differentiation of Sfrp1−/−; Sfrp2−/− retinas was not 
due to a premature onset of cell differentiation because we found no 
Tuj1+ differentiating neurons in either control or mutant retinas at 
E10.5 (data not shown). However, half a day later Tuj+ and Islet1/2+ 
RGCs in mutant retinas clearly outnumbered those in control retinas 
(Fig. 1i–l). This difference was associated with a marked increase in 
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Figure 1 Neurogenesis is impaired in the 
central retina of Sfrp1−/−; Sfrp2−/− embryos.  
(a–r) Frontal cryostat sections of E16.5 (a–h,q,r), 
E12.5 (o,p), E11.5 (i–l) and E10.5 (m,n) control 
and Sfrp1−/−; Sfrp2−/− retinas immunostained 
with antibodies against Tuj1 (differentiated 
cells), Islet1 (RGCs and amacrine cells), Pax6 
(RGCs and amacrine cells), Otx2 (bipolar 
cells and photoreceptors), PKC (bipolar cells) 
and BrdU (proliferating precursors) and 
counterstained with DAPI (blue; a–h and k,l). 
RGCs and amacrine cells are increased, whereas 
bipolar cells are decreased in the mutant retinas. 
Proliferation in the mutant retinas is increased at 
early stages but is reduced at E16.5 as compared 
to controls (compare r to q). (s) Quantification of 
BrdU+, Islet1+, Otx2+ and PKC+ cells. Positive 
cells were counted in equivalent areas of the 
central retina. Error bars are s.e.m. of at least 
three sections from four different embryos  
(n = 4). cNR, central neural retina; le, lens;  
RPE, retina pigmented epithelium. *P < 0.05; 
**P < 0.01; ***P < 0.001. Scale bar,  
30 µm (a–l,q,r); 60 µm (o,p); 100 µm (m,n).
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BrdU+ proliferating cells, which was already evident in the neural 
retinas of E10.5 Sfrp1−/−; Sfrp2−/− embryos when compared to control 
littermates (Fig. 1m,n). Furthermore, analysis of the distribution of 
E10.5 Sfrp1−/−; Sfrp2−/− retinal cells during the cell cycle using flow 
 cytometry–based DNA content analysis revealed an increased distri-
bution in the G2/M phase (G1, 55%; S, 29.3%; G2, 6.58%) when com-
pared to that of control littermates (G1, 51.8%; S, 30.4%; G2, 3.08%). 
This increase was only transient because at E16.5 the number of BrdU-
positive cells was significantly reduced in the Sfrp1−/−; Sfrp2−/− retinas 
as compared with controls (P = 0.006; Fig. 1q–s). Thus, inactivation of 
Sfrp1 and 2 seemed to force the generation of progenitor cells and their 
differentiation into early born neurons, possibly depleting the prolifer-
ating progenitor pool and consequently reducing late-born cell types.
Sfrp1 and Sfrp2 inhibit Notch signaling
The number of progenitor cells available for neural differentiation 
at any given time is controlled by Notch signaling2. To search for a 
Wnt-independent mechanism that could explain the neural retina 
phenotype of Sfrp mutants, we tested whether the Notch pathway was 
normally activated. Upon ligand binding, the Notch receptor becomes 
susceptible to two sequential proteolytic cleavages that enable the 
release of an active intracellular form of Notch (NICD). NICD trans-
locates to the nucleus where it interacts with the CSL transcription 
factor and recruits coactivators to turn on the expression of Notch 
target genes, such as Hes5 (ref. 18). Nuclear localization of NICD is 
then a reliable determinant of Notch signaling activation18.
In E12.5 control retinas, the number of NICD+ progenitor cells 
that were available for neural differentiation occupied only a reduced 
central region19 (Fig. 2a) whereas in the Sfrp1 and 2 mutants a sub-
stantially larger number of NICD+ cells were distributed in most of the 
neural retina (Fig. 2b). With time, this difference became progressively 
inverted: at E13.5 the number of NICD+ cells was similar in control 
and mutant retinas but by E16.5 mutant retinas tended to contain 
fewer NICD+ cells than control retinas (Fig. 2c–f,k). Consistent with 
broad activation of the Notch pathway, the distribution of Hes5 was 
similarly expanded in the Sfrp1−/−; Sfrp2−/−retinas (Fig. 2g,h), whereas 
that of the Notch ligand Delta-like1 (Dll-1), which is repressed upon 
activation of Notch signaling18 were abnormally low in the mutant 
neural retina (Fig. 2i,j). Quantitative RT-PCR analysis of Hes5 (0.90 ± 
0.11 in mutants versus 0.41 ± 0.007 in controls; n = 3, P < 0.05) and 
Dll-1 (0.602 ± 0.052 in mutants versus 0.81 ± 0.048 in controls; n = 3, 
P < 0.05) mRNA levels from E12.5 and E13.5 control and Sfrp knockout 
retinas confirmed these variations. Together these data indicated that, 
in the absence of Sfrp1 and 2, Notch signaling was abnormally active in 
a larger number of retinal progenitors; this explains the early increase 
in cell proliferation. In turn, this simultaneous activation suppressed 
ligand expression, prematurely terminated proliferation of retinal 
progenitors and favored their differentiation, explaining the accumu-
lation of early-differentiating neurons in Sfrp-null retinas.
We reasoned that if Sfrps directly or indirectly downregulate Notch 
activity, similar alterations should occur in other brain regions where 
Notch and Sfrp1 and 2 are coexpressed, such as the telencephalon20,21. 
Indeed, western blot analysis of E12.5 Sfrp1−/−; Sfrp2−/− and control 
cortex revealed that Notch was expressed at similar levels in both 
extracts but that NICD expression was fourfold higher in the mutants 
(Fig. 2l). This increase was paralleled by defects in telencephalic 
neurogenesis similar to those observed in the retina (I.C., P.B. and 
P.E., unpublished observations).
ADAM10 inhibition rescues the Sfrp mutant retinal phenotype
The disintegrin and metalloprotease transmembrane protein ADAM10 
is responsible for the first proteolytic cleavage of the Notch receptor 
on ligand binding22,23. ADAM10-mediated shedding of the Notch 
ectodomain is a limiting step for the subsequent proteolysis by the 
γ-secretase–presenilin complex, which releases the NICD. ADAM10 is 
inhibited by TIMPs24 through the activity of their NTR modules24,25. 
Because Sfrp1 and 2 contain NTR modules8, we postulated that they 
might normally downregulate the activity of ADAM10. If this were the 
case, inhibition of ADAM10 activity should counteract the impaired 
neurogenesis observed in the Sfrp1−/−; Sfrp2−/− neural retina.
G1254023X is a synthetic compound that inhibits ADAM10 with 
high affinity26. We investigated its effect on retinal neurogenesis 
using organotypic optic cup cultures from E11.5 control and Sfrp1−/−; 
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Figure 2 Notch signaling is transiently upregulated in Sfrp1−/−; Sfrp2−/− 
retinas. (a–j) Frontal cryostat sections of E12.5 (a,b,g,h), E13.5 (c,d,i,j) 
and E16.5 (e,f) control and mutant embryos immunostained with 
antibodies against NICD (a–f) or hybridized with probes specific for Hes5 
(g,h) or Dll-1 (i,j). Note the initial expansion of NICD and Hes5 expression 
in the mutants (arrowheads in g,h). The expression of Dll-1 is instead 
downregulated. (k) Quantification of the number of NICD+ cells in the 
neural retina. Positive cells were counted in equivalent areas. Error bars 
are s.e.m. of at least three sections. Four embryos were analyzed in each 
case (n = 4). (l) Western blot analysis of the levels of Notch processing 
in lysates of E12.5 cortex from mutant and control embryos. The cleaved 
Notch fragment (NICD) is increased in the mutants as determined by  
band intensity quantification normalized with α-tubulin (3.5 versus 1.2 in 
controls), although Notch is expressed at similar levels in both tissues 
(1.482 versus 1.46 in controls). The data represent a typical experiment, 
which was repeated four times with similar results. Scale bar: 30 µm (a–f); 
50 µm (i,j); 100 µm (g,h).
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Sfrp2−/− embryos (Fig. 3). After 24 h, culture conditions and treatment 
with vehicle (DMSO) alone did not significantly modify the difference 
in the rate of proliferation (measured by the number of BrdU+ cells, 
P = 0.377) or differentiation (number of Islet1+ cells, P = 0.461) 
observed in vivo between control and Sfrp1−/−; Sfrp2−/− embry-
onic retinas (Figs. 1s and 3i,j and Supplementary Fig. 3). Addition 
of G1254023X to the culture medium of control retinas reduced 
the rate of cell proliferation when compared to vehicle treatment 
(Supplementary Fig. 3). Exposure of Sfrp1−/−;Sfrp2−/− optic cups to 
low concentrations of G1254023X was sufficient to reduce the number 
of BrdU+ cells to values statistically undistinguishable from those of 
controls (Fig. 3a,c,i). However, increasing G1254023X concentrations 
(5 µM) further reduced the number of BrdU+ cells in Sfrp1−/−; Sfrp2−/− 
retinas to values below those of control retinas, supporting the idea 
that normally Sfrp1 and Sfrp2 negatively modulate, but do not com-
pletely block, Notch processing. Notably, G1254023X did not signifi-
cantly change the number of Islet1+ cells in the Sfrp1−/− Sfrp2−/− optic 
cup cultures at low doses (P = 0.279), but at higher concentrations 
favored cell differentiation (Fig. 3e–h,j). Probably, downregulation of 
ADAM10 at a time when a substantial amount of early-born neurons 
has been already generated (Fig. 1l,s) is not sufficient to restrain cell 
cycle exit in the mutants. Rather, further inhibition of Notch activation 
promotes neuronal differentiation, as reported in the retina2.
Sfrps interfere with the proteolysis of ADAM10 substrates
Together, the above findings supported the possibility that the 
Sfrp1−/−; Sfrp2−/− retinal phenotype could be at least in part explained 
by uncontrolled activity of ADAM10. We next postulated that, if this 
was the case, the processing of physiological ADAM10 substrates 
other than Notch should be equally altered in Sfrp null retinas.
ADAM10 sheds the extracellular domain of N-cadherin and 
L1-CAM, two cell adhesion molecules that are abundantly expressed 
in embryonic retinas. This proteolytic cleavage produces fragments 
of 40 kDa and 32 kDa, respectively, and is a prerequisite for further 
proteolysis by a γ-secretase, which generates intracellular peptides 
of 35 kDa for N-cadherin27 and 28 kDa for L1-CAM28. Western blot 
analysis of extracts from E13 and E16.5 Sfrp1−/−; Sfrp2−/− and control 
retinas showed that the amount of L1-CAM 32 kDa and N-cadherin 
35 kDa peptides were almost doubled in the mutants (70% and 68% of 
control values, respectively), although both proteins were expressed at 
similar levels in both genotypes (Fig. 4a,b). Consistent with the latter 
observation, membrane-bound active β-catenin, which requires intact 
N-cadherin to tether the membrane27, was almost undetectable in the 
mutant retinas (Fig. 4c,d).
In addition to neural development, ADAM10 is crucial for tissue 
homeostasis. Most notably, ADAM10 is responsible for the nonamy-
loidogenic processing of APP, a key protein in the onset of Alzheimer’s 
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disease. ADAM10-mediated processing of APP cleaves the protein 
within the βamyloid peptide, preventing its toxic generation and pro-
moting the shedding of a large soluble APP ectodomain29 (sAPPα). 
APP is poorly expressed in the developing retina (not shown) but its 
intact and sAPP forms are abundant in the subventricular zone of the 
lateral ventricle in adult mice30. If Sfrp1 normally antagonizes the 
α-secretase activity of ADAM10, sAPPα should be enriched in the lateral 
ventricle of adult Sfrp1−/− mice. Comparative western blot analysis of 
isolated lateral ventricle regions from Sfrp1−/− and wild-type brains 
confirmed an eightfold increase in sAPP in the mutants (Fig. 5a).
sAPPα is constitutively released from the surface of most cultured 
cells. Consistently, the amount of sAPPα recovered from CHO cells 
stably transfected with Sfrp1, but not Sfrp2, was substantially reduced 
(47%) compared to control, mock-transfected CHO cells, although 
APP was expressed at similar levels in all the cell lines (Fig. 5b). 
Similarly, the addition of soluble recombinant Sfrp1, but not Sfrp2, 
substantially reduced (35%) the levels of sAPPα recovered from the 
medium of CHO cells (Fig. 5c), further demonstrating that Sfrp1 is a 
specific inhibitor of ADAM10-mediated APP processing. The differ-
ence between Sfrp1 and Sfrp2 on APP processing raises the possibility 
that the inhibitory specificity of Sfrps may be influenced by the nature 
of the substrate, as shown for other TIMPs31.
Together, these data indicate that Sfrp1, and probably Sfrp2, act as 
ADAM10-specific TIMPS.
Sfrp1 and ADAM10 physically interact
TIMPs usually exert their action by binding to their target metal-
loproteases31. To test whether Sfrps acted with a similar mechanism, 
we investigated whether Sfrp1 and ADAM10 physically interact. 
To this end we attempted to coimmunoprecipitate Sfrp1 and ADAM10 
from embryonic retinal tissue and cortical tissue, in which Sfrp1 is 
more abundantly expressed.
Sfrp1-specific antibodies immunoprecipitated ADAM10 from wild-
type but not from Sfrp1−/−; Sfrp2−/− tissues (Fig. 6a). Unfortunately, we 
found that ADAM10 antibodies were not efficient in reverse immuno-
precipitation experiments. To circumvent this problem, we cotrans-
fected Sfrp1-HA and ADAM10-myc constructs in 293T cells and 
analyzed the derived cell lysates to demonstrate that antibodies to myc 
specifically coimmunoprecipitated Sfrp1-HA with ADAM10 (Fig. 6b). 
Furthermore, secreted AP-tagged Sfrp1 seemed to bind more abundantly 
on ADAM10-overexpressing CHO cells than on mock-transfected cells, 
which constitutively express low ADAM10 levels31 (Fig. 6c–f).
Sfrp1 targets ADAM10 function independently of Wnt
The above findings support the idea that Sfrps can bind ADAM10 
and directly modulate its function. However, the partial rescue of the 
Figure 5 Sfrps interferes with ADAM10-mediated processing  
of APP. (a) Western blot analysis of total (APP) and soluble (sAPPα) 
present in lysates from the subventricular zone of the lateral  
ventricles from wild-type (WT) and Sfrp1−/− adult brains. The amount  
of sAPPα fragment is increased in mutants (normalized density  
values to α-tubulin: 11.1 versus 1.32 in controls). The data  
represent a typical experiment, which was repeated three times  
with similar results. (b,c) Western blot analysis of total APP and  
soluble sAPPα, respectively, in the cell lysate and conditioned  
medium of CHO cells stably transfected with Sfrp2 or Sfrp1  
constructs (b, left column; densitometric analysis of sAPPα in  
the medium normalized to Ponceau-stained vector: 10.9 ± 2.2;  
Sfrp2: 13.3 ± 0.7; Sfrp1: 5.2 ± 1.7) or of CHO cells incubated  
with purified Sfrp1 or Sfrp2 proteins (c; densitometric analysis  
of sAPPα in the medium normalized to Ponceau-stained vector: 10.0 ± 1.6; Sfrp2: 11.8 ± 0.7; Sfrp1: 4.1 ± 2.2). In both cases Sfrp1, but not 
Sfrp2, decreases the amount of secreted APP without changing the levels of APP in the cell lysates.
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Sfrp phenotype by an ADAM10 inhibitor together with the notion 
that, in different contexts, Wnt and Notch activities are tightly linked 
prompted us to test whether Sfrps downregulate ADAM10 independ-
ently of Wnt signaling.
To this end we turned to the Drosophila wing imaginal disc, the 
development of which is regulated by both Wnt and Notch signaling. 
In contrast to the vertebrate retina, the interactions between these two 
pathways and their direct and specific downstream targets have been 
unequivocally identified in Drosophila32. Drosophila offers also a natu-
ral Sfrp-null background because no apparent Sfrp homolog has been 
identified in its genome8. Nevertheless, wingless efficiently binds to 
Sfrp1 (ref. 33) mimicking the vertebrate Wnt1 or Wnt8 interaction34.
Taking advantage of this interaction, we have shown that 
HhGal4>UAS–Sfrp1 ectopic expression of Sfrp1 in the posterior 
compartment of the Drosophila wing imaginal disc interferes with the 
symmetrical gradient of wingless at the dorsoventral boundary of the 
wing imaginal disc (Fig. 7). It thereby prevents, in the posterior but not 
in the anterior compartment that serves as control, the expression of 
Senseless (Sens), a canonical target normally activated by high wing-
less levels in two discrete and symmetrical stripes at the dorsoventral 
compartment boundary35 (P.E., A. Sandonis, C.I., A. Shimono, I.G. and 
P.B., unpublished observations) (Fig. 7a,b). We thus tested whether 
Sfrp1 could similarly interfere with the expression of genes that are 
directly activated by Notch signaling. Cut, one such target, is symmet-
rically expressed in the stripes of Sens at the dorsoventral compartment 
boundary32. In the HhGal4>UAS–Sfrp1 wing discs, Cut expression 
was totally abolished in the posterior but not the anterior compart-
ment (Fig. 7c), supporting the idea that Sfrp1 interferes with Notch 
signaling. Consistently, the wings of adult UAS-myc-Sfrp1>Hh–Gal4 
flies had notches in the posterior wing margin, a phenotype charac-
teristic of alterations in the wingless and Notch pathways (Fig. 7e,f). 
Most notably, forced expression of Kuzbanian (Kuz; the Drosophila 
ADAM10 homolog) together with Sfrp1 in the posterior compart-
ment completely rescued Cut expression, whereas it had no effect on 
expression of the wingless target Sens (Fig. 7d). Together these results 
strongly support the idea that Sfrp1 targets ADAM10 (Kuz) function, 
thereby interfering with Notch signaling independently of Wnt.
DISCUSSION
The onset and progression of neurogenesis in the vertebrate retina is 
regulated by interactions among the fibroblast growth factor, sonic 
hedgehog (Shh), Wnt and Notch signaling pathways. Comparison 
of the mechanisms that operate in different species offers two key 
observations. First, there are species-specific differences in the pre-
cise composition and onset of each pathway, which reflect individual 
retinal characteristics36. Second, individual elements of one pathway 
respond or are used in other signaling cascades or cellular activities. 
For example, in the eye, Hes1, an established Notch target, is also 
independently regulated by Shh and Wnt signaling37,38, and β-catenin, 
a key element of Wnt signaling, has a well characterized function in 
cell-cell adhesion5. We have shown that Sfrps, which modulate Wnt 
signaling, act as negative regulators of Notch. This Sfrp function pro-
vides an additional example of how individual molecules are shared 
by different signaling cascades. Mechanistically, Sfrps bind and, inde-
pendently of Wnt, downregulate the α-secretase activity of ADAM10, 
which is responsible for the proteolytic cleavage of the Notch recep-
tor and thus for subsequent pathway activation23. Furthermore, by 
targeting ADAM10, Sfrps regulate the proteolysis of other specific 
substrates, including N-cadherin, L1-CAM and APP.
These conclusions stem from the initial observation that in Sfrp1−/−; 
Sfrp2−/− embryos the periphery of the optic cup is not specified and 
the neural retina is abnormally thick. Specification of the optic cup 
periphery depends on Wnt signaling activation3,4. Sfrp1 and 2 are 
required to activate canonical signaling in the periphery of the 
optic cup, probably by promoting the diffusion of Wnt ligands (P.E., 
A. Sandonis, C.I., A. Shimono, I.G. and P.B., unpublished observa-
tions). However, this mechanism could not explain the transient 
increase in proliferation and enhanced generation of early born 
neurons in the Sfrp1−/−; Sfrp2−/− neural retina, because previous 
studies had shown that Wnt signaling is not important for retinal 
neurogenesis in mice5,6. We also considered it unlikely that the reti-
nal phenotype could be secondary to the vascular defects observed 
in Sfrp1- and 2-null mice, because neurogenesis proceeds normally 
in embryos in which the hyaloid artery does not form39. Instead, we 
showed that abnormal retinal neurogenesis could be explained by a 
transient increase in Notch signaling, probably caused by enhanced 
ADAM10 activity. In support of this interpretation, pharmacologi-
cal inhibition of ADAM10 rescued the enhanced cell proliferation of 
Sfrp1−/−; Sfrp2−/− neural retinas. Furthermore, conditional inactiva-
tion of Adam10 in neural progenitor cells causes depletion of early 
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Figure 7 Sfrp1 interacts with Kuz in Drosophila wing imaginal discs.  
(a,b) Sens (blue) and extracellular wingless (ecWg) expressions (red) in a 
UAS-myc-Sfrp1>Hh-Gal4 wing imaginal disc. The wingless (Wg) target Sens 
is repressed in the posterior compartment where Sfrp1 is expressed  
(Myc in green) but not in the anterior compartment that serves as a control. 
(c) Cut (green) and Hh (red) expressions in Hh-Gal4>UAS-myc-Sfrp1 
wing discs. Note the repression of the Notch target Cut (open arrowhead) 
in the area where Sfrp1 is expressed (Hh in red). (d) Sens (blue) and 
Cut (green) expression in a UAS-myc-Sfrp1/UAS-Kuz>Hh-Gal4 wing disc 
(Myc in red). The ectopic expression of both Sfrp1 and Kuz rescues the 
expression of the Notch target Cut (arrowhead) but has no effect on that 
of the Wg target Sens. (e) Adult UAS-myc-Sfrp1>Hh-Gal4 wing phenotype 
showing notches in the posterior wing margin, a phenotype characteristic 
of wingless and Notch signaling alterations. (f) Wild-type wing. Scale bar, 
40 µm (a–d); 200 µm (e,f).
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progenitors and a reduction in α-secretase–mediated processing of 
APP22, a phenotype opposite to that observed in Sfrp1−/−; Sfrp2−/− 
retinas or in the cortex of Sfrp1−/− embryos (I.C., P.B. and P.E., unpub-
lished observations), where Notch and APP processing are upregu-
lated. Similar defects also characterize the cortex of embryos that lack 
RECK (reversion-inducing cysteine-rich protein with Kazal motifs), 
a membrane protein that is localized to cortical precursor cells and is 
thought to inhibit ADAM10 sheddase activity but using Notch ligands 
as substrates40.
Our analysis of the Sfrp-null ocular phenotype together with over-
expression studies in the Drosophila wing disc support the idea that 
Sfrps independently modulate Wnt and Notch. Sfrp1 in the posterior 
compartment of the Drosophila wing imaginal disc interferes with the 
expression of Wnt and Notch target genes but coexpression of Sfrp1 
and ADAM10 (Kuz) completely rescue the expression of Notch targets 
but not of wingless targets. Therefore, when coactivated, these path-
ways may compete for Sfrp-mediated regulation, providing an addi-
tional frame in which to interpret the reported functional interaction 
between Wnt-canonical and Notch signaling in several contexts41.
The ADAM family of metalloproteases is large. Phylogenetic and 
functional analysis of the human members indicates that ADAM10 is 
closely related to ADAM17 but that they are separated by other family 
members. The distributions of Adam10 and Adam17 largely overlap 
and initial studies suggested that both metalloproteases participated 
in Notch and APP cleavage29,42. Therefore, we cannot exclude the 
possibility that abnormal activity of ADAM17 might contribute to 
the ocular phenotype of Sfrp1−/−; Sfrp2−/− mice. The existence of 
Sfrp-mediated regulation of ADAM17 might, for example, help to 
explain why specific pharmacological inhibition of ADAM10 only 
partially rescued the retinal phenotype of Sfrp1−/−; Sfrp2−/−embryos. 
However, we favor the hypothesis that, at least in the CNS, Sfrp1 and 
2 largely target ADAM10 function. Indeed, genetic inactivation in 
mice indicates that Adam10 has a preponderant function in the devel-
oping CNS and cardiovascular system, whereas Adam17 regulates 
epithelial maturation of multiple organs42. Furthermore, recent stud-
ies have shown that at least in the CNS Notch, APP and N-cadherin 
are ADAM10-specific substrates22,43. In line with these findings, we 
have shown that the proteolytic processing of these three substrates, 
as well as that of L1-CAM, was altered in Sfrp1−/−; Sfrp2−/− mice. 
Nevertheless, future studies in other tissues, where ADAM17 appears 
to be preponderant, should help to resolve the specificity of Sfrps on 
ADAM regulation.
Sfrp2 and Sizzled, a nonmammalian Sfrp family member, have been 
shown to regulate Tolloid metalloproteinases (also known as pro-
collagen C-proteinases), but with different functions. In vertebrates, 
BMP activity is in part controlled by the BMP antagonist Chordin 
which, in turn, is inactivated through cleavage by Tolloid. Sizzled, 
but apparently not Sfrp2 (ref. 13), binds to Tolloid and behaves as a 
TIMP to competitively inhibit its enzymatic activity, thereby prevent-
ing Chordin cleavage15,16. Sfrp2 instead interacts through its CRD 
with the nonprotease domain of Tolloid proteases and enhances or 
inhibits their procollagen-C proteinase activity13 depending on its 
concentration14. The way in which Sfrp1, and possibly Sfrp2, inhibits 
ADAM10 is unclear but might be similar to the above mechanisms.
Sfrps, TIMPs and PCOLCEs share similarities in the NTR domain; 
in TIMPs and POLCEs, this domain is thought to interfere with pro-
tease activity44. The structure of ADAM10 comprises, adjacent to 
the catalytic and disintegrin domains, a cysteine-rich motif that is 
thought to mediate interactions with other molecules42. In a plausible 
model (Supplementary Fig. 4), binding of the respective cysteine-
rich motifs may be responsible for Sfrp-ADAM interactions, which 
would bring the Sfrp NTR domain close to the ADAM10 catalytic 
site. Thus, Sfrp1 or 2 would interfere with the enzymatic activity of 
ADAM10 by competing for substrate binding. Given the molecular 
diversity of metalloprotease substrates, it is possible that the inhibi-
tory specificity may be in part linked to the nature of the substrates, 
as suggested by the specific effect of Sfrp1 but not Sfrp2 on APP 
processing. This possibility is supported by tissue distribution. In 
fact, APP and Sfrp1, but not Sfrp2, are particularly abundant in the 
telencephalon. By contrast, ADAM10-mediated processing of Notch 
in the retina seems to involve both Sfrp1 and Sfrp2.
Independently of the precise mechanism of action, the dual role 
of Sfrps in the regulation of Wnt signaling and ADAM10 activity 
might be relevant in different pathological situations, especially 
in neurodegenerative diseases or metastatic events, where both 
Wnt signaling components and metalloproteases have key roles41. 
For example, ADAM10 confers metastatic capacity on colorectal 
 cancer45. Loss of SFRP1 and SFRP2 expression due to promoter 
hypermethylation occurs frequently in proliferating and invasive 
tumors8. Conversely, ectopic Sfrp1 expression inhibits tumor growth 
and lung metastasis induced by inoculation of an invasive tumori-
genic cell line46, notably associated with changes in both Wnt– 
β-catenin and extracellular matrix components46. Thus, potentia-
tion of Sfrp1 activity might control both Wnt-mediated tumor pro-
liferation and ADAM-mediated invasion.
On the contrary, our results point to the inhibition of Sfrp1 as a 
potential mechanism for preventing the toxic accumulation of Aβ 
peptides, one of the landmarks of Alzheimer disease. Indeed, in 
the absence of Sfrp1 function, APP processing should shift toward 
the production of sAPPα, thus preventing the generation of Aβ, as 
recently shown for SIRT1, a deacetylase that directly activates the 
transcription of ADAM10 (ref. 47). Whether this would be beneficial 
in patients with Alzheimer’s disease is worth testing, although it is 
becoming apparent that the contribution of APP proteolytic deriva-
tives to the pathology of Alzheimer’s disease is more complex than 
was originally envisaged.
METhODS
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
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Animals. Sfrp1−/−; Sfrp2+/− mutant mice were generated as described9 and 
crossed to generate Sfrp1−/−; Sfrp2−/− double-mutant embryos. Sfrp1−/−; Sfrp2+/− 
mice were mated with a 129 and C57BL/6 mixed background to obtain Sfrp1+/−; 
Sfrp2+/− double-heterozygous strain and further used to generate single Sfrp1 and 
Sfrp2 mutants. The eyes of Sfrp1−/− and Sfrp2−/− single mutants were normal and 
undistinguishable from those of age-matched wild types and therefore littermates 
were often used as controls for the double mutant embryos.
Antibodies. We used the following primary antibodies: mouse monoclonal 
anti-BrdU (1:500, Boehringer Manheim), mouse monoclonal anti-Islet1 (1:500, 
Hybridoma Bank, 39.4D5); rabbit polyclonal anti-Otx2 (1:500, Abcam); rabbit 
polyclonal anti-Calbindin-28K (1:2,000, Swant); mouse monoclonal anti-active 
β-catenin (ABC) (1:200, Millipore), mouse monoclonal anti-Myc (1:2,000, clone 
9E10); rabbit polyclonal anti-Pax6 (1:500, Covance); mouse monoclonal anti-PKC 
(1:400, Sigma-Aldrich); mouse monoclonal anti-βIII-tubulin (1:4,000, Promega), 
rabbit polyclonal anti-cleaved Notch1 Val1744 (1:200, Cell Signaling), goat poly-
clonal Notch 1 (Santa Cruz) rabbit polyclonal anti-HA (1:2,000, Sigma-Aldrich), 
mouse monoclonal anti-HA (1:2,000, Sigma-Aldrich), rabbit polyclonal anti-Myc 
(Sigma-Aldrich), mouse monoclonal anti-amyloid precursor protein A4 (1:5,000, 
Millipore, clone 22C11), rabbit polyclonal anti-soluble APPα (1:500, Covance) 
rabbit polyclonal anti-Sfrp1 (1:500, AbCam), rabbit polyclonal anti-NG2 (1:500, 
Chemicon), mouse monoclonal N-cadherin C-terminal domain (1:500, Zymed 
Laboratories, clone 3B9), rabbit polyclonal 74 5H7 to the cytoplasmic part of 
L1 (a gift from V.P. Lemmon), goat polyclonal anti-Adam10 (1:500, RD) guinea-
pig anti-Sens35 (1:1,000, a gift from H. Bellen), rabbit anti-Hh (1:800, a gift 
from T. Tabata); mouse anti-wingless (1:50) and anti-Cut (prepared from cells 
obtained from the DSHB) and Lectin from Tomato biotin-conjugated (1:150, 
Sigma-Aldrich). Secondary antibodies: rabbit Alexa 488, rabbit Alexa 594, mouse 
Alexa 488 (1:2,000, Molecular Probes).
In situ hybridization (ISH), immunohistochemistry (IHc) and histological 
analysis. E9–13.5 embryos were immersion-fixed in 4% paraformaldehyde (PFA)-
phosphate buffer (wt/vol) for 3 h. Older embryos were transcardially perfused with 
the same fixative and post-fixed for 2 h. Tissue was then washed in phosphate buffer 
saline (PBS), incubated in a 30% sucrose-PBS solution (wt/vol) and embedded and 
frozen in a 7.5% gelatin in 15% sucrose solution (wt/vol). Cryostat sections were 
processed for ISH and IHC. ISH was performed with standard protocols. The follow-
ing digoxigenin-labeled antisense riboprobes were used: Dll-1, Hes5, Sfrp1 and 
Sfrp2. For BrdU analysis, pregnant mice were injected intraperitoneally with BrdU 
(50 µg g−1), put to death 1 h later and processed for BrdU ICH. ICH analysis was 
performed as described but sections processed for Otx2, Pax6, Islet-1, phospho-
Smad-1,5,8 and NICD were boiled at 115 °C for 2 min in 10 mM citrate buffer using 
a decloaking chamber (Biocare Medical) for antigen retrieval. NICD IHC was per-
formed as described19 and amplified with TSA (PerkinElmer). Immunostaining of the 
Drosophila imaginal discs was performed according to standard protocols and that of 
extracellular wingless as described48. Fluorescence-stained imaginal discs were exam-
ined using a confocal laser-scanning microscope (LSM510 Vertical, Zeiss). We ana-
lyzed a minimum of five double mutant embryos for each experimental condition.
organotypic optic cup cultures. Optic cups from E11.5 mice were dissected, 
embedded in collagen matrices and cultured for 24 h in DMEM-F12 medium 
supplemented with N2 (Gibco) and different doses of the ADAM10 inhibitor 
G1254023X resuspended in DMSO (a gift from A. Ludwig) or DMSO alone. 
Cultures were incubated with BrdU (10 µM) for ten minutes before fixation 
in 4% PFA for 2 h. Cultured optic cups were then processed for immunohisto-
chemistry as described above. We analyzed a minimum of five optic cups for 
each experimental condition.
overexpression of Sfrp1 and kuzbanian in Drosophila. Sfrp1 cDNA was fused 
in frame to a C-terminal Myc tag and cloned into a pUAST vector to generate 
transgenic fly lines expressing SFRP1 under the UAS promoter. The UAS-Kuz 
was a gift from S. Campuzano. UAS-Sfrp1 and UAS-Kuz were expressed using 
the Hh-Gal4 driver49.
Immunoprecipitations and western blot analysis. E13 telencephalic and E15 
ocular tissue from wild-type or Sfrp1- and 2-null embryos was isolated and 
homogenized in lysis buffer (150 mM NaCl, 2% TritonX-100 (wt/vol), 50 mM 
Tris, pH 8) containing proteinase and metalloprotease inhibitors (phenanthro-
line, Sigma). The lysates were centrifuged for 20 min at 4 °C, the supernatants 
were precleared in protein G–agarose beads (Sigma-Aldrich), pre-blocked 
with 1% BSA (wt/vol) for 1 h at 4 °C and centrifuged at 2,000 r.p.m. The super-
natants were incubated with anti-Sfrp1 (1 µg) overnight at 4 °C in a rotor shaker. 
Protein G–agarose beads were added for 1 h, collected by centrifugation at 400g. 
and washed five times with lysis buffer before adding sample buffer without 
2-mercaptoethanol. Beads were boiled for 5 min, collected by centrifugation and 
the supernatants resolved in 10% SDS-PAGE. Subconfluent HEK 293T cells were 
transiently cotransfected with constructs encoding mouse Sfrp1-HA and mouse 
ADAM10-myc using the FuGENE HD Transfection Reagent (Roche). After 48 h, 
cells were scraped in lysis buffer and immunoprecipitations were performed as 
described50. To detect sAPP, we plated CHO cells in 10-mm dishes in DMEM-
F12 10% FCS (wt/vol). After 24 h, cells were incubated with serum-free DMEM 
in the presence of purified Sfrp1 or Sfrp2. Thereafter cell-conditioned medium 
was collected and concentrated on concanavalin-A beads (GE Healthcare). After 
electrophoresis, proteins were transferred to PDVF membranes (Hybond-P, 
Amersham), checked by Ponceau red staining and probed with antibodies against 
APP (mouse monoclonal anti-Alzheimer precursor protein A4). Western blot 
analysis was performed with tissues or cell lines lysed as above. Primary antibodies 
were detected with peroxidase-conjugated secondary antibodies followed by ECL 
Advanced Western Blotting Detection Kit (Amersham). Immunoprecipitations 
and western blots were repeated at least three times and gave similar results.
RnA extraction and Q-PcR. mRNA from stage E12.5 and E13.5 embryo-
nic retinas was extracted using the QuickPrep Micro mRNA Purification Kit 
(GE Healthcare) and treated with DNase I. cDNAs were obtained by random 
priming reverse transcription using the First-Strand cDNA Synthesis Kit 
(GE Healthcare). RT-PCR reactions were run in triplicate in 96-well plates with 
the SYBR Green PCR Master Mix (Applied Biosystems), using an ABI PRISM 
7700 Sequence Detection System (Applied Biosystems). Q-RT-PCR reactions were 
performed with 3 µl of cDNA, which was used for β-actin mRNA amplification 
for normalization and Hes5 mRNA. Primers were the following: Hes5 forward: 
5′-TTCAGCAAGTGACTTCTGCGA-3′; Hes5 reverse: 5′-TCATAGAACCC 
CCGGTGGT-3′; β-actin forward: 5′-AGGTGTGATGGTGGGAATGG-3′; 
Dll forward: 5′-TTGGGCTTCTTTAAC; Dll-1 reverse: 5′-TCCACACACTCG 
TTAG-3′; β-actin reverse: 5′-GCCTCGTCACCCACATAGGA-3′. Data acquisi-
tion and analysis of the real-time RT-PCR assays were performed using the 7500 
System SDS Software (v2.0.1, Applied Biosystems). The SYBR Green–double-
stranded DNA complex signal was normalized to the passive reference dye (ROX) 
to correct for non-PCR-related well-to-well fluorescent fluctuations. Experiments 
were independently replicated at least three times.
Binding of Sfrp1 to Adam-myc overexpressing cHo line. The PCDNA3.1–AP-
3myc-Sfrp1 construct was engineered using the PCDNA3.1–AP-3myc plasmid 
provided by J. Nathans. HEK293 cells were transiently transfected with PCDNA–
AP-3myc-Sfrp1 or PCDNA-AP (alkaline phosphatase) plasmids and conditioned 
media were recovered after 48 h. Control or stably transfected Adam10 CHO 
cells were grown in polylysine-coated coverslips. Cells were incubated with con-
ditioned medium containing the AP or AP-3myc-Sfrp1 fusion protein for 90 min 
and the detection of bound AP was performed using standard protocols.
Statistical analysis. Normality of the distribution was tested by Kolmogorov-
Smirnov test. Statistical significance was determined by t-test. One-way ANOVA 
was used to compare statistical significance among more than two groups. Post 
hoc analysis was performed for assessing specific group comparisons (Tukey), 
when the F value was significant. Values are expressed as means ± s.e.m. 
Calculations were made using the SPSS statistical package version 17.0 using a 
significance level of 0.05.
48. Torroja, C., Gorfinkiel, N. & Guerrero, I. Patched controls the Hedgehog gradient 
by endocytosis in a dynamin-dependent manner, but this internalization does not 
play a major role in signal transduction. Development 131, 2395–2408 (2004).
49. Tanimoto, H., Itoh, S., ten Dijke, P. & Tabata, T. Hedgehog creates a gradient of 
DPP activity in Drosophila wing imaginal discs. Mol. Cell 5, 59–71 (2000).
50. Rodriguez, J. et al. SFRP1 regulates the growth of retinal ganglion cell axons through 
the Fz2 receptor. Nat. Neurosci. 8, 1301–1309 (2005).
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